<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Psoriasis - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Psoriasis" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Psoriasis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Psoriasis&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Psoriasis" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Psoriasis","wgTitle":"Psoriasis","wgCurRevisionId":601607406,"wgRevisionId":601607406,"wgArticleId":101965,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages containing cite templates with deprecated parameters","CS1 errors: dates","Good articles","Articles using fixed number of columns in reflist","Commons category template with no category set","Commons category with page title same as on Wikidata","Articles with Open Directory Project links","Psoriasis"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Psoriasis","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q179945"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Psoriasis skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Psoriasis</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div style="display:none; right:10px;" class="metadata topicon nopopups" id="good-star"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/15px-Symbol_support_vote.svg.png" width="15" height="15" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/23px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/30px-Symbol_support_vote.svg.png 2x" /></a></div>
<table class="infobox" cellspacing="3" style="border-spacing:3px;width:22em;">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey;">Psoriasis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><i>Classification and external resources</i></td>
</tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/File:Psoriasis_on_back1.jpg" class="image"><img alt="Psoriasis on back1.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Psoriasis_on_back1.jpg/230px-Psoriasis_on_back1.jpg" width="230" height="225" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f5/Psoriasis_on_back1.jpg/345px-Psoriasis_on_back1.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/f/f5/Psoriasis_on_back1.jpg 2x" /></a><br />
<div>Back and arms of a person with psoriasis</div>
</td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_L" title="ICD-10 Chapter L" class="mw-redirect">L</a><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2010/en#/L40">40</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=696">696</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/177900">177900</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb10895.htm">10895</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000434.htm">000434</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/emerg/topic489.htm">emerg/489</a> Dermatology:<a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic365.htm#">derm/365</a> plaque<br />
<a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic361.htm#">derm/361</a> guttate<br />
<a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic363.htm#">derm/363</a> nails<br />
<a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic366.htm#">derm/366</a> pustular<br />
Arthritis <a rel="nofollow" class="external text" href="http://www.emedicine.com/derm/topic918.htm#">derm/918</a><br />
Radiology <a rel="nofollow" class="external text" href="http://www.emedicine.com/radio/topic578.htm#">radio/578</a><br />
Physical Medicine <a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic120.htm#">pmr/120</a></td>
</tr>
<tr>
<th scope="row" style="text-align:left;"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&amp;term=D011565">D011565</a></td>
</tr>
</table>
<p><b>Psoriasis</b> (pronounced <span class="nowrap"><span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/</a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'s' in 'sigh'" style="border-bottom:1px dotted">s</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ɵ/ variable 1st 'o' in 'omission'" style="border-bottom:1px dotted">ɵ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ˈ/ primary stress follows" style="border-bottom:1px dotted">ˈ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'r' in 'rye'" style="border-bottom:1px dotted">r</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/aɪ/ long 'i' in 'bide'" style="border-bottom:1px dotted">aɪ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/./ syllable break" style="border-bottom:1px dotted">.</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ə/ 'a' in 'about'" style="border-bottom:1px dotted">ə</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'s' in 'sigh'" style="border-bottom:1px dotted">s</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ɨ/ 'e' in 'roses'" style="border-bottom:1px dotted">ɨ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'s' in 'sigh'" style="border-bottom:1px dotted">s</span></a></span><span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/</a></span></span>; from <a href="/wiki/Greek_language" title="Greek language">Greek</a> ψωρίασις, meaning "itching condition" or "being itchy",<sup id="cite_ref-Ritchlin2007_1-0" class="reference"><a href="#cite_note-Ritchlin2007-1"><span>[</span>1<span>]</span></a></sup> from <i>psora</i> "itch" and <i>-sis</i> "action, condition"; also termed <b>psoriasis vulgaris</b>),<sup id="cite_ref-Menter2008_2-0" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> is a common, chronic relapsing/remitting <a href="/wiki/Immune-mediated_disease" title="Immune-mediated disease" class="mw-redirect">immune-mediated</a> <a href="/wiki/Skin_disease" title="Skin disease" class="mw-redirect">skin disease</a> characterized by <a href="/wiki/Erythema" title="Erythema">red</a>, scaly patches, <a href="/wiki/Papule" title="Papule">papules</a>, and <a href="/wiki/Plaque_(dermatology)" title="Plaque (dermatology)" class="mw-redirect">plaques</a>, which usually <a href="/wiki/Pruritus" title="Pruritus" class="mw-redirect">itch</a>.<sup id="cite_ref-Menter2008_2-1" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> The skin lesions seen in psoriasis may vary in severity from minor localized patches to complete body coverage.<sup id="cite_ref-Menter2008_2-2" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> The disease affects 2–4% of the general population.<sup id="cite_ref-Parisi2013_3-0" class="reference"><a href="#cite_note-Parisi2013-3"><span>[</span>3<span>]</span></a></sup></p>
<p>There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> Plaque psoriasis is the most common form and typically manifests as red and white scaly patches on the <a href="/wiki/Epidermis" title="Epidermis">top layer of the skin</a>. Skin cells rapidly accumulate at these plaque sites and create a silvery-white appearance. Plaques frequently occur on the skin of the <a href="/wiki/Elbow-joint" title="Elbow-joint" class="mw-redirect">elbows</a> and <a href="/wiki/Knee" title="Knee">knees</a>, but can affect any area, including the <a href="/wiki/Scalp" title="Scalp">scalp</a>, <a href="/wiki/Palm_(hand)" title="Palm (hand)" class="mw-redirect">palms of hands</a> and <a href="/wiki/Sole_(foot)" title="Sole (foot)">soles of feet</a>, and <a href="/wiki/Sex_organ" title="Sex organ">genitals</a>. In contrast to <a href="/wiki/Eczema" title="Eczema" class="mw-redirect">eczema</a>, psoriasis is more likely to be found on the <a href="/wiki/Extensor" title="Extensor" class="mw-redirect">outer side</a> of the joint. <a href="/wiki/Nail_(anatomy)" title="Nail (anatomy)">Fingernails</a> and toenails are frequently affected (psoriatic nail dystrophy) and can be seen as an isolated sign. <a href="/wiki/Inflammation" title="Inflammation">Inflammation</a> of the joints in the context of psoriatic disease, known as <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a>, affects up to 30% of individuals with psoriasis.<sup id="cite_ref-Jain2012_5-0" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup></p>
<p>The causes of psoriasis are not fully understood. Psoriasis is not purely a skin disorder and can have a negative impact on many organ systems. Psoriasis has been associated with an increased risk of certain <a href="/wiki/Cancer" title="Cancer">cancers</a>, <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> and other immune-mediated disorders such as <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> and <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a>. It is generally considered a <a href="/wiki/Genetic_disease" title="Genetic disease" class="mw-redirect">genetic disease</a> thought to be triggered or influenced by environmental factors.<sup id="cite_ref-Menter2008_2-3" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> Psoriasis develops when the immune system mistakes a normal <a href="/wiki/Keratinocyte" title="Keratinocyte">skin cell</a> for a <a href="/wiki/Pathogen" title="Pathogen">pathogen</a>, and sends out faulty <a href="/wiki/Cytokine" title="Cytokine">signals</a> that cause overproduction of new skin cells. It is not contagious.<sup id="cite_ref-Weller2008_6-0" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup> <a href="/wiki/Oxidative_stress" title="Oxidative stress">Oxidative stress</a>,<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Stress_(medicine)" title="Stress (medicine)" class="mw-redirect">stress</a>, and withdrawal of a systemic <a href="/wiki/Corticosteroid" title="Corticosteroid">corticosteroid</a> have each been suggested as a trigger for psoriasis.<sup id="cite_ref-Chong2013_8-0" class="reference"><a href="#cite_note-Chong2013-8"><span>[</span>8<span>]</span></a></sup> Injury to the skin can trigger local psoriatic skin changes known as the <a href="/wiki/Koebner_phenomenon" title="Koebner phenomenon">Koebner phenomenon</a>.<sup id="cite_ref-Ely2010_9-0" class="reference"><a href="#cite_note-Ely2010-9"><span>[</span>9<span>]</span></a></sup></p>
<p>No cure is available for psoriasis,<sup id="cite_ref-Weller2008_6-1" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup> but various treatments can help to control the symptoms.<sup id="cite_ref-Johnson_166.E2.80.9372_10-0" class="reference"><a href="#cite_note-Johnson_166.E2.80.9372-10"><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-Jobling_R_2007_953.E2.80.934_11-0" class="reference"><a href="#cite_note-Jobling_R_2007_953.E2.80.934-11"><span>[</span>11<span>]</span></a></sup> Though many treatments are available, psoriasis can be difficult to treat due to its chronic recurrent nature. A new generation of targeted immune therapies is being subjected to rigorous investigation in order to advance treatment options for psoriasis.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Plaque"><span class="tocnumber">1.1</span> <span class="toctext">Plaque</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Pustular"><span class="tocnumber">1.2</span> <span class="toctext">Pustular</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Other_skin_lesions"><span class="tocnumber">1.3</span> <span class="toctext">Other skin lesions</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Psoriatic_arthritis"><span class="tocnumber">1.4</span> <span class="toctext">Psoriatic arthritis</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Nail_changes"><span class="tocnumber">1.5</span> <span class="toctext">Nail changes</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Medical_signs"><span class="tocnumber">1.6</span> <span class="toctext">Medical signs</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Genetics"><span class="tocnumber">2.1</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Lifestyle"><span class="tocnumber">2.2</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#HIV"><span class="tocnumber">2.3</span> <span class="toctext">HIV</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Medications"><span class="tocnumber">2.4</span> <span class="toctext">Medications</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Mechanism"><span class="tocnumber">3</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Classification"><span class="tocnumber">5</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-16"><a href="#Morphological"><span class="tocnumber">5.1</span> <span class="toctext">Morphological</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Pathogenetic"><span class="tocnumber">5.2</span> <span class="toctext">Pathogenetic</span></a></li>
<li class="toclevel-2 tocsection-18"><a href="#Severity"><span class="tocnumber">5.3</span> <span class="toctext">Severity</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-20"><a href="#Topical_agents"><span class="tocnumber">6.1</span> <span class="toctext">Topical agents</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Phototherapy"><span class="tocnumber">6.2</span> <span class="toctext">Phototherapy</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Systemic_agents"><span class="tocnumber">6.3</span> <span class="toctext">Systemic agents</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Alternative_therapy"><span class="tocnumber">6.4</span> <span class="toctext">Alternative therapy</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-24"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-25"><a href="#Cardiovascular_disease"><span class="tocnumber">7.1</span> <span class="toctext">Cardiovascular disease</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Other_diseases"><span class="tocnumber">7.2</span> <span class="toctext">Other diseases</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-27"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-28"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-29"><a href="#Society_and_culture"><span class="tocnumber">10</span> <span class="toctext">Society and culture</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#Research"><span class="tocnumber">11</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#Further_reading"><span class="tocnumber">13</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1 tocsection-33"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Plaque">Plaque</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=2" title="Edit section: Plaque">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Psoriasis2010.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Psoriasis2010.JPG/220px-Psoriasis2010.JPG" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Psoriasis2010.JPG/330px-Psoriasis2010.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Psoriasis2010.JPG/440px-Psoriasis2010.JPG 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Psoriasis2010.JPG" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Psoriatic plaque, showing a silvery center surrounded by a reddened border.</div>
</div>
</div>
<p>Psoriasis vulgaris (also known as chronic stationary psoriasis or plaque-like psoriasis) is the most common form and affects 85%–90% of people with psoriasis.<sup id="cite_ref-Palfreeman2013_12-0" class="reference"><a href="#cite_note-Palfreeman2013-12"><span>[</span>12<span>]</span></a></sup> Plaque psoriasis typically appears as raised areas of inflamed skin covered with silvery white scaly skin. These areas are called plaques and are most commonly found on the elbows, knees, scalp, and back.<sup id="cite_ref-Palfreeman2013_12-1" class="reference"><a href="#cite_note-Palfreeman2013-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-DAVIDSONS2010_13-0" class="reference"><a href="#cite_note-DAVIDSONS2010-13"><span>[</span>13<span>]</span></a></sup> <a href="/wiki/Psoriatic_erythroderma" title="Psoriatic erythroderma">Psoriatic erythroderma</a> (erythrodermic psoriasis) involves widespread inflammation and exfoliation of the skin over most of the body surface. It may be accompanied by severe itching, swelling and pain. It is often the result of an exacerbation of unstable plaque psoriasis, particularly following the abrupt withdrawal of systemic glucocorticoids.<sup id="cite_ref-Zattra2012_14-0" class="reference"><a href="#cite_note-Zattra2012-14"><span>[</span>14<span>]</span></a></sup> This form of psoriasis can be fatal as the extreme inflammation and exfoliation disrupt the body's ability to <a href="/wiki/Thermoregulation" title="Thermoregulation">regulate temperature</a> and perform barrier functions.<sup id="cite_ref-DermNZ_15-0" class="reference"><a href="#cite_note-DermNZ-15"><span>[</span>15<span>]</span></a></sup></p>
<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:33px auto;"><a href="/wiki/File:Psoriasis2010a.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ac/Psoriasis2010a.JPG/120px-Psoriasis2010a.JPG" width="120" height="84" /></a></div>
</div>
<div class="gallerytext">
<p>Plaques of psoriasis</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:15px auto;"><a href="/wiki/File:Psoriasis.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Psoriasis.jpg/58px-Psoriasis.jpg" width="58" height="120" /></a></div>
</div>
<div class="gallerytext">
<p>A person's arm covered with plaque psoriasis</p>
</div>
</div>
</li>
<li class="gallerybox" style="width: 155px">
<div style="width: 155px">
<div class="thumb" style="width: 150px;">
<div style="margin:18px auto;"><a href="/wiki/File:Psoriasis_of_the_palms.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Psoriasis_of_the_palms.jpg/120px-Psoriasis_of_the_palms.jpg" width="120" height="114" /></a></div>
</div>
<div class="gallerytext">
<p>Psoriasis of the palms</p>
</div>
</div>
</li>
</ul>
<h3><span class="mw-headline" id="Pustular">Pustular</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=3" title="Edit section: Pustular">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">Generalized pustular psoriasis</a></div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Psoriasis_manum.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Psoriasis_manum.jpg/220px-Psoriasis_manum.jpg" width="220" height="169" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/70/Psoriasis_manum.jpg/330px-Psoriasis_manum.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/70/Psoriasis_manum.jpg/440px-Psoriasis_manum.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Psoriasis_manum.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Severe <a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">pustular psoriasis</a>.</div>
</div>
</div>
<p>Pustular psoriasis appears as raised bumps filled with noninfectious pus (<a href="/wiki/Pustules" title="Pustules" class="mw-redirect">pustules</a>).<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> The skin under and surrounding the pustules is red and tender.<sup id="cite_ref-Raychaudhuri2014_17-0" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> Pustular psoriasis can be localized, commonly to the hands and feet (palmoplantar pustulosis), or generalized with widespread patches occurring randomly on any part of the body. <a href="/wiki/Acrodermatitis_continua" title="Acrodermatitis continua" class="mw-redirect">Acrodermatitis continua</a> is a form of localized psoriasis limited to the fingers and toes that may spread to the hands and feet.<sup id="cite_ref-Raychaudhuri2014_17-1" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Pustulosis_palmaris_et_plantaris" title="Pustulosis palmaris et plantaris">Pustulosis palmaris et plantaris</a> is another form of localized pustular psoriasis similar to acrodermatitis continua with pustules erupting from red, tender, scaly skin found on the palms of the hands and the soles of the feet.<sup id="cite_ref-Raychaudhuri2014_17-2" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup></p>
<p><a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">Generalized pustular psoriasis</a> (pustular psoriasis of von Zumbusch), also known as <a href="/wiki/Impetigo_herpetiformis" title="Impetigo herpetiformis">impetigo herpetiformis</a> during pregnancy,<sup id="cite_ref-Naik2013_18-0" class="reference"><a href="#cite_note-Naik2013-18"><span>[</span>18<span>]</span></a></sup> is a rare and severe form of psoriasis that may require hospitalization. The development of generalized pustular psoriasis is often caused by an infection, abrupt withdrawal of topical corticosteroid treatment, pregnancy, <a href="/wiki/Hypocalcemia" title="Hypocalcemia" class="mw-redirect">hypocalcemia</a>, medications, or following an irritating topical treatment for plaque psoriasis.<sup id="cite_ref-Raychaudhuri2014_17-3" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> This form of psoriasis is characterized by an acute onset of numerous pustules on top of tender red skin. This skin eruption is often accompanied by a <a href="/wiki/Fever" title="Fever">fever</a>, <a href="/wiki/Myalgia" title="Myalgia">muscle aches</a>, <a href="/wiki/Nausea" title="Nausea">nausea</a>, and an <a href="/wiki/Leukocytosis" title="Leukocytosis">elevated white blood cell count</a>.<sup id="cite_ref-Raychaudhuri2014_17-4" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Annular_pustular_psoriasis" title="Annular pustular psoriasis">Annular pustular psoriasis</a> (APP) is a rare form of generalized pustular psoriasis and is the most common type of pustular psoriasis seen during childhood.<sup id="cite_ref-Naik2013_18-1" class="reference"><a href="#cite_note-Naik2013-18"><span>[</span>18<span>]</span></a></sup> APP tends to occur in women more frequently than in men and is usually less severe than other forms of generalized pustular psoriasis such as impetigo herpetiformis.<sup id="cite_ref-Naik2013_18-2" class="reference"><a href="#cite_note-Naik2013-18"><span>[</span>18<span>]</span></a></sup> This form of psoriasis is characterized by ring-shaped plaques with pustules around the edges and yellow crusting.<sup id="cite_ref-Naik2013_18-3" class="reference"><a href="#cite_note-Naik2013-18"><span>[</span>18<span>]</span></a></sup> APP most often affects the torso, neck, arms, and legs.<sup id="cite_ref-Naik2013_18-4" class="reference"><a href="#cite_note-Naik2013-18"><span>[</span>18<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_skin_lesions">Other skin lesions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=4" title="Edit section: Other skin lesions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Psoriasis_guttata.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Psoriasis_guttata.jpg/220px-Psoriasis_guttata.jpg" width="220" height="300" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Psoriasis_guttata.jpg/330px-Psoriasis_guttata.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e9/Psoriasis_guttata.jpg/440px-Psoriasis_guttata.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Psoriasis_guttata.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Example of <a href="/wiki/Guttate_psoriasis" title="Guttate psoriasis">guttate psoriasis</a>.</div>
</div>
</div>
<p>Additional types of psoriasis affecting the skin include inverse psoriasis, guttate psoriasis, oral psoriasis, and seborrheic-like psoriasis.<sup id="cite_ref-Andrews_19-0" class="reference"><a href="#cite_note-Andrews-19"><span>[</span>19<span>]</span></a></sup></p>
<p><a href="/wiki/Inverse_psoriasis" title="Inverse psoriasis">Inverse psoriasis</a> (also known as flexural psoriasis) appears as smooth inflamed patches of skin. The patches frequently affect <a href="/wiki/Skin_fold" title="Skin fold">skin folds</a>, particularly around the <a href="/wiki/Genitals" title="Genitals" class="mw-redirect">genitals</a> (between the thigh and groin), the <a href="/wiki/Armpit" title="Armpit" class="mw-redirect">armpits</a>, in the skin folds of an overweight abdomen (known as <a href="/wiki/Panniculus" title="Panniculus">panniculus</a>), between the buttocks in the intergluteal cleft, and under the <a href="/wiki/Breasts" title="Breasts" class="mw-redirect">breasts</a> in the <a href="/wiki/Inframammary_fold" title="Inframammary fold">inframammary fold</a>. Heat, trauma, and infection are thought to play a role in the development of this atypical form of psoriasis.<sup id="cite_ref-Weigle2013_20-0" class="reference"><a href="#cite_note-Weigle2013-20"><span>[</span>20<span>]</span></a></sup> <a href="/wiki/Napkin_psoriasis" title="Napkin psoriasis">Napkin psoriasis</a> is a subtype of psoriasis common in infants characterized by red papules with silver scale in the diaper area that may extend to the torso or limbs.<sup id="cite_ref-Gudjonsson2012_21-0" class="reference"><a href="#cite_note-Gudjonsson2012-21"><span>[</span>21<span>]</span></a></sup> Napkin psoriasis is often misdiagnosed as <a href="/wiki/Irritant_diaper_dermatitis" title="Irritant diaper dermatitis">napkin dermatitis</a>.<sup id="cite_ref-Gelmetti2009_22-0" class="reference"><a href="#cite_note-Gelmetti2009-22"><span>[</span>22<span>]</span></a></sup></p>
<p><a href="/wiki/Guttate_psoriasis" title="Guttate psoriasis">Guttate psoriasis</a> is characterized by numerous small, scaly, red or pink, teardrop-shaped lesions (papules). These numerous spots of psoriasis appear over large areas of the body, primarily the trunk, but also the limbs and scalp. Guttate psoriasis is often preceded by a <a href="/wiki/Group_A_beta-hemolytic_streptococcus" title="Group A beta-hemolytic streptococcus" class="mw-redirect">streptococcal</a> infection, typically <a href="/wiki/Streptococcal_pharyngitis" title="Streptococcal pharyngitis">streptococcal pharyngitis</a>.<sup id="cite_ref-Weigle2013_20-1" class="reference"><a href="#cite_note-Weigle2013-20"><span>[</span>20<span>]</span></a></sup> The reverse is not true.</p>
<p>Oral psoriasis is very rare,<sup id="cite_ref-Yesudian2012_23-0" class="reference"><a href="#cite_note-Yesudian2012-23"><span>[</span>23<span>]</span></a></sup> in contrast to <a href="/wiki/Lichen_planus" title="Lichen planus">lichen planus</a>, another common papulosquamous disorder that commonly involves both the skin and mouth. When psoriasis involves the oral mucosa (the lining of the mouth), it may be asymptomatic,<sup id="cite_ref-Yesudian2012_23-1" class="reference"><a href="#cite_note-Yesudian2012-23"><span>[</span>23<span>]</span></a></sup> but it may appear as white or grey-yellow plaques.<sup id="cite_ref-Yesudian2012_23-2" class="reference"><a href="#cite_note-Yesudian2012-23"><span>[</span>23<span>]</span></a></sup> <a href="/wiki/Fissured_tongue" title="Fissured tongue">Fissured tongue</a> is the most common finding in those with oral psoriasis and has been reported to occur in 6.5-20% of people with psoriasis affecting the skin. The microscopic appearance of oral mucosa affected by <a href="/wiki/Geographic_tongue" title="Geographic tongue">geographic tongue</a> (migratory stomatitis) is very similar to the appearance of psoriasis.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup> However, modern studies have failed to demonstrate any link between the two conditions.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></p>
<p><a href="/wiki/Seborrheic-like_psoriasis" title="Seborrheic-like psoriasis">Seborrheic-like psoriasis</a> is a common form of psoriasis with clinical aspects of psoriasis and <a href="/wiki/Seborrheic_dermatitis" title="Seborrheic dermatitis" class="mw-redirect">seborrheic dermatitis</a> and may be difficult to distinguish from the latter. This form of psoriasis typically manifests as red plaques with greasy scales in areas of higher <a href="/wiki/Sebum" title="Sebum" class="mw-redirect">sebum</a> production such as the <a href="/wiki/Scalp" title="Scalp">scalp</a>, <a href="/wiki/Forehead" title="Forehead">forehead</a>, <a href="/wiki/Nasolabial_fold" title="Nasolabial fold">skin folds next to the nose</a>, skin surrounding the mouth, skin on the chest above the <a href="/wiki/Sternum" title="Sternum">sternum</a>, and in <a href="/wiki/Intertriginous" title="Intertriginous">skin folds</a>.<sup id="cite_ref-Gudjonsson2012_21-1" class="reference"><a href="#cite_note-Gudjonsson2012-21"><span>[</span>21<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Psoriatic_arthritis">Psoriatic arthritis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=5" title="Edit section: Psoriatic arthritis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a></div>
<p>Psoriatic arthritis involves joint and surrounding <a href="/wiki/Connective_tissue" title="Connective tissue">connective tissue</a> inflammation and can occur in any joint, but most commonly affects the joints of the fingers and toes. This can result in a sausage-shaped swelling of the fingers and toes known as <a href="/wiki/Dactylitis" title="Dactylitis">dactylitis</a>. Psoriatic arthritis can also affect the hips, knees, spine (<a href="/wiki/Spondylitis" title="Spondylitis">spondylitis</a>), and <a href="/wiki/Sacroiliac_joint" title="Sacroiliac joint">sacroiliac joint</a> (<a href="/wiki/Sacroiliitis" title="Sacroiliitis">sacroiliitis</a>).<sup id="cite_ref-Krawczyk2013_26-0" class="reference"><a href="#cite_note-Krawczyk2013-26"><span>[</span>26<span>]</span></a></sup> Approximately 30% of individuals with psoriasis will develop psoriatic arthritis.<sup id="cite_ref-Palfreeman2013_12-2" class="reference"><a href="#cite_note-Palfreeman2013-12"><span>[</span>12<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Nail_changes">Nail changes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=6" title="Edit section: Nail changes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Luszczyca_paznokcia.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Luszczyca_paznokcia.jpg/220px-Luszczyca_paznokcia.jpg" width="220" height="248" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Luszczyca_paznokcia.jpg/330px-Luszczyca_paznokcia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b3/Luszczyca_paznokcia.jpg/440px-Luszczyca_paznokcia.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Luszczyca_paznokcia.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Psoriasis of a fingernail, with visible pitting.</div>
</div>
</div>
<p><a href="/wiki/Psoriatic_nails" title="Psoriatic nails">Psoriasis can affect the nails</a> and produces a variety of changes in the appearance of finger and toe nails. Nail psoriasis occurs in 40-45% of people with psoriasis affecting the skin and has a lifetime incidence of 80-90% in those with psoriatic arthritis.<sup id="cite_ref-Tan2012_27-0" class="reference"><a href="#cite_note-Tan2012-27"><span>[</span>27<span>]</span></a></sup> These changes include pitting of the nails (pinhead sized depressions in the nail-seen in 70% with nail psoriasis), <a href="/wiki/Leukonychia" title="Leukonychia">whitening of the nail</a>, <a href="/wiki/Splinter_hemorrhage" title="Splinter hemorrhage">small areas of bleeding from capillaries under the nail</a>, yellow-reddish discoloration of the nails known as the oil drop or salmon spot, thickening of the skin under the nail (subungual hyperkeratosis), loosening and separation of the nail (<a href="/wiki/Onycholysis" title="Onycholysis">onycholysis</a>), and crumbling of the nail.<sup id="cite_ref-Tan2012_27-1" class="reference"><a href="#cite_note-Tan2012-27"><span>[</span>27<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medical_signs">Medical signs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=7" title="Edit section: Medical signs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In addition to the appearance and distribution of the rash, specific <a href="/wiki/Medical_sign" title="Medical sign">medical signs</a> may be used by medical practitioners to assist with diagnosis. These may include <a href="/wiki/Auspitz%27s_sign" title="Auspitz's sign">Auspitz's sign</a> (pinpoint bleeding when scale is removed), <a href="/wiki/Koebner_phenomenon" title="Koebner phenomenon">Koebner phenomenon</a> (psoriatic skin lesions induced by trauma to the skin)<sup id="cite_ref-Gudjonsson2012_21-2" class="reference"><a href="#cite_note-Gudjonsson2012-21"><span>[</span>21<span>]</span></a></sup> and <a href="/wiki/Pruritus" title="Pruritus" class="mw-redirect">itching</a> and pain localized to papules and plaques.<sup id="cite_ref-Weigle2013_20-2" class="reference"><a href="#cite_note-Weigle2013-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-Gudjonsson2012_21-3" class="reference"><a href="#cite_note-Gudjonsson2012-21"><span>[</span>21<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=8" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The cause of psoriasis is not fully understood, but a number of theories exist.</p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=9" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/List_of_human_leukocyte_antigen_alleles_associated_with_cutaneous_conditions" title="List of human leukocyte antigen alleles associated with cutaneous conditions">List of human leukocyte antigen alleles associated with cutaneous conditions</a></div>
<p>Around one-third of people with psoriasis report a <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">family history</a> of the disease, and researchers have identified genetic <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">loci</a> associated with the condition. <a href="/wiki/Twin" title="Twin">Identical twin</a> studies suggest a 70% chance of a twin developing psoriasis if the other twin has the disorder. The risk is around 20% for <a href="/wiki/Twin" title="Twin">non-identical twins</a>. These findings suggest both a genetic susceptibility and an environmental response in developing psoriasis.<sup id="cite_ref-Krueger_28-0" class="reference"><a href="#cite_note-Krueger-28"><span>[</span>28<span>]</span></a></sup></p>
<p>Psoriasis has a strong hereditary component, and many genes are associated with it, but it is unclear how those genes work together. Most of the identified genes relate to the immune system, particularly the <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> (MHC) and <a href="/wiki/T_cells" title="T cells" class="mw-redirect">T cells</a>. Genetic studies are valuable due to their ability to identify molecular mechanisms and pathways for further study and potential drug targets.<sup id="cite_ref-Nestle_29-0" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<p>Classic genomewide <a href="/wiki/Linkage_analysis" title="Linkage analysis" class="mw-redirect">linkage analysis</a> has identified nine locations (loci) on different chromosomes associated with psoriasis. They are called psoriasis susceptibility 1 through 9 (<i><a href="/wiki/PSORS1" title="PSORS1" class="mw-redirect">PSORS1</a></i> through <i>PSORS9</i>). Within those loci are genes on pathways that lead to inflammation. Certain variations (<a href="/wiki/Mutation" title="Mutation">mutations</a>) of those genes are commonly found in psoriasis.<sup id="cite_ref-Nestle_29-1" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> Genome-wide association scans have identified other genes that are altered to characteristic variants in psoriasis. Some of these genes express inflammatory signal proteins, which affect cells in the immune system that are also involved in psoriasis. Some of these genes are also involved in other autoimmune diseases.<sup id="cite_ref-Nestle_29-2" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<p>The major determinant is PSORS1, which probably accounts for 35%–50% of psoriasis heritability. It controls genes that affect the immune system or encode skin proteins that are overabundant with psoriasis. <i>PSORS1</i> is located on <a href="/wiki/Chromosome_6" title="Chromosome 6" class="mw-redirect">chromosome 6</a> in the <a href="/wiki/Major_histocompatibility_complex" title="Major histocompatibility complex">major histocompatibility complex</a> (MHC), which controls important immune functions. Three genes in the PSORS1 locus have a strong association with psoriasis vulgaris: HLA-C variant HLA-Cw6,<sup id="cite_ref-Prieto2013_30-0" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup> which encodes a MHC class I protein; <i><a href="/wiki/CCHCR1" title="CCHCR1">CCHCR1</a></i>, variant WWC, which encodes a coiled protein that is overexpressed in psoriatic epidermis; and <i>CDSM</i>, variant allele 5, which encodes <a href="/wiki/Corneodesmosin" title="Corneodesmosin">corneodesmosin</a>, which is expressed in the granular and <a href="/wiki/Cornified_layer" title="Cornified layer" class="mw-redirect">cornified layers</a> of the epidermis and upregulated in psoriasis.<sup id="cite_ref-Nestle_29-3" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<p>Two major immune system genes under investigation are interleukin-12 subunit beta (<i>IL12B</i>) on <a href="/wiki/Chromosome_5_(human)" title="Chromosome 5 (human)">chromosome 5q</a>, which expresses interleukin-12B; and <i><a href="/wiki/IL23R" title="IL23R" class="mw-redirect">IL23R</a></i> on chromosome 1p, which expresses the interleukin-23 receptor, and is involved in T cell differentiation. Interleukin-23 receptor and <i>IL12B</i> have both been strongly linked with psoriasis.<sup id="cite_ref-Prieto2013_30-1" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup> T cells are involved in the inflammatory process that leads to psoriasis.<sup id="cite_ref-Nestle_29-4" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> These genes are on the pathway that up-regulate tumor necrosis factor-α and <a href="/wiki/NF-%CE%BAB" title="NF-κB">nuclear factor κB</a>, two genes involved in inflammation.<sup id="cite_ref-Nestle_29-5" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> Recently, the first gene directly linked to psoriasis has been identified. Studies have suggested that a rare mutation in the gene encoding for the <i><a href="/wiki/CARD14" title="CARD14">CARD14</a></i> protein plus an environmental trigger was enough to cause plaque psoriasis (the most common form of psoriasis).<sup id="cite_ref-Jordan1_31-0" class="reference"><a href="#cite_note-Jordan1-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-Jordan2_32-0" class="reference"><a href="#cite_note-Jordan2-32"><span>[</span>32<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=10" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Conditions that have been reported as accompanying a worsening of the disease include chronic infections, stress, and changes in season and <a href="/wiki/Climate" title="Climate">climate</a>.<sup id="cite_ref-Prieto2013_30-2" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup> Others include hot water, scratching psoriasis skin lesions, skin dryness, excessive alcohol consumption, smoking, and obesity.<sup id="cite_ref-Prieto2013_30-3" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-Clarke2011_33-0" class="reference"><a href="#cite_note-Clarke2011-33"><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-Richard2013_34-0" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="HIV">HIV</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=11" title="Edit section: HIV">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>People with the advanced <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV</a> often exhibit psoriasis.<sup id="cite_ref-Fife2007_35-0" class="reference"><a href="#cite_note-Fife2007-35"><span>[</span>35<span>]</span></a></sup> The <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> of psoriasis in HIV-positive individuals is comparable to that of HIV-negative individuals, however, psoriasis tends to be more severe in people infected with <a href="/wiki/Human_immunodeficiency_virus" title="Human immunodeficiency virus" class="mw-redirect">HIV</a>.<sup id="cite_ref-Cedeno2011_36-0" class="reference"><a href="#cite_note-Cedeno2011-36"><span>[</span>36<span>]</span></a></sup> There is a much higher prevalence of psoriatic arthritis in HIV-positive individuals with psoriasis than in those without the infection.<sup id="cite_ref-Cedeno2011_36-1" class="reference"><a href="#cite_note-Cedeno2011-36"><span>[</span>36<span>]</span></a></sup> The immune response in those infected with HIV is typically characterized by <a href="/wiki/Cytokine" title="Cytokine">cellular signals</a> from <a href="/wiki/T_helper_cell" title="T helper cell">Th2 subset of CD4+ helper T cells</a>,<sup id="cite_ref-Fife2007_35-1" class="reference"><a href="#cite_note-Fife2007-35"><span>[</span>35<span>]</span></a></sup> whereas the immune response in psoriasis vulgaris is characterized by a pattern of cellular signals typical of <a href="/wiki/Th1_cell" title="Th1 cell" class="mw-redirect">Th1 subset of CD4+ helper T cells</a> and <a href="/wiki/T_helper_17_cell" title="T helper 17 cell">Th17 helper T cells</a>.<sup id="cite_ref-Wong2013_37-0" class="reference"><a href="#cite_note-Wong2013-37"><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-Martin2013_38-0" class="reference"><a href="#cite_note-Martin2013-38"><span>[</span>38<span>]</span></a></sup> It is hypothesized that the diminished CD4+-T cell presence causes an overactivation of CD8+-T cells, which are responsible for the exacerbation of psoriasis in HIV-positive people. Psoriasis in those with HIV/AIDS is often severe and may be untreatable with conventional therapy.<sup id="cite_ref-Rice_39-0" class="reference"><a href="#cite_note-Rice-39"><span>[</span>39<span>]</span></a></sup> People with HIV constitute 1% of all people with psoriasis.<sup id="cite_ref-Rice_39-1" class="reference"><a href="#cite_note-Rice-39"><span>[</span>39<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=12" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Drug-induced psoriasis may occur with <a href="/wiki/Beta_blocker" title="Beta blocker">beta blockers</a>,<sup id="cite_ref-Jain2012_5-1" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Lithium" title="Lithium">lithium</a>,<sup id="cite_ref-Jain2012_5-2" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Antimalarial_medication" title="Antimalarial medication">antimalarial medications</a>,<sup id="cite_ref-Jain2012_5-3" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Non-steroidal_anti-inflammatory_drug" title="Non-steroidal anti-inflammatory drug">non-steroidal anti-inflammatory drugs</a>,<sup id="cite_ref-Jain2012_5-4" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Terbinafine" title="Terbinafine">terbinafine</a>, <a href="/wiki/Calcium_channel_blockers" title="Calcium channel blockers" class="mw-redirect">calcium channel blockers</a>, <a href="/wiki/Captopril" title="Captopril">captopril</a>, <a href="/wiki/Glyburide" title="Glyburide" class="mw-redirect">glyburide</a>, <a href="/wiki/Granulocyte_colony-stimulating_factor" title="Granulocyte colony-stimulating factor">granulocyte colony-stimulating factor</a>,<sup id="cite_ref-Jain2012_5-5" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Interleukin" title="Interleukin">interleukins</a>, <a href="/wiki/Interferon" title="Interferon">interferons</a>,<sup id="cite_ref-Jain2012_5-6" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Hypolipidemic_agent" title="Hypolipidemic agent">lipid-lowering drugs</a>,<sup id="cite_ref-Andrews_19-1" class="reference"><a href="#cite_note-Andrews-19"><span>[</span>19<span>]</span></a></sup><sup class="reference" style="white-space:nowrap;">:197</sup> and paradoxically <a href="/wiki/TNF_inhibitor" title="TNF inhibitor">TNF inhibitors</a> such as <a href="/wiki/Infliximab" title="Infliximab">infliximab</a> or <a href="/wiki/Adalimumab" title="Adalimumab">adalimumab</a>.<sup id="cite_ref-Guerra2013_40-0" class="reference"><a href="#cite_note-Guerra2013-40"><span>[</span>40<span>]</span></a></sup> Withdrawal of corticosteroids (topical steroid cream) can aggravate psoriasis due to the '<a href="/wiki/Rebound_effect" title="Rebound effect">rebound effect</a>' of corticosteroids.<sup id="cite_ref-Weller2008_6-2" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism">Mechanism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=13" title="Edit section: Mechanism">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Psoriasis is characterized by an abnormally excessive and rapid growth of the <a href="/wiki/Epidermis_(skin)" title="Epidermis (skin)">epidermal layer of the skin</a>.<sup id="cite_ref-Ouyang2010_41-0" class="reference"><a href="#cite_note-Ouyang2010-41"><span>[</span>41<span>]</span></a></sup> Abnormal production of skin cells (especially during <a href="/wiki/Wound_repair" title="Wound repair" class="mw-redirect">wound repair</a>) and an overabundance of skin cells result from the sequence of pathological events in psoriasis.<sup id="cite_ref-Raychaudhuri2014_17-5" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> Skin cells are replaced every 3-5 days in psoriasis rather than the usual 28-30 days.<sup id="cite_ref-Parrish2012_42-0" class="reference"><a href="#cite_note-Parrish2012-42"><span>[</span>42<span>]</span></a></sup> These changes are believed to stem from the premature maturation of <a href="/wiki/Keratinocytes" title="Keratinocytes" class="mw-redirect">keratinocytes</a> induced by an inflammatory cascade in the <a href="/wiki/Dermis" title="Dermis">dermis</a> involving <a href="/wiki/Dendritic_cell" title="Dendritic cell">dendritic cells</a>, <a href="/wiki/Macrophages" title="Macrophages" class="mw-redirect">macrophages</a>, and <a href="/wiki/T_cell" title="T cell">T cells</a> (three subtypes of <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a>).<sup id="cite_ref-Palfreeman2013_12-3" class="reference"><a href="#cite_note-Palfreeman2013-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-Cedeno2011_36-2" class="reference"><a href="#cite_note-Cedeno2011-36"><span>[</span>36<span>]</span></a></sup> These immune cells move from the <a href="/wiki/Dermis" title="Dermis">dermis</a> to the <a href="/wiki/Epidermis_(skin)" title="Epidermis (skin)">epidermis</a> and secrete inflammatory chemical signals (cytokines) such as <a href="/wiki/Tumor_necrosis_factor-%CE%B1" title="Tumor necrosis factor-α" class="mw-redirect">tumor necrosis factor-α</a>, <a href="/wiki/Interleukin_1_family" title="Interleukin 1 family">interleukin-1β</a>, and <a href="/wiki/Interleukin-6" title="Interleukin-6" class="mw-redirect">interleukin-6</a>, and <a href="/wiki/Interleukin-22" title="Interleukin-22" class="mw-redirect">interleukin-22</a>.<sup id="cite_ref-Nestle_29-6" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> These secreted inflammatory signals are believed to stimulate skin cells (keratinocytes) to proliferate.<sup id="cite_ref-Nestle_29-7" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> One hypothesis is that psoriasis involves a defect in regulatory T cells, and in the regulatory cytokine <a href="/wiki/Interleukin-10" title="Interleukin-10" class="mw-redirect">interleukin-10</a>.<sup id="cite_ref-Nestle_29-8" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<p>Gene mutations of proteins involved in the skin's ability to function as a barrier have been identified as markers of susceptibility for the development of psoriasis.<sup id="cite_ref-Roberson2010_43-0" class="reference"><a href="#cite_note-Roberson2010-43"><span>[</span>43<span>]</span></a></sup><sup id="cite_ref-Ramos2012_44-0" class="reference"><a href="#cite_note-Ramos2012-44"><span>[</span>44<span>]</span></a></sup></p>
<p><a href="/wiki/Deoxyribonucleic_acid" title="Deoxyribonucleic acid" class="mw-redirect">DNA</a> is an inflammatory stimulus in psoriasis<sup id="cite_ref-Dombrowski2012_45-0" class="reference"><a href="#cite_note-Dombrowski2012-45"><span>[</span>45<span>]</span></a></sup> and stimulates the receptors on certain dendritic cells, which in turn produce the cytokine interferon-α.<sup id="cite_ref-Dombrowski2012_45-1" class="reference"><a href="#cite_note-Dombrowski2012-45"><span>[</span>45<span>]</span></a></sup> In response to these chemical messages from dendritic cells and T cells, keratinocytes also secrete cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor-α, which signal downstream inflammatory cells to arrive and stimulate additional inflammation.<sup id="cite_ref-Nestle_29-9" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<p><a href="/wiki/Dendritic_cell" title="Dendritic cell">Dendritic cells</a> bridge the <a href="/wiki/Innate_immune_system" title="Innate immune system">innate immune system</a> and <a href="/wiki/Adaptive_immune_system" title="Adaptive immune system">adaptive immune system</a>. They are increased in psoriatic lesions<sup id="cite_ref-Ouyang2010_41-1" class="reference"><a href="#cite_note-Ouyang2010-41"><span>[</span>41<span>]</span></a></sup> and induce the proliferation of T cells and type 1 helper T cells (Th1). Targeted immunotherapy as well as psoralen and <a href="/wiki/Ultraviolet_A" title="Ultraviolet A" class="mw-redirect">ultraviolet A</a> (PUVA) therapy can reduce the number of dendritic cells and favors a <a href="/wiki/Th2_cell" title="Th2 cell" class="mw-redirect">Th2 cell</a> cytokine secretion pattern over a Th1/Th17 cell cytokine profile.<sup id="cite_ref-Nestle_29-10" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-Wong2013_37-1" class="reference"><a href="#cite_note-Wong2013-37"><span>[</span>37<span>]</span></a></sup> Psoriatic T cells move from the dermis into the epidermis and secrete interferon-γ and <a href="/wiki/Interleukin-17" title="Interleukin-17" class="mw-redirect">interleukin-17</a>.<sup id="cite_ref-Mudigonda2012_46-0" class="reference"><a href="#cite_note-Mudigonda2012-46"><span>[</span>46<span>]</span></a></sup> Interleukin-23 is known to induce the production of interleukin-17 and interleukin-22.<sup id="cite_ref-Ouyang2010_41-2" class="reference"><a href="#cite_note-Ouyang2010-41"><span>[</span>41<span>]</span></a></sup><sup id="cite_ref-Mudigonda2012_46-1" class="reference"><a href="#cite_note-Mudigonda2012-46"><span>[</span>46<span>]</span></a></sup> Interleukin-22 works in combination with interleukin-17 to induce keratinocytes to secrete neutrophil-attracting cytokines.<sup id="cite_ref-Mudigonda2012_46-2" class="reference"><a href="#cite_note-Mudigonda2012-46"><span>[</span>46<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=14" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>A <a href="/wiki/Medical_diagnosis" title="Medical diagnosis">diagnosis</a> of psoriasis is usually based on the appearance of the skin. Skin characteristics typical for psoriasis are scaly, <a href="/wiki/Erythema" title="Erythema">red</a>, plaques, papules, or patches of skin that may be painful and <a href="/wiki/Pruritus" title="Pruritus" class="mw-redirect">itch</a>.<sup id="cite_ref-Weigle2013_20-3" class="reference"><a href="#cite_note-Weigle2013-20"><span>[</span>20<span>]</span></a></sup> There are no special blood tests or diagnostic procedures needed to make the diagnosis.<sup id="cite_ref-Johnson_166.E2.80.9372_10-1" class="reference"><a href="#cite_note-Johnson_166.E2.80.9372-10"><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-Raychaudhuri2014_17-6" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup></p>
<p>The <a href="/wiki/Differential_diagnosis" title="Differential diagnosis">differential diagnosis</a> of psoriasis includes dermatological conditions similar in appearance such as <a href="/wiki/Discoid_eczema" title="Discoid eczema" class="mw-redirect">discoid eczema</a>, <a href="/wiki/Seborrhoeic_eczema" title="Seborrhoeic eczema" class="mw-redirect">seborrhoeic eczema</a>, <a href="/wiki/Pityriasis_rosea" title="Pityriasis rosea">pityriasis rosea</a> (may be confused with guttate psoriasis), <a href="/wiki/Tinea_unguium" title="Tinea unguium" class="mw-redirect">nail fungus</a> (may be confused with nail psoriasis) or <a href="/wiki/Cutaneous_T_cell_lymphoma" title="Cutaneous T cell lymphoma">cutaneous T cell lymphoma</a> (50% of individuals with this cancer are initially <a href="/wiki/Misdiagnosis" title="Misdiagnosis" class="mw-redirect">misdiagnosed</a> with psoriasis).<sup id="cite_ref-Weller2008_6-3" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup> Dermatologic manifestations of systemic illnesses such as the rash of <a href="/wiki/Secondary_syphilis" title="Secondary syphilis" class="mw-redirect">secondary syphilis</a> may also be confused with psoriasis.<sup id="cite_ref-Weller2008_6-4" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup></p>
<p>If the clinical diagnosis is uncertain, a skin <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> or scraping may be performed to rule out other disorders and to confirm the diagnosis. Skin from a biopsy will show clubbed <a href="/wiki/Rete_pegs" title="Rete pegs">epidermal projections that interdigitate with dermis</a> on microscopy. <a href="/wiki/Acanthosis" title="Acanthosis">Epidermal thickening</a> is another characteristic histologic finding of psoriasis lesions.<sup id="cite_ref-Raychaudhuri2014_17-7" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-Kunz2009_47-0" class="reference"><a href="#cite_note-Kunz2009-47"><span>[</span>47<span>]</span></a></sup> The <a href="/wiki/Stratum_granulosum" title="Stratum granulosum">stratum granulosum</a> layer of the epidermis is often missing or significantly decreased in psoriatic lesions; the skin cells from the <a href="/wiki/Stratum_corneum" title="Stratum corneum">most superficial layer of skin</a> are also abnormally as they never fully mature. Unlike their mature counterparts, <a href="/wiki/Parakeratosis" title="Parakeratosis">these superficial cells keep their nucleus</a>.<sup id="cite_ref-Raychaudhuri2014_17-8" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup> Inflammatory infiltrates can typically be visualized on microscopy when examining skin tissue or joint tissue affected by psoriasis. Epidermal skin tissue affected by psoriatic inflammation often has many CD8+ T cells while a predominance of CD4+ T the inflammatory infiltrates of the dermal layer of skin and the joints.<sup id="cite_ref-Raychaudhuri2014_17-9" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=15" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Morphological">Morphological</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=16" title="Edit section: Morphological">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<table class="wikitable" style="float:right; margin-left: 10px; text-align:center">
<tr>
<th>Psoriasis Type</th>
<th>ICD-10 Code</th>
</tr>
<tr>
<td>Psoriasis vulgaris</td>
<td>L40.0</td>
</tr>
<tr>
<td><a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">Generalized pustular psoriasis</a></td>
<td>L40.1</td>
</tr>
<tr>
<td><a href="/wiki/Acrodermatitis_continua" title="Acrodermatitis continua" class="mw-redirect">Acrodermatitis continua</a></td>
<td>L40.2</td>
</tr>
<tr>
<td><a href="/wiki/Pustulosis_palmaris_et_plantaris" title="Pustulosis palmaris et plantaris">Pustulosis palmaris et plantaris</a></td>
<td>L40.3</td>
</tr>
<tr>
<td><a href="/wiki/Guttate_psoriasis" title="Guttate psoriasis">Guttate psoriasis</a></td>
<td>L40.4</td>
</tr>
<tr>
<td><a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a></td>
<td>L40.50</td>
</tr>
<tr>
<td>Psoriatic spondylitis</td>
<td>L40.53</td>
</tr>
<tr>
<td><a href="/wiki/Inverse_psoriasis" title="Inverse psoriasis">Inverse psoriasis</a></td>
<td>L40.8</td>
</tr>
</table>
<p>Psoriasis is classified as a <a href="/wiki/Papulosquamous_disorder" title="Papulosquamous disorder">papulosquamous disorder</a> and is most commonly subdivided into different categories based on histological characteristics.<sup id="cite_ref-Menter2008_2-4" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Jain2012_5-7" class="reference"><a href="#cite_note-Jain2012-5"><span>[</span>5<span>]</span></a></sup> Variants include plaque, pustular, guttate, and flexural psoriasis. Each form has a dedicated <a href="/wiki/ICD-10" title="ICD-10">ICD-10</a> code.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup> Psoriasis can also be classified into nonpustular and <a href="/wiki/Pustule" title="Pustule" class="mw-redirect">pustular</a> types.<sup id="cite_ref-Fitz2_49-0" class="reference"><a href="#cite_note-Fitz2-49"><span>[</span>49<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Pathogenetic">Pathogenetic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=17" title="Edit section: Pathogenetic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Another classification scheme considers genetic and demographic factors. Type 1 has a positive family history, starts before the age of 40 and is associated with the <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">human leukocyte antigen</a>, <a href="/wiki/HLA-C" title="HLA-C">HLA-Cw6</a>. Conversely, type 2 does not show a family history, presents before age 40 and is not associated with HLA-Cw6.<sup id="cite_ref-Kupetsky2013_50-0" class="reference"><a href="#cite_note-Kupetsky2013-50"><span>[</span>50<span>]</span></a></sup> Type 1 accounts for about 75% of persons with psoriasis.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup></p>
<p>The classification of psoriasis as an autoimmune disease has sparked considerable debate. Researchers have proposed differing descriptions of psoriasis and psoriatic arthritis; some authors have classified them as autoimmune diseases<sup id="cite_ref-Raychaudhuri2014_17-10" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-Prieto2013_30-4" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-Weidemann2013_52-0" class="reference"><a href="#cite_note-Weidemann2013-52"><span>[</span>52<span>]</span></a></sup> while others have classified them as distinct from autoimmune diseases and referred to them as <a href="/wiki/Immune-mediated_inflammatory_diseases" title="Immune-mediated inflammatory diseases">immune-mediated inflammatory diseases</a>.<sup id="cite_ref-Nestle_29-11" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-Han2012_53-0" class="reference"><a href="#cite_note-Han2012-53"><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-Quatresooz_54-0" class="reference"><a href="#cite_note-Quatresooz-54"><span>[</span>54<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Severity">Severity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=18" title="Edit section: Severity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Distribution_of_psoriasis_severity.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Distribution_of_psoriasis_severity.svg/220px-Distribution_of_psoriasis_severity.svg.png" width="220" height="194" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Distribution_of_psoriasis_severity.svg/330px-Distribution_of_psoriasis_severity.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Distribution_of_psoriasis_severity.svg/440px-Distribution_of_psoriasis_severity.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Distribution_of_psoriasis_severity.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Distribution of severity</div>
</div>
</div>
<p>The severity of psoriasis has no universally agreed upon definition. Mild psoriasis has been defined as a percentage of body surface area (BSA)≤10, a <a href="/wiki/Psoriasis_Area_Severity_Index" title="Psoriasis Area Severity Index" class="mw-redirect">Psoriasis Area Severity Index</a> (PASI) score ≤10, and a dermatology life quality index (DLQI) score ≤10.<sup id="cite_ref-Mrowietz2011_55-0" class="reference"><a href="#cite_note-Mrowietz2011-55"><span>[</span>55<span>]</span></a></sup> Moderate to severe psoriasis was defined by the same group as BSA &gt;10 or PASI score &gt;10 and a DLQI score &gt;10.<sup id="cite_ref-Mrowietz2011_55-1" class="reference"><a href="#cite_note-Mrowietz2011-55"><span>[</span>55<span>]</span></a></sup> The DLQI is a 10 question tool used to measure the impact of several dermatologic diseases on daily functioning. The DLQI score ranges from 0 (minimal impairment) to 30 (maximal impairment) and is calculated with each answer being assigned 0-3 points with higher scores indicating greater social or occupational impairment.<sup id="cite_ref-Mease2011_56-0" class="reference"><a href="#cite_note-Mease2011-56"><span>[</span>56<span>]</span></a></sup></p>
<p>The Psoriasis Area Severity Index is the most widely used measurement tool for psoriasis. PASI assesses the severity of lesions and the area affected and combines these two factors into a single score from 0 (no disease) to 72 (maximal disease).<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span>[</span>57<span>]</span></a></sup> Nevertheless, the PASI can be too unwieldy to use outside of research settings, which has led to attempts to simplify the index for clinical use.<sup id="cite_ref-pmid15530297_58-0" class="reference"><a href="#cite_note-pmid15530297-58"><span>[</span>58<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=19" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Psoriasis_treatment_ladder.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Psoriasis_treatment_ladder.svg/220px-Psoriasis_treatment_ladder.svg.png" width="220" height="178" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Psoriasis_treatment_ladder.svg/330px-Psoriasis_treatment_ladder.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Psoriasis_treatment_ladder.svg/440px-Psoriasis_treatment_ladder.svg.png 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Psoriasis_treatment_ladder.svg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Schematic of psoriasis treatment ladder</div>
</div>
</div>
<p>While no cure is available for psoriasis,<sup id="cite_ref-Weller2008_6-5" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup> there are many treatment options. Topical agents are typically used for mild disease, phototherapy for moderate disease, and systemic agents for severe disease.<sup id="cite_ref-Lancet07_59-0" class="reference"><a href="#cite_note-Lancet07-59"><span>[</span>59<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Topical_agents">Topical agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=20" title="Edit section: Topical agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Topical corticosteroid preparations are the most effective agents when used continuously for 8 weeks; <a href="/wiki/Retinoid" title="Retinoid">retinoids</a> and <a href="/wiki/Coal_tar" title="Coal tar">coal tar</a> were found to be of limited benefit and may be no better than <a href="/wiki/Placebo" title="Placebo">placebo</a>.<sup id="cite_ref-Samarasekera2013_60-0" class="reference"><a href="#cite_note-Samarasekera2013-60"><span>[</span>60<span>]</span></a></sup> Greater benefit has been observed with very potent corticosteroids when compared to potent corticosteroids. Vitamin D analogues such as <a href="/wiki/Paricalcitol" title="Paricalcitol">paricalcitol</a> were found to be significantly superior to placebo. Combination therapy with vitamin D and a corticosteroid was superior to either treatment alone and vitamin D was found to be superior to coal tar for chronic plaque psoriasis.<sup id="cite_ref-Mason2013_61-0" class="reference"><a href="#cite_note-Mason2013-61"><span>[</span>61<span>]</span></a></sup></p>
<p>Moisturizers and emollients such as <a href="/wiki/Mineral_oil" title="Mineral oil">mineral oil</a>, <a href="/wiki/Vaseline" title="Vaseline">vaseline</a>, <a href="/wiki/Calcipotriol" title="Calcipotriol">calcipotriol</a>, and <a href="/wiki/Decubal" title="Decubal" class="mw-redirect">decubal</a> (an oil in water emollient) were found to increase the clearance of psoriatic plaques. Emollients have been shown to be even more effective at clearing psoriatic plaques when combined with phototherapy.<sup id="cite_ref-Asztalos2013_62-0" class="reference"><a href="#cite_note-Asztalos2013-62"><span>[</span>62<span>]</span></a></sup> However, certain emollients have no impact on psoriasis plaque clearance or may even decrease the clearance achieved with phototherapy. The emollient <a href="/wiki/Salicylic_acid" title="Salicylic acid">salicylic acid</a> is structurally similar to <a href="/wiki/Para-aminobenzoic_acid" title="Para-aminobenzoic acid" class="mw-redirect">para-aminobenzoic acid</a> (PABA), commonly found in sunscreen, and is known to interfere with phototherapy in psoriasis. <a href="/wiki/Coconut_oil" title="Coconut oil">Coconut oil</a>, when used as an emollient in psoriasis, has been found to decrease plaque clearance with phototherapy.<sup id="cite_ref-Asztalos2013_62-1" class="reference"><a href="#cite_note-Asztalos2013-62"><span>[</span>62<span>]</span></a></sup> Medicated creams and ointments applied directly to psoriatic plaques can help reduce inflammation, remove built-up scale, reduce skin turnover, and clear affected skin of plaques. Ointment and creams containing <a href="/wiki/Coal_tar" title="Coal tar">coal tar</a>, <a href="/wiki/Dithranol" title="Dithranol">dithranol</a>, <a href="/wiki/Corticosteroid" title="Corticosteroid">corticosteroids</a> (i.e. <a href="/wiki/Desoximetasone" title="Desoximetasone">desoximetasone</a>), <a href="/wiki/Fluocinonide" title="Fluocinonide">fluocinonide</a>, <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a><sub>3</sub> analogs (for example, calcipotriol), and <a href="/wiki/Retinoid" title="Retinoid">retinoids</a> are routinely used. The use of the <a href="/wiki/Finger_tip_unit" title="Finger tip unit">finger tip unit</a> may be helpful in guiding how much topical treatment to use.<sup id="cite_ref-Clarke2011_33-1" class="reference"><a href="#cite_note-Clarke2011-33"><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup></p>
<p>Another topical therapy used to treat psoriasis is a form of <a href="/wiki/Balneotherapy" title="Balneotherapy">balneotherapy</a>, which involves daily baths in the <a href="/wiki/Dead_Sea" title="Dead Sea">Dead Sea</a>. This is usually done for four weeks and with varying amounts of sun exposure. This is cost-effective and it has been propagated as an effective way to treat psoriasis without medication.<sup id="cite_ref-Halverstam2008_64-0" class="reference"><a href="#cite_note-Halverstam2008-64"><span>[</span>64<span>]</span></a></sup> Decreases of PASI scores greater than 75% and remission for several months have commonly been observed.<sup id="cite_ref-Halverstam2008_64-1" class="reference"><a href="#cite_note-Halverstam2008-64"><span>[</span>64<span>]</span></a></sup> Most of the benefits and side-effects of this therapy are attributed to the effects of the ultraviolet radiation from the sun. Side-effects may be mild such as itchiness, <a href="/wiki/Folliculitis" title="Folliculitis">folliculitis</a>, <a href="/wiki/Sunburn" title="Sunburn">sunburn</a>, <a href="/wiki/Poikiloderma" title="Poikiloderma">poikiloderma</a>, and a theoretical risk of nonmelanoma skin cancer or melanoma has been suggested.<sup id="cite_ref-Halverstam2008_64-2" class="reference"><a href="#cite_note-Halverstam2008-64"><span>[</span>64<span>]</span></a></sup> However, more recent studies have determined that there does not appear to be increased risk of melanoma in the long-term.<sup id="cite_ref-Katz2012_65-0" class="reference"><a href="#cite_note-Katz2012-65"><span>[</span>65<span>]</span></a></sup> Data are inconclusive with respect to nonmelanoma skin cancer risk, but support the idea that the therapy is associated with an increased risk of benign forms of sun-induced skin damage such as, but not limited to, <a href="/wiki/Actinic_elastosis" title="Actinic elastosis">actinic elastosis</a> or <a href="/wiki/Solar_lentigines" title="Solar lentigines" class="mw-redirect">liver spots</a>.<sup id="cite_ref-Katz2012_65-1" class="reference"><a href="#cite_note-Katz2012-65"><span>[</span>65<span>]</span></a></sup> Dead Sea balneotherapy is also effective for psoriatic arthritis.<sup id="cite_ref-Katz2012_65-2" class="reference"><a href="#cite_note-Katz2012-65"><span>[</span>65<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Phototherapy">Phototherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=21" title="Edit section: Phototherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Phototherapy" title="Phototherapy" class="mw-redirect">Phototherapy</a> in the form of <a href="/wiki/Sunlight" title="Sunlight">sunlight</a> has long been used for psoriasis.<sup id="cite_ref-Lancet07_59-1" class="reference"><a href="#cite_note-Lancet07-59"><span>[</span>59<span>]</span></a></sup> <a href="/wiki/Wavelength" title="Wavelength">Wavelengths</a> of 311–313&#160;<a href="/wiki/Nanometer" title="Nanometer" class="mw-redirect">nanometers</a> are most effective, and special lamps have been developed for this application.<sup id="cite_ref-Lancet07_59-2" class="reference"><a href="#cite_note-Lancet07-59"><span>[</span>59<span>]</span></a></sup> The exposure time should be controlled to avoid over exposure and burning of the skin. The UVB lamps should have a timer that will turn off the lamp when the time ends. The amount of light used is determined by a person's skin type.<sup id="cite_ref-Lancet07_59-3" class="reference"><a href="#cite_note-Lancet07-59"><span>[</span>59<span>]</span></a></sup> Increased rates of cancer from treatment appear to be small.<sup id="cite_ref-Lancet07_59-4" class="reference"><a href="#cite_note-Lancet07-59"><span>[</span>59<span>]</span></a></sup> Narrow band UVB light (NBUVB) phototherapy has been demonstrated to have similar efficacy to PUVA.<sup id="cite_ref-Dogra2010_66-0" class="reference"><a href="#cite_note-Dogra2010-66"><span>[</span>66<span>]</span></a></sup></p>
<p>A major mechanism of NBUVB is the induction of <a href="/wiki/DNA" title="DNA">DNA</a> damage in the form of <a href="/wiki/Pyrimidine_dimer" title="Pyrimidine dimer">pyrimidine dimers</a>. This type of phototherapy is useful in the treatment of psoriasis because the formation of these dimers interferes with the <a href="/wiki/Cell_cycle" title="Cell cycle">cell cycle</a> and stops it. The interruption of the cell cycle induced by NBUVB opposes the characteristic rapid division of skin cells seen in psoriasis.<sup id="cite_ref-Dogra2010_66-1" class="reference"><a href="#cite_note-Dogra2010-66"><span>[</span>66<span>]</span></a></sup> The activity of many types of immune cells found in the skin is also effectively suppressed by NBUVB phototherapy treatments. The most common short-term side effect of this form of phototherapy is redness of the skin; less common side effects of NBUVB phototherapy are itching and <a href="/wiki/Blister" title="Blister">blistering</a> of the treated skin, irritation of the eyes in the form of <a href="/wiki/Conjunctivitis" title="Conjunctivitis">conjunctival inflammation</a> or <a href="/wiki/Keratitis" title="Keratitis">inflammation of the cornea</a>, or <a href="/wiki/Herpes_labialis" title="Herpes labialis">cold sores</a> due to reactivation of the <a href="/wiki/Herpes_simplex_virus" title="Herpes simplex virus">herpes simplex virus</a> in the skin surrounding the lips. Eye protection is usually given during phototherapy treatments.<sup id="cite_ref-Dogra2010_66-2" class="reference"><a href="#cite_note-Dogra2010-66"><span>[</span>66<span>]</span></a></sup></p>
<p><a href="/wiki/Psoralen" title="Psoralen">Psoralen</a> and ultraviolet A phototherapy (<a href="/wiki/PUVA_therapy" title="PUVA therapy">PUVA</a>) combines the oral or topical administration of psoralen with exposure to ultraviolet A (UVA) light. The <a href="/wiki/Mechanism_of_action" title="Mechanism of action">mechanism of action</a> of PUVA is unknown, but probably involves activation of psoralen by UVA light, which inhibits the abnormally rapid production of the cells in psoriatic skin. There are multiple mechanisms of action associated with PUVA, including effects on the skin's immune system. PUVA is associated with <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Headache" title="Headache">headache</a>, <a href="/wiki/Fatigue_(physical)" title="Fatigue (physical)" class="mw-redirect">fatigue</a>, burning, and itching. Long-term treatment is associated with <a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma" class="mw-redirect">squamous cell carcinoma</a> (but not with <a href="/wiki/Melanoma" title="Melanoma">melanoma</a>).<sup id="cite_ref-Richard2013_34-1" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Lapolla2011_67-0" class="reference"><a href="#cite_note-Lapolla2011-67"><span>[</span>67<span>]</span></a></sup> A combination therapy for moderate to severe psoriasis using PUVA plus <a href="/wiki/Acitretin" title="Acitretin">acitretin</a> resulted in benefit, but acitretin use has been associated with <a href="/wiki/Birth_defect" title="Birth defect" class="mw-redirect">birth defects</a> and <a href="/wiki/Hepatotoxicity" title="Hepatotoxicity">liver damage</a>.<sup id="cite_ref-Dunn2011_68-0" class="reference"><a href="#cite_note-Dunn2011-68"><span>[</span>68<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Systemic_agents">Systemic agents</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=22" title="Edit section: Systemic agents">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Psoriasis_infliximab_ar1182-2.gif" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/21/Psoriasis_infliximab_ar1182-2.gif/220px-Psoriasis_infliximab_ar1182-2.gif" width="220" height="229" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/21/Psoriasis_infliximab_ar1182-2.gif/330px-Psoriasis_infliximab_ar1182-2.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/21/Psoriasis_infliximab_ar1182-2.gif/440px-Psoriasis_infliximab_ar1182-2.gif 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Psoriasis_infliximab_ar1182-2.gif" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Pictures of a patient with psoriasis (and <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">psoriatic arthritis</a>) at baseline and 8 weeks after initiation of <a href="/wiki/Infliximab" title="Infliximab">infliximab</a> therapy.</div>
</div>
</div>
<p>Psoriasis resistant to <a href="/wiki/Topical" title="Topical" class="mw-redirect">topical treatment</a> and <a href="/wiki/Light_therapy" title="Light therapy">phototherapy</a> may be treated with systemic therapies including oral <a href="/wiki/Medication" title="Medication" class="mw-redirect">medications</a> or <a href="/wiki/Injection_(medicine)" title="Injection (medicine)">injectable treatments</a>.<sup id="cite_ref-Dogra2013_69-0" class="reference"><a href="#cite_note-Dogra2013-69"><span>[</span>69<span>]</span></a></sup> Patients undergoing systemic treatment must have regular <a href="/wiki/Blood_test" title="Blood test">blood</a> and <a href="/wiki/Liver_function_tests" title="Liver function tests">liver function tests</a> to check for medication toxicities.<sup id="cite_ref-Dogra2013_69-1" class="reference"><a href="#cite_note-Dogra2013-69"><span>[</span>69<span>]</span></a></sup> <a href="/wiki/Pregnancy" title="Pregnancy">Pregnancy</a> must be avoided for most of these treatments. The majority of people experience a recurrence of psoriasis after systemic treatment is discontinued.</p>
<p>Non-biologic systemic treatments frequently used for psoriasis include <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a>, <a href="/wiki/Ciclosporin" title="Ciclosporin">ciclosporin</a>, <a href="/wiki/Hydroxycarbamide" title="Hydroxycarbamide">hydroxycarbamide</a>, <a href="/wiki/Fumarate" title="Fumarate" class="mw-redirect">fumarates</a> such as <a href="/wiki/Dimethyl_fumarate" title="Dimethyl fumarate">dimethyl fumarate</a>, and <a href="/wiki/Retinoids" title="Retinoids" class="mw-redirect">retinoids</a>.<sup id="cite_ref-Rustin2012_70-0" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup> Methotrexate and ciclosporin are <a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">drugs that suppress the immune system</a>; retinoids are synthetic forms of <a href="/wiki/Vitamin_A" title="Vitamin A">vitamin A</a>. These agents are also regarded as first-line treatments for psoriatic erythroderma.<sup id="cite_ref-Zattra2012_14-1" class="reference"><a href="#cite_note-Zattra2012-14"><span>[</span>14<span>]</span></a></sup></p>
<p><a href="/wiki/Biologic_medical_product" title="Biologic medical product">Biologics</a> are manufactured proteins that interrupt the immune process involved in psoriasis. Unlike generalised immunosuppressive drug therapies such as methotrexate, biologics target specific aspects of the immune system contributing to psoriasis.<sup id="cite_ref-Rustin2012_70-1" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup> These medications are generally well-tolerated and limited long-term outcome data have demonstrated biologics to be safe for long-term use in moderate to severe plaque psoriasis.<sup id="cite_ref-Rustin2012_70-2" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-Griffiths2012_71-0" class="reference"><a href="#cite_note-Griffiths2012-71"><span>[</span>71<span>]</span></a></sup> However, due to their immunosuppressive actions, biologics have been associated with a small increase in the risk for infection.<sup id="cite_ref-Rustin2012_70-3" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup> Professional guidelines regard biologics as third-line treatment for plaque psoriasis following inadequate response to topical treatment, phototherapy, and non-biologic systemic treatments.<sup id="cite_ref-Griffiths2012_71-1" class="reference"><a href="#cite_note-Griffiths2012-71"><span>[</span>71<span>]</span></a></sup> The safety of biologics during pregnancy has not been assessed. European guidelines recommend avoiding biologics if a pregnancy is planned; anti-TNF therapies such as infliximab are not recommended for use in chronic carriers of the <a href="/wiki/Hepatitis_B_virus" title="Hepatitis B virus">hepatitis B virus</a> or individuals infected with <a href="/wiki/HIV" title="HIV">HIV</a>.<sup id="cite_ref-Rustin2012_70-4" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup></p>
<p>Several monoclonal antibodies target cytokines, the molecules that cells use to send inflammatory signals to each other. <a href="/wiki/Tumor_necrosis_factor_%CE%B1" title="Tumor necrosis factor α" class="mw-redirect">TNF-α</a> is one of the main executor inflammatory cytokines. Four <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibodies</a> (MAbs) (<a href="/wiki/Infliximab" title="Infliximab">infliximab</a>, <a href="/wiki/Adalimumab" title="Adalimumab">adalimumab</a>, <a href="/wiki/Golimumab" title="Golimumab">golimumab</a>, and <a href="/wiki/Certolizumab_pegol" title="Certolizumab pegol">certolizumab pegol</a>) and one recombinant TNF-α <a href="/wiki/Decoy_receptor" title="Decoy receptor" class="mw-redirect">decoy receptor</a>, <a href="/wiki/Etanercept" title="Etanercept">etanercept</a>, have been developed to inhibit TNF-α signaling. Additional monoclonal antibodies have been developed against pro-inflammatory cytokines <a href="/wiki/Interleukin-12" title="Interleukin-12" class="mw-redirect">interleukin-12</a>, <a href="/wiki/Interleukin-23" title="Interleukin-23" class="mw-redirect">interleukin-23</a> and <a href="/wiki/Interleukin-17" title="Interleukin-17" class="mw-redirect">interleukin-17</a><sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup> and inhibit the inflammatory pathway at a different point than the anti-TNF-α antibodies.<sup id="cite_ref-Nestle_29-12" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup> IL-12 and IL-23 share a common domain, <a href="/wiki/Interleukin-12_subunit_beta" title="Interleukin-12 subunit beta" class="mw-redirect">p40</a>, which is the target of the recently <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA-approved</a> <a href="/wiki/Ustekinumab" title="Ustekinumab">ustekinumab</a>.<sup id="cite_ref-Prieto2013_30-5" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup></p>
<p>Two drugs that target T cells are <a href="/wiki/Efalizumab" title="Efalizumab">efalizumab</a> and <a href="/wiki/Alefacept" title="Alefacept">alefacept</a>. Efalizumab is a monoclonal antibody that specifically targets the <a href="/wiki/CD11a" title="CD11a">CD11a</a> subunit of <a href="/wiki/LFA-1" title="LFA-1" class="mw-redirect">LFA-1</a>.<sup id="cite_ref-Rustin2012_70-5" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup> It also blocks the adhesion molecules on the <a href="/wiki/Endothelial" title="Endothelial" class="mw-redirect">endothelial</a> cells that line blood vessels, which attract T cells. Efalizumab was voluntarily withdrawn from the European market in February 2009 and from the US market in June 2009 by the manufacturer due to the medication's association with cases of <a href="/wiki/Progressive_multifocal_leukoencephalopathy" title="Progressive multifocal leukoencephalopathy">progressive multifocal leukoencephalopathy</a>.<sup id="cite_ref-Rustin2012_70-6" class="reference"><a href="#cite_note-Rustin2012-70"><span>[</span>70<span>]</span></a></sup> Alefacept also blocks the molecules that dendritic cells use to communicate with T cells and even causes <a href="/wiki/Natural_killer_cell" title="Natural killer cell">natural killer cells</a> to kill T cells as a way of controlling inflammation.<sup id="cite_ref-Nestle_29-13" class="reference"><a href="#cite_note-Nestle-29"><span>[</span>29<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Alternative_therapy">Alternative therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=23" title="Edit section: Alternative therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Uncontrolled studies have suggested that individuals with psoriasis or psoriatic arthritis may benefit from a diet supplemented with <a href="/wiki/Fish_oil" title="Fish oil">fish oil</a> rich in <a href="/wiki/Eicosapentaenoic_acid" title="Eicosapentaenoic acid">eicosapentaenoic acid</a> (EPA) and <a href="/wiki/Docosahexaenoic_acid" title="Docosahexaenoic acid">docosahexaenoic acid</a> (DHA).<sup id="cite_ref-Kaimal2010_73-0" class="reference"><a href="#cite_note-Kaimal2010-73"><span>[</span>73<span>]</span></a></sup> Conflicting evidence exists indicating that there may be an increased incidence of psoriasis in people with <a href="/wiki/Celiac_disease" title="Celiac disease" class="mw-redirect">celiac disease</a>. Psoriatic disease severity decreased after 3 months of a gluten free diet in patients with <a href="/wiki/Anti-gliadin_antibodies" title="Anti-gliadin antibodies">anti-gliadin antibodies</a>.<sup id="cite_ref-Kaimal2010_73-1" class="reference"><a href="#cite_note-Kaimal2010-73"><span>[</span>73<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=24" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Psoriasis is known to have a negative impact on the <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> of both the affected person and the individual's family members.<sup id="cite_ref-Prieto2013_30-6" class="reference"><a href="#cite_note-Prieto2013-30"><span>[</span>30<span>]</span></a></sup> Depending on the severity and location of outbreaks, individuals may experience significant physical discomfort and some disability. Itching and pain can interfere with basic functions, such as self-care and <a href="/wiki/Sleep" title="Sleep">sleep</a>.<sup id="cite_ref-Parrish2012_42-1" class="reference"><a href="#cite_note-Parrish2012-42"><span>[</span>42<span>]</span></a></sup> Participation in <a href="/wiki/Sport" title="Sport">sporting</a> activities, certain occupations, and caring for family members can become difficult activities for those with plaques located on their <a href="/wiki/Hands" title="Hands" class="mw-redirect">hands</a> and <a href="/wiki/Foot" title="Foot">feet</a>.<sup id="cite_ref-Parrish2012_42-2" class="reference"><a href="#cite_note-Parrish2012-42"><span>[</span>42<span>]</span></a></sup> Plaques on the scalp can be particularly embarrassing, as flaky plaque in the hair can be mistaken for <a href="/wiki/Dandruff" title="Dandruff">dandruff</a>.<sup id="cite_ref-Dessinioti2013_74-0" class="reference"><a href="#cite_note-Dessinioti2013-74"><span>[</span>74<span>]</span></a></sup></p>
<p>Individuals with psoriasis may feel self-conscious about their appearance and have a poor self-image that stems from fear of public rejection and psychosexual concerns. Psoriasis has been associated with low self-esteem and <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a> is more common among those with the condition.<sup id="cite_ref-Menter2008_2-5" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> People with psoriasis often feel prejudiced against due to the commonly held incorrect belief that psoriasis is contagious.<sup id="cite_ref-Parrish2012_42-3" class="reference"><a href="#cite_note-Parrish2012-42"><span>[</span>42<span>]</span></a></sup> Psychological distress can lead to significant <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a> and <a href="/wiki/Social_isolation" title="Social isolation">social isolation</a>; a high rate of <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">thoughts about suicide</a> has been associated with psoriasis.<sup id="cite_ref-Gelmetti2009_22-1" class="reference"><a href="#cite_note-Gelmetti2009-22"><span>[</span>22<span>]</span></a></sup> Many tools exist to measure the quality of life of patients with psoriasis and other dermatological disorders. Clinical research has indicated individuals often experience a diminished quality of life.<sup id="cite_ref-Bhosle_75-0" class="reference"><a href="#cite_note-Bhosle-75"><span>[</span>75<span>]</span></a></sup> Children with psoriasis may encounter <a href="/wiki/Bullying" title="Bullying">bullying</a>.<sup id="cite_ref-76" class="reference"><a href="#cite_note-76"><span>[</span>76<span>]</span></a></sup></p>
<p>Several conditions are associated with psoriasis. These occur more frequently in older people. Nearly half of individuals with psoriasis over the age of 65 have at least three comorbidities, and two-thirds have at least two comorbidities.<sup id="cite_ref-Habif2010_77-0" class="reference"><a href="#cite_note-Habif2010-77"><span>[</span>77<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Cardiovascular_disease">Cardiovascular disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=25" title="Edit section: Cardiovascular disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Psoriasis has been associated with <a href="/wiki/Obesity" title="Obesity">obesity</a><sup id="cite_ref-Menter2008_2-6" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> and several other cardiovascular and metabolic disturbances. People affected by psoriasis have a 27% increased risk of developing diabetes. Severe psoriasis may confer an even greater risk of developing diabetes than milder cases. Younger people with psoriasis may also be at increased risk for developing diabetes.<sup id="cite_ref-Habif2010_77-1" class="reference"><a href="#cite_note-Habif2010-77"><span>[</span>77<span>]</span></a></sup><sup id="cite_ref-Armstrong2013_78-0" class="reference"><a href="#cite_note-Armstrong2013-78"><span>[</span>78<span>]</span></a></sup> Individuals with psoriasis or psoriatic arthritis have a slightly higher risk of heart disease and heart attacks when compared to the general population. Cardiovascular disease risk appeared to be correlated with the severity of psoriasis and its duration. There is no strong evidence to suggest that psoriasis is associated with an increased risk of death from cardiovascular events. Methotrexate may provide a degree of protection for the heart.<sup id="cite_ref-Richard2013_34-2" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-Habif2010_77-2" class="reference"><a href="#cite_note-Habif2010-77"><span>[</span>77<span>]</span></a></sup></p>
<p>The odds of having hypertension are 1.58 times higher in people with psoriasis than those without the condition; these odds are even higher with severe cases of psoriasis. A similar association was noted in people who have psoriatic arthritis—the odds of having hypertension were found to be 2.07 times greater when compared to odds of the general population. The link between psoriasis and hypertension is not currently understood. Mechanisms hypothesized to be involved in this relationship include the following: dysregulation of the <a href="/wiki/Renin-angiotensin_system" title="Renin-angiotensin system" class="mw-redirect">renin-angiotensin system</a>, elevated levels of <a href="/wiki/Endothelin_1" title="Endothelin 1">endothelin 1</a> in the blood, and increased <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>.<sup id="cite_ref-Armstrong2013_78-1" class="reference"><a href="#cite_note-Armstrong2013-78"><span>[</span>78<span>]</span></a></sup><sup id="cite_ref-Hypertension2013_79-0" class="reference"><a href="#cite_note-Hypertension2013-79"><span>[</span>79<span>]</span></a></sup> The incidence of the heart rhythm abnormality <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">atrial fibrillation</a> is 1.31 times higher in people with mild psoriasis and 1.63 times higher in people with severe psoriasis.<sup id="cite_ref-Tablazon2013_80-0" class="reference"><a href="#cite_note-Tablazon2013-80"><span>[</span>80<span>]</span></a></sup> There may be a slightly increased risk of stroke associated with psoriasis, especially in severe cases.<sup id="cite_ref-Richard2013_34-3" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>81<span>]</span></a></sup> Treating <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">high levels of cholesterol</a> with <a href="/wiki/Statin" title="Statin">statins</a> has been associated with decreased psoriasis severity, as measured by PASI score, and has also been associated with improvements in other cardiovascular disease risk factors such as markers of inflammation.<sup id="cite_ref-Ghazizadeh2011_82-0" class="reference"><a href="#cite_note-Ghazizadeh2011-82"><span>[</span>82<span>]</span></a></sup> These cardioprotective effects are attributed to ability of statins to improve blood lipid profile and because of their anti-inflammatory effects. Statin use in those with psoriasis and hyperlipidemia was associated with decreased levels of <a href="/wiki/High-sensitivity_C-reactive_protein" title="High-sensitivity C-reactive protein" class="mw-redirect">high-sensitivity C-reactive protein</a> and <a href="/wiki/TNF%CE%B1" title="TNFα" class="mw-redirect">TNFα</a> as well as decreased activity of the immune protein <a href="/wiki/Lymphocyte_function-associated_antigen_1" title="Lymphocyte function-associated antigen 1">LFA-1</a>.<sup id="cite_ref-Ghazizadeh2011_82-1" class="reference"><a href="#cite_note-Ghazizadeh2011-82"><span>[</span>82<span>]</span></a></sup> Compared to individuals without psoriasis, those affected by psoriasis are more likely to satisfy the criteria for <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>.<sup id="cite_ref-Raychaudhuri2014_17-11" class="reference"><a href="#cite_note-Raychaudhuri2014-17"><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-Tablazon2013_80-1" class="reference"><a href="#cite_note-Tablazon2013-80"><span>[</span>80<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_diseases">Other diseases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=26" title="Edit section: Other diseases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The rates of <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> and <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a> is increased when compared with the general population, by factor 3.8 and 7.5 respectively.<sup id="cite_ref-Menter2008_2-7" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup> Few studies have evaluated the association of <a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a> with psoriasis, and the relationship has been questioned.<sup id="cite_ref-Menter2008_2-8" class="reference"><a href="#cite_note-Menter2008-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Hsu2012_83-0" class="reference"><a href="#cite_note-Hsu2012-83"><span>[</span>83<span>]</span></a></sup> Psoriasis has been associated with a 16% increase in overall relative risk for non-skin cancer.<sup id="cite_ref-Richard2013_34-4" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup> People with psoriasis have a 52% increased risk <a href="/wiki/Lung_cancer" title="Lung cancer">cancers of the lung and bronchus</a>, a 205% increase in the risk of developing <a href="/wiki/Esophageal_cancer" title="Esophageal cancer">cancers of the upper gastrointestinal tract</a>, a 31% increase in the risk of developing <a href="/wiki/Urologic_disease" title="Urologic disease">cancers of the urinary tract</a>, a 90% increase in the risk of developing <a href="/wiki/Liver_cancer" title="Liver cancer">liver cancer</a>, and a 46% increase in the risk of developing <a href="/wiki/Pancreatic_cancer" title="Pancreatic cancer">pancreatic cancer</a>.<sup id="cite_ref-Richard2013_34-5" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup> The risk for development of non-melanoma skin cancers was also increased. Psoriasis increased the risk of developing <a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma" class="mw-redirect">squamous cell carcinoma</a> of the skin by 431% and increased the risk of <a href="/wiki/Basal_cell_carcinoma" title="Basal cell carcinoma" class="mw-redirect">basal cell carcinoma</a>) by 100%.<sup id="cite_ref-Richard2013_34-6" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup> There is no increased risk of <a href="/wiki/Melanoma" title="Melanoma">melanoma</a> associated with psoriasis.<sup id="cite_ref-Richard2013_34-7" class="reference"><a href="#cite_note-Richard2013-34"><span>[</span>34<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=27" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Psoriasis is estimated to affect 2-4% of the population of the western world.<sup id="cite_ref-Parisi2013_3-1" class="reference"><a href="#cite_note-Parisi2013-3"><span>[</span>3<span>]</span></a></sup> The rate of psoriasis varies according to age, gender, region and ethnicity; a combination of environmental and genetic factors is thought to be responsible for these differences.<sup id="cite_ref-Parisi2013_3-2" class="reference"><a href="#cite_note-Parisi2013-3"><span>[</span>3<span>]</span></a></sup> It can occur at any age, although it most commonly appears for the first time between the ages of 15 and 25 years. Approximately one third of psoriasis patients report being diagnosed before age 20.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup> Psoriasis affects both <a href="/wiki/Sex" title="Sex">sexes</a> equally.<sup id="cite_ref-Kupetsky2013_50-1" class="reference"><a href="#cite_note-Kupetsky2013-50"><span>[</span>50<span>]</span></a></sup></p>
<p>People with <a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">inflammatory bowel disease</a> such as <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a> or <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a> are at an increased risk of developing psoriasis.<sup id="cite_ref-Guerra2013_40-1" class="reference"><a href="#cite_note-Guerra2013-40"><span>[</span>40<span>]</span></a></sup> Psoriasis is more common in countries farther from the <a href="/wiki/Equator" title="Equator">equator</a>.<sup id="cite_ref-Guerra2013_40-2" class="reference"><a href="#cite_note-Guerra2013-40"><span>[</span>40<span>]</span></a></sup> Persons of white European ancestry are more likely to have psoriasis and the condition is relatively uncommon in African Americans and extremely uncommon in Native Americans.<sup id="cite_ref-Weller2008_6-6" class="reference"><a href="#cite_note-Weller2008-6"><span>[</span>6<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=28" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Scholars believe psoriasis to have been included among the various skin conditions called <i><a href="/wiki/Tzaraath" title="Tzaraath">tzaraath</a></i> (translated as leprosy) in the <a href="/wiki/Hebrew_Bible" title="Hebrew Bible">Hebrew Bible</a>, a condition imposed as a punishment for slander. The patient was deemed "impure" (see <a href="/wiki/Tumah_and_taharah" title="Tumah and taharah">tumah and taharah</a>) during their afflicted phase and is ultimately treated by the <a href="/wiki/Kohen" title="Kohen">kohen</a>.<sup id="cite_ref-Gruber2004_85-0" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup> However, it is more likely that this confusion arose from the use of the same Greek term for both conditions. The Greeks used the term lepra (λεπρα) for scaly skin conditions. They used the term psora to describe itchy skin conditions.<sup id="cite_ref-Gruber2004_85-1" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup> It became known as <i>Willan's lepra</i> in the late 18th century when English <a href="/wiki/Dermatologist" title="Dermatologist" class="mw-redirect">dermatologists</a> <a href="/wiki/Robert_Willan" title="Robert Willan">Robert Willan</a> and Thomas Bateman differentiated it from other skin diseases. Leprosy, they said, is distinguished by the regular, circular form of patches, while psoriasis is always irregular. Willan identified two categories: <i>leprosa graecorum</i> and <i>psora leprosa</i>.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup></p>
<p>Psoriasis is thought to have first been described in <a href="/wiki/Ancient_Rome" title="Ancient Rome">Ancient Rome</a> by <a href="/wiki/Cornelius_Celsus" title="Cornelius Celsus" class="mw-redirect">Cornelius Celsus</a>. The British dermatologist <a href="/wiki/Thomas_Bateman" title="Thomas Bateman">Thomas Bateman</a> described a possible link between psoriasis and arthritic symptoms in 1813.<sup id="cite_ref-Benedek2013_87-0" class="reference"><a href="#cite_note-Benedek2013-87"><span>[</span>87<span>]</span></a></sup></p>
<p>The history of psoriasis is littered with treatments of dubious effectiveness and high toxicity. In the 18th and 19th centuries, <a href="/wiki/Fowler%27s_solution" title="Fowler's solution">Fowler's solution</a>, which contains a <a href="/wiki/Poisonous" title="Poisonous" class="mw-redirect">poisonous</a> and <a href="/wiki/Carcinogenic" title="Carcinogenic" class="mw-redirect">carcinogenic</a> <a href="/wiki/Arsenic" title="Arsenic">arsenic</a> compound, was used by dermatologists as a treatment for psoriasis.<sup id="cite_ref-Gruber2004_85-2" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup> <a href="/wiki/Mercury_(element)" title="Mercury (element)">Mercury</a> was also used for psoriasis treatment during this time period.<sup id="cite_ref-Gruber2004_85-3" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup> <a href="/wiki/Sulfur" title="Sulfur">Sulfur</a>, <a href="/wiki/Iodine" title="Iodine">iodine</a>, <a href="/wiki/Phenol" title="Phenol">phenol</a> were also commonly used treatments for psoriasis during this era when it was incorrectly believed that psoriasis was an infectious disease.<sup id="cite_ref-Gruber2004_85-4" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup> Coal tars were widely used with ultraviolet light irradiation as a topical treatment approach in the early 1900s.<sup id="cite_ref-Gruber2004_85-5" class="reference"><a href="#cite_note-Gruber2004-85"><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-Benedek2013_Part_2_88-0" class="reference"><a href="#cite_note-Benedek2013_Part_2-88"><span>[</span>88<span>]</span></a></sup> During the same time period, psoriatic arthritis cases were treated with intravenously administered gold preparations in the same manner as <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>.<sup id="cite_ref-Benedek2013_Part_2_88-1" class="reference"><a href="#cite_note-Benedek2013_Part_2-88"><span>[</span>88<span>]</span></a></sup> All of these treatments have been replaced with modern topical and systemic therapies.</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=29" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The International Federation of Psoriasis Associations (IFPA) is the global umbrella organization for national and regional psoriasis patient associations and also gathers the leading experts in psoriasis and psoriatic arthritis research for scientific conferences every three years.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup> The Psoriasis International Network, a program of the <a href="/w/index.php?title=Fondation_Ren%C3%A9_Touraine&amp;action=edit&amp;redlink=1" class="new" title="Fondation René Touraine (page does not exist)">Fondation René Touraine</a>, gathers dermatologists, <a href="/wiki/Rheumatologist" title="Rheumatologist" class="mw-redirect">rheumatologists</a> and other caregivers involved in the management of psoriasis.</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=30" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The role of <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> in the pathogenesis of psoriasis is currently under investigation. Preliminary research has suggested that <a href="/wiki/Antioxidant" title="Antioxidant">antioxidants</a> such as <a href="/wiki/Polyphenol" title="Polyphenol">polyphenols</a> may have beneficial effects on the inflammation characteristic of psoriasis.<sup id="cite_ref-Dubois2013_90-0" class="reference"><a href="#cite_note-Dubois2013-90"><span>[</span>90<span>]</span></a></sup></p>
<p>Many novel drugs being researched target the <a href="/wiki/Th17" title="Th17" class="mw-redirect">Th17</a>/<a href="/wiki/Interleukin_23_subunit_alpha" title="Interleukin 23 subunit alpha">IL-23</a> axis,<sup id="cite_ref-Dubois2013_90-1" class="reference"><a href="#cite_note-Dubois2013-90"><span>[</span>90<span>]</span></a></sup> particularly <a href="/wiki/Interleukin_23_subunit_alpha" title="Interleukin 23 subunit alpha">IL-23p19</a> inhibitors, as IL-23p19 is present in increased concentrations in psoriasis skin lesions while contributing less to protection against opportunistic infections.<sup id="cite_ref-Patel2012_91-0" class="reference"><a href="#cite_note-Patel2012-91"><span>[</span>91<span>]</span></a></sup> Other cytokines such as <a href="/wiki/IL-17" title="IL-17">IL-17</a> and <a href="/wiki/IL-22" title="IL-22">IL-22</a> also have been targets for inhibition as they play important roles in the pathogenesis of psoriasis.<sup id="cite_ref-Patel2012_91-1" class="reference"><a href="#cite_note-Patel2012-91"><span>[</span>91<span>]</span></a></sup> Another avenue of research has focused on the use of <a href="/wiki/Vascular_endothelial_growth_factor_receptor_tyrosine_kinase_inhibitor" title="Vascular endothelial growth factor receptor tyrosine kinase inhibitor" class="mw-redirect">vascular endothelial growth factor inhibitors</a> to treat psoriasis.<sup id="cite_ref-Weidemann2013_52-1" class="reference"><a href="#cite_note-Weidemann2013-52"><span>[</span>52<span>]</span></a></sup> Oral agents being investigated as an alternative to drugs administered by injection include <a href="/wiki/Janus_kinase_inhibitor" title="Janus kinase inhibitor">Janus kinase inhibitor</a> inhibitors, <a href="/wiki/Protein_kinase_C" title="Protein kinase C">protein kinase C</a> inhibitors, <a href="/wiki/Mitogen-activated_protein_kinase" title="Mitogen-activated protein kinase">mitogen-activated protein kinase</a> inhibitors, and <a href="/wiki/PDE4_inhibitor" title="PDE4 inhibitor" class="mw-redirect">phosphodiesterase 4 inhibitors</a>, all of which have proven effective in various phase 2 and 3 clinical trials.<sup id="cite_ref-Dubois2013_90-2" class="reference"><a href="#cite_note-Dubois2013-90"><span>[</span>90<span>]</span></a></sup><sup id="cite_ref-Patel2012_91-2" class="reference"><a href="#cite_note-Patel2012-91"><span>[</span>91<span>]</span></a></sup> However, these agents have potential severe side-effects due to their immunosuppressive mechanisms.<sup id="cite_ref-Patel2012_91-3" class="reference"><a href="#cite_note-Patel2012-91"><span>[</span>91<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=31" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Ritchlin2007-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ritchlin2007_1-0">^</a></b></span> <span class="reference-text"><span class="citation book">Ritchlin, Christopher; Fitzgerald, Oliver (2007). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=RN-B2g2YjmAC&amp;pg=PA4&amp;lpg=PA4"><i>Psoriatic and Reactive Arthritis: A Companion to Rheumatology</i></a> (1st ed.). Maryland Heights, Miss.: Mosby. p.&#160;4. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-323-03622-1" title="Special:BookSources/978-0-323-03622-1">978-0-323-03622-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aufirst=Christopher&amp;rft.aulast=Ritchlin&amp;rft.au=Ritchlin%2C+Christopher&amp;rft.btitle=Psoriatic+and+Reactive+Arthritis%3A+A+Companion+to+Rheumatology&amp;rft.date=2007&amp;rft.edition=1st&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DRN-B2g2YjmAC%26pg%3DPA4%26lpg%3DPA4&amp;rft.isbn=978-0-323-03622-1&amp;rft.pages=4&amp;rft.place=Maryland+Heights%2C+Miss.&amp;rft.pub=Mosby&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Menter2008-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Menter2008_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Menter2008_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Menter2008_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Menter2008_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Menter2008_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Menter2008_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Menter2008_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Menter2008_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Menter2008_2-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Menter, A.,Gottlieb, A., Feldman, S.R., Van Voorhees, A.S., Leonardi, C.L., Gordon, K.B., Lebwohl, M., Koo, JY., Elmets, C.A., Korman, N.J., Beutner, K.R., Bhushan, R. (May 2008). "Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics". <i>J Am Acad Dermatol</i> <b>58</b> (5): 826–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2008.02.039">10.1016/j.jaad.2008.02.039</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18423260">18423260</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Guidelines+of+care+for+the+management+of+psoriasis+and+psoriatic+arthritis%3A+Section+1.+Overview+of+psoriasis+and+guidelines+of+care+for+the+treatment+of+psoriasis+with+biologics&amp;rft.aulast=Menter%2C+A.%2CGottlieb%2C+A.%2C+Feldman%2C+S.R.%2C+Van+Voorhees%2C+A.S.%2C+Leonardi%2C+C.L.%2C+Gordon%2C+K.B.%2C+Lebwohl%2C+M.%2C+Koo%2C+JY.%2C+Elmets%2C+C.A.%2C+Korman%2C+N.J.%2C+Beutner%2C+K.R.%2C+Bhushan%2C+R.&amp;rft.au=Menter%2C+A.%2CGottlieb%2C+A.%2C+Feldman%2C+S.R.%2C+Van+Voorhees%2C+A.S.%2C+Leonardi%2C+C.L.%2C+Gordon%2C+K.B.%2C+Lebwohl%2C+M.%2C+Koo%2C+JY.%2C+Elmets%2C+C.A.%2C+Korman%2C+N.J.%2C+Beutner%2C+K.R.%2C+Bhushan%2C+R.&amp;rft.date=May+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2008.02.039&amp;rft_id=info%3Apmid%2F18423260&amp;rft.issue=5&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=826%E2%80%9350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Parisi2013-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Parisi2013_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Parisi2013_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Parisi2013_3-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Parisi R, Symmons DP, Griffiths CE, Ashcroft DM; Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team (February 2013). "Global epidemiology of psoriasis: a systematic review of incidence and prevalence". <i>J Invest Dermatol</i> <b>133</b> (2): 377–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fjid.2012.339">10.1038/jid.2012.339</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23014338">23014338</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Global+epidemiology+of+psoriasis%3A+a+systematic+review+of+incidence+and+prevalence&amp;rft.aulast=Parisi+R%2C+Symmons+DP%2C+Griffiths+CE%2C+Ashcroft+DM%3B+Identification+and+Management+of+Psoriasis+and+Associated+ComorbidiTy+%28IMPACT%29+project+team&amp;rft.au=Parisi+R%2C+Symmons+DP%2C+Griffiths+CE%2C+Ashcroft+DM%3B+Identification+and+Management+of+Psoriasis+and+Associated+ComorbidiTy+%28IMPACT%29+project+team&amp;rft.date=February+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fjid.2012.339&amp;rft_id=info%3Apmid%2F23014338&amp;rft.issue=2&amp;rft.jtitle=J+Invest+Dermatol&amp;rft.pages=377%E2%80%9385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation web">University of California, Davis, Department of Dermatology. <a rel="nofollow" class="external text" href="http://www.ucdmc.ucdavis.edu/dermatology/patient_information/psoriasis.html">"Psoriasis"</a><span class="reference-accessdate">. Retrieved 22 April 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aulast=University+of+California%2C+Davis%2C+Department+of+Dermatology&amp;rft.au=University+of+California%2C+Davis%2C+Department+of+Dermatology&amp;rft.btitle=Psoriasis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.ucdmc.ucdavis.edu%2Fdermatology%2Fpatient_information%2Fpsoriasis.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jain2012-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jain2012_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jain2012_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jain2012_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jain2012_5-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jain2012_5-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Jain2012_5-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Jain2012_5-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Jain2012_5-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Jain, Sima (2012). <a rel="nofollow" class="external text" href="http://books.google.com/?id=r4Xzi0LKROcC&amp;printsec=frontcover&amp;dq=dermatology#v=onepage&amp;q=psoriasis&amp;f=false"><i>Dermatology&#160;: illustrated study guide and comprehensive board review</i></a>. New York: Springer. pp.&#160;83–87. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4419-0524-6" title="Special:BookSources/978-1-4419-0524-6">978-1-4419-0524-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aufirst=Sima&amp;rft.au=Jain%2C+Sima&amp;rft.aulast=Jain&amp;rft.btitle=Dermatology+%3A+illustrated+study+guide+and+comprehensive+board+review&amp;rft.date=2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3Dr4Xzi0LKROcC%26printsec%3Dfrontcover%26dq%3Ddermatology%23v%3Donepage%26q%3Dpsoriasis%26f%3Dfalse&amp;rft.isbn=978-1-4419-0524-6&amp;rft.pages=83%E2%80%9387&amp;rft.place=New+York&amp;rft.pub=Springer&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Weller2008-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Weller2008_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Weller2008_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Weller2008_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Weller2008_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Weller2008_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Weller2008_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Weller2008_6-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Weller, Richard; John AA Hunter, John Savin, Mark Dahl (2008). <a rel="nofollow" class="external text" href="http://books.google.com/?id=5RHM0Nerk9gC&amp;printsec=frontcover&amp;dq=dermatology#v=onepage&amp;q=psoriasis&amp;f=false"><i>Clinical dermatology</i></a> (4th ed.). Malden, Mass.: Blackwell Pub. pp.&#160;54–70. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4443-0009-3" title="Special:BookSources/978-1-4443-0009-3">978-1-4443-0009-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aufirst=Richard&amp;rft.aulast=Weller&amp;rft.au=Weller%2C+Richard&amp;rft.btitle=Clinical+dermatology&amp;rft.date=2008&amp;rft.edition=4th&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3D5RHM0Nerk9gC%26printsec%3Dfrontcover%26dq%3Ddermatology%23v%3Donepage%26q%3Dpsoriasis%26f%3Dfalse&amp;rft.isbn=978-1-4443-0009-3&amp;rft.pages=54%E2%80%9370&amp;rft.place=Malden%2C+Mass.&amp;rft.pub=Blackwell+Pub.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Zhou Q, Mrowietz U, Rostami-Yazdi M (October 2009). "Oxidative stress in the pathogenesis of psoriasis". <i>Free Radic Biol Med</i> <b>47</b> (7): 891–905. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.freeradbiomed.2009.06.033">10.1016/j.freeradbiomed.2009.06.033</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19577640">19577640</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Oxidative+stress+in+the+pathogenesis+of+psoriasis&amp;rft.aulast=Zhou+Q%2C+Mrowietz+U%2C+Rostami-Yazdi+M&amp;rft.au=Zhou+Q%2C+Mrowietz+U%2C+Rostami-Yazdi+M&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.freeradbiomed.2009.06.033&amp;rft_id=info%3Apmid%2F19577640&amp;rft.issue=7&amp;rft.jtitle=Free+Radic+Biol+Med&amp;rft.pages=891%E2%80%93905&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Chong2013-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chong2013_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chong HT, Kopecki Z, Cowin AJ (August 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3766987">"Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis"</a>. <i>Biomed Res Int</i> <b>2013</b> (168321). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2013%2F168321">10.1155/2013/168321</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3766987">3766987</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24062996">24062996</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Lifting+the+silver+flakes%3A+the+pathogenesis+and+management+of+chronic+plaque+psoriasis&amp;rft.au=Chong+HT%2C+Kopecki+Z%2C+Cowin+AJ&amp;rft.aulast=Chong+HT%2C+Kopecki+Z%2C+Cowin+AJ&amp;rft.date=August+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3766987&amp;rft_id=info%3Adoi%2F10.1155%2F2013%2F168321&amp;rft_id=info%3Apmc%2F3766987&amp;rft_id=info%3Apmid%2F24062996&amp;rft.issue=168321&amp;rft.jtitle=Biomed+Res+Int&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2013" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ely2010-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ely2010_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ely JW, Seabury Stone M (March 2010). <a rel="nofollow" class="external text" href="http://www.aafp.org/afp/2010/0315/p735.html">"The generalized rash: part II. Diagnostic approach"</a>. <i>Am Fam Physician</i> <b>81</b> (6): 735–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20229972">20229972</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=The+generalized+rash%3A+part+II.+Diagnostic+approach&amp;rft.au=Ely+JW%2C+Seabury+Stone+M&amp;rft.aulast=Ely+JW%2C+Seabury+Stone+M&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.aafp.org%2Fafp%2F2010%2F0315%2Fp735.html&amp;rft_id=info%3Apmid%2F20229972&amp;rft.issue=6&amp;rft.jtitle=Am+Fam+Physician&amp;rft.pages=735%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Johnson_166.E2.80.9372-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Johnson_166.E2.80.9372_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Johnson_166.E2.80.9372_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Johnson MA, Armstrong AW (2012). "Clinical and Histologic Diagnostic Guidelines for Psoriasis: A Critical Review". <i>Clin Rev Allerg Immunol</i> <b>44</b> (2): 166–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs12016-012-8305-3">10.1007/s12016-012-8305-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22278173">22278173</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Clinical+and+Histologic+Diagnostic+Guidelines+for+Psoriasis%3A+A+Critical+Review&amp;rft.au=Johnson+MA%2C+Armstrong+AW&amp;rft.aulast=Johnson+MA%2C+Armstrong+AW&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs12016-012-8305-3&amp;rft_id=info%3Apmid%2F22278173&amp;rft.issue=2&amp;rft.jtitle=Clin+Rev+Allerg+Immunol&amp;rft.pages=166%E2%80%9372&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jobling_R_2007_953.E2.80.934-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jobling_R_2007_953.E2.80.934_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jobling R (2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1865393">"Psoriasis"</a>. <i>BMJ</i> <b>334</b> (7600): 953–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.39184.615150.802">10.1136/bmj.39184.615150.802</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1865393">1865393</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17478850">17478850</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis&amp;rft.au=Jobling+R&amp;rft.aulast=Jobling+R&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1865393&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39184.615150.802&amp;rft_id=info%3Apmc%2F1865393&amp;rft_id=info%3Apmid%2F17478850&amp;rft.issue=7600&amp;rft.jtitle=BMJ&amp;rft.pages=953%E2%80%934&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=334" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Palfreeman2013-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Palfreeman2013_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Palfreeman2013_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Palfreeman2013_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Palfreeman2013_12-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Palfreeman AC, McNamee KE, McCann FE (March 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3615921">"New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast"</a>. <i>Drug Des Devel Ther</i> <b>7</b>: 201–210. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2147%2FDDDT.S32713">10.2147/DDDT.S32713</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3615921">3615921</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23569359">23569359</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=New+developments+in+the+management+of+psoriasis+and+psoriatic+arthritis%3A+a+focus+on+apremilast&amp;rft.aulast=Palfreeman+AC%2C+McNamee+KE%2C+McCann+FE&amp;rft.au=Palfreeman+AC%2C+McNamee+KE%2C+McCann+FE&amp;rft.date=March+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3615921&amp;rft_id=info%3Adoi%2F10.2147%2FDDDT.S32713&amp;rft_id=info%3Apmc%2F3615921&amp;rft_id=info%3Apmid%2F23569359&amp;rft.jtitle=Drug+Des+Devel+Ther&amp;rft.pages=201%E2%80%93210&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DAVIDSONS2010-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-DAVIDSONS2010_13-0">^</a></b></span> <span class="reference-text"><span class="citation book">Colledge, N.R.; Walker, B.R.; Ralston, S.H., ed. (2010). <i>Davidson's principles and practice of medicine.</i> (21st ed.). Edinburgh: Churchill Livingstone/Elsevier. pp.&#160;1260–1261. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7020-3084-0" title="Special:BookSources/978-0-7020-3084-0">978-0-7020-3084-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.btitle=Davidson%27s+principles+and+practice+of+medicine.&amp;rft.date=2010&amp;rft.edition=21st&amp;rft.genre=book&amp;rft.isbn=978-0-7020-3084-0&amp;rft.pages=1260%E2%80%931261&amp;rft.place=Edinburgh&amp;rft.pub=Churchill+Livingstone%2FElsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zattra2012-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zattra2012_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zattra2012_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Zattra E, Belloni Fortina A, Peserico A, Alaibac M (May 2012). <a rel="nofollow" class="external text" href="http://www.jle.com/en/revues/medecine/ejd/e-docs/00/04/76/03/article.phtml">"Erythroderma in the era of biological therapies"</a>. <i>Eur J Dermatol</i> <b>22</b> (2): 167–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1684%2Fejd.2011.1569">10.1684/ejd.2011.1569</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22321651">22321651</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Erythroderma+in+the+era+of+biological+therapies&amp;rft.aulast=Zattra+E%2C+Belloni+Fortina+A%2C+Peserico+A%2C+Alaibac+M&amp;rft.au=Zattra+E%2C+Belloni+Fortina+A%2C+Peserico+A%2C+Alaibac+M&amp;rft.date=May+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jle.com%2Fen%2Frevues%2Fmedecine%2Fejd%2Fe-docs%2F00%2F04%2F76%2F03%2Farticle.phtml&amp;rft_id=info%3Adoi%2F10.1684%2Fejd.2011.1569&amp;rft_id=info%3Apmid%2F22321651&amp;rft.issue=2&amp;rft.jtitle=Eur+J+Dermatol&amp;rft.pages=167%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DermNZ-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-DermNZ_15-0">^</a></b></span> <span class="reference-text"><span class="citation web">Stanway A. <a rel="nofollow" class="external text" href="http://dermnetnz.org/scaly/erythrodermic-psoriasis.html">"Erythrodermic psoriasis"</a>. DermNet NZ<span class="reference-accessdate">. Retrieved 16 March 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aulast=Stanway+A&amp;rft.au=Stanway+A&amp;rft.btitle=Erythrodermic+psoriasis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fdermnetnz.org%2Fscaly%2Ferythrodermic-psoriasis.html&amp;rft.pub=DermNet+NZ&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF Jr, Kalb RE (2012). "Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation". <i>J Am Acad Dermatol</i> <b>67</b> (2): 279–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2011.01.032">10.1016/j.jaad.2011.01.032</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22609220">22609220</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Treatment+of+pustular+psoriasis%3A+From+the+Medical+Board+of+the+National+Psoriasis+Foundation&amp;rft.aulast=Robinson+A%2C+Van+Voorhees+AS%2C+Hsu+S%2C+Korman+NJ%2C+Lebwohl+MG%2C+Bebo+BF+Jr%2C+Kalb+RE&amp;rft.au=Robinson+A%2C+Van+Voorhees+AS%2C+Hsu+S%2C+Korman+NJ%2C+Lebwohl+MG%2C+Bebo+BF+Jr%2C+Kalb+RE&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2011.01.032&amp;rft_id=info%3Apmid%2F22609220&amp;rft.issue=2&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=279%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Raychaudhuri2014-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Raychaudhuri2014_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Raychaudhuri2014_17-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Raychaudhuri SK, Maverakis E, Raychaudhuri SP (January 2014). "Diagnosis and classification of psoriasis". <i>Autoimmun Rev</i>. S1568-9972 (14): 00020–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.autrev.2014.01.008">10.1016/j.autrev.2014.01.008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24434359">24434359</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Diagnosis+and+classification+of+psoriasis&amp;rft.aulast=Raychaudhuri+SK%2C+Maverakis+E%2C+Raychaudhuri+SP&amp;rft.au=Raychaudhuri+SK%2C+Maverakis+E%2C+Raychaudhuri+SP&amp;rft.date=January+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2014.01.008&amp;rft_id=info%3Apmid%2F24434359&amp;rft.issue=14&amp;rft.jtitle=Autoimmun+Rev&amp;rft.pages=00020%E2%80%932&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=S1568-9972" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Naik2013-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Naik2013_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Naik2013_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Naik2013_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Naik2013_18-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Naik2013_18-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Naik HB, Cowen EW (July 2013). "Autoinflammatory pustular neutrophilic diseases". <i>Dermatol Clin</i> <b>31</b> (3): 405–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.det.2013.04.001">10.1016/j.det.2013.04.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23827244">23827244</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Autoinflammatory+pustular+neutrophilic+diseases&amp;rft.aulast=Naik+HB%2C+Cowen+EW&amp;rft.au=Naik+HB%2C+Cowen+EW&amp;rft.date=July+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.det.2013.04.001&amp;rft_id=info%3Apmid%2F23827244&amp;rft.issue=3&amp;rft.jtitle=Dermatol+Clin&amp;rft.pages=405%E2%80%9325&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Andrews-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Andrews_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Andrews_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">James, William; Berger, Timothy; Elston, Dirk (2005). <i>Andrews' Diseases of the Skin: Clinical Dermatology</i> (10th ed.). Saunders. pp.&#160;191–7. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7216-2921-0" title="Special:BookSources/0-7216-2921-0">0-7216-2921-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.au=James%2C+William%3B+Berger%2C+Timothy%3B+Elston%2C+Dirk&amp;rft.aulast=James%2C+William%3B+Berger%2C+Timothy%3B+Elston%2C+Dirk&amp;rft.btitle=Andrews%27+Diseases+of+the+Skin%3A+Clinical+Dermatology&amp;rft.date=2005&amp;rft.edition=10th&amp;rft.genre=book&amp;rft.isbn=0-7216-2921-0&amp;rft.pages=191%E2%80%937&amp;rft.pub=Saunders&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Weigle2013-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Weigle2013_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Weigle2013_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Weigle2013_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Weigle2013_20-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Weigle N, McBane S (May 2013). "Psoriasis". <i>Am Fam Physician</i> <b>87</b> (9): 626–33. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23668525">23668525</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis&amp;rft.aulast=Weigle+N%2C+McBane+S&amp;rft.au=Weigle+N%2C+McBane+S&amp;rft.date=May+2013&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F23668525&amp;rft.issue=9&amp;rft.jtitle=Am+Fam+Physician&amp;rft.pages=626%E2%80%9333&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=87" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gudjonsson2012-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gudjonsson2012_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gudjonsson2012_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Gudjonsson2012_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Gudjonsson2012_21-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Gudjonsson JE, Elder JT, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (2012). "18: Psoriasis". <i>Fitzpatrick's Dermatology in General Medicine</i> (8th ed.). New York: McGraw-Hill. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-07-166904-3" title="Special:BookSources/0-07-166904-3">0-07-166904-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Fitzpatrick%27s+Dermatology+in+General+Medicine&amp;rft.au=Gudjonsson+JE%2C+Elder+JT%2C+Goldsmith+LA%2C+Katz+SI%2C+Gilchrest+BA%2C+Paller+AS%2C+Leffell+DJ%2C+Wolff+K&amp;rft.aulast=Gudjonsson+JE%2C+Elder+JT%2C+Goldsmith+LA%2C+Katz+SI%2C+Gilchrest+BA%2C+Paller+AS%2C+Leffell+DJ%2C+Wolff+K&amp;rft.btitle=18%3A+Psoriasis&amp;rft.date=2012&amp;rft.edition=8th&amp;rft.genre=bookitem&amp;rft.isbn=0-07-166904-3&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gelmetti2009-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gelmetti2009_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gelmetti2009_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gelmetti C (January 2009). "Therapeutic moisturizers as adjuvant therapy for psoriasis patients". <i>Am J Clin Dermatol</i> <b>10</b> (Suppl 1): 7–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F0128071-200910001-00002">10.2165/0128071-200910001-00002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19209948">19209948</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Therapeutic+moisturizers+as+adjuvant+therapy+for+psoriasis+patients&amp;rft.au=Gelmetti+C&amp;rft.aulast=Gelmetti+C&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F0128071-200910001-00002&amp;rft_id=info%3Apmid%2F19209948&amp;rft.issue=Suppl+1&amp;rft.jtitle=Am+J+Clin+Dermatol&amp;rft.pages=7%E2%80%9312&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Yesudian2012-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Yesudian2012_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Yesudian2012_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Yesudian2012_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Yesudian PD, Chalmers RJ, Warren RB, Griffiths CE (January 2012). "In search of oral psoriasis". <i>Arch Dermatol Res</i> <b>304</b> (1): 1–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00403-011-1175-3">10.1007/s00403-011-1175-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21927905">21927905</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=In+search+of+oral+psoriasis&amp;rft.aulast=Yesudian+PD%2C+Chalmers+RJ%2C+Warren+RB%2C+Griffiths+CE&amp;rft.au=Yesudian+PD%2C+Chalmers+RJ%2C+Warren+RB%2C+Griffiths+CE&amp;rft.date=January+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00403-011-1175-3&amp;rft_id=info%3Apmid%2F21927905&amp;rft.issue=1&amp;rft.jtitle=Arch+Dermatol+Res&amp;rft.pages=1%E2%80%935&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=304" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation book">Ship, Martin S. Greenberg, Michael Glick, Jonathan A. (2008). <i>Burket's oral medicine</i> (11th ed.). Hamilton, Ont.: BC Decker. pp.&#160;103–104. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-55009-345-2" title="Special:BookSources/1-55009-345-2">1-55009-345-2</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.aufirst=Martin+S.+Greenberg%2C+Michael+Glick%2C+Jonathan+A.&amp;rft.aulast=Ship&amp;rft.au=Ship%2C+Martin+S.+Greenberg%2C+Michael+Glick%2C+Jonathan+A.&amp;rft.btitle=Burket%27s+oral+medicine&amp;rft.date=2008&amp;rft.edition=11th&amp;rft.genre=book&amp;rft.isbn=1-55009-345-2&amp;rft.pages=103%E2%80%93104&amp;rft.place=Hamilton%2C+Ont.&amp;rft.pub=BC+Decker&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Reamy,BV Derby R, Bunt CW (March 2010). "Common tongue conditions in primary care". <i>Am Fam Physician</i> <b>81</b> (5): 627–34. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20187599">20187599</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Common+tongue+conditions+in+primary+care&amp;rft.aulast=Reamy%2CBV+Derby+R%2C+Bunt+CW&amp;rft.au=Reamy%2CBV+Derby+R%2C+Bunt+CW&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F20187599&amp;rft.issue=5&amp;rft.jtitle=Am+Fam+Physician&amp;rft.pages=627%E2%80%9334&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=81" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Krawczyk2013-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Krawczyk2013_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Krawczyk-Wasielewska A, Skorupska E, Samborski W (April 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3834688">"Sacroiliac joint pain as an important element of psoriatic arthritis diagnosis"</a>. <i>Postepy Dermatol Alergol</i> <b>30</b> (2): 108–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.5114%2Fpdia.2013.34161">10.5114/pdia.2013.34161</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3834688">3834688</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24278057">24278057</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Sacroiliac+joint+pain+as+an+important+element+of+psoriatic+arthritis+diagnosis&amp;rft.au=Krawczyk-Wasielewska+A%2C+Skorupska+E%2C+Samborski+W&amp;rft.aulast=Krawczyk-Wasielewska+A%2C+Skorupska+E%2C+Samborski+W&amp;rft.date=April+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834688&amp;rft_id=info%3Adoi%2F10.5114%2Fpdia.2013.34161&amp;rft_id=info%3Apmc%2F3834688&amp;rft_id=info%3Apmid%2F24278057&amp;rft.issue=2&amp;rft.jtitle=Postepy+Dermatol+Alergol&amp;rft.pages=108%E2%80%9312&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tan2012-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tan2012_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tan2012_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tan ES, Chong WS, Tey HL (December 2012). "Nail psoriasis: a review". <i>Am J Clin Dermatol</i> <b>13</b> (6): 375–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F11597000-000000000-00000">10.2165/11597000-000000000-00000</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22784035">22784035</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Nail+psoriasis%3A+a+review&amp;rft.aulast=Tan+ES%2C+Chong+WS%2C+Tey+HL&amp;rft.au=Tan+ES%2C+Chong+WS%2C+Tey+HL&amp;rft.date=December+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11597000-000000000-00000&amp;rft_id=info%3Apmid%2F22784035&amp;rft.issue=6&amp;rft.jtitle=Am+J+Clin+Dermatol&amp;rft.pages=375%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Krueger-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Krueger_28-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Krueger G, Ellis CN (2005). "Psoriasis—recent advances in understanding its pathogenesis and treatment". <i>J. Am. Acad. Dermatol.</i> <b>53</b> (1 Suppl 1): S94–100. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2005.04.035">10.1016/j.jaad.2005.04.035</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15968269">15968269</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis%E2%80%94recent+advances+in+understanding+its+pathogenesis+and+treatment&amp;rft.au=Krueger+G%2C+Ellis+CN&amp;rft.aulast=Krueger+G%2C+Ellis+CN&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2005.04.035&amp;rft_id=info%3Apmid%2F15968269&amp;rft.issue=1+Suppl+1&amp;rft.jtitle=J.+Am.+Acad.+Dermatol.&amp;rft.pages=S94%E2%80%93100&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=53" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nestle-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nestle_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nestle_29-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nestle_29-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nestle_29-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nestle_29-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nestle_29-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nestle_29-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nestle_29-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nestle_29-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nestle_29-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nestle_29-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nestle_29-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nestle_29-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nestle_29-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Nestle FO, Kaplan DH, Barker J (2009). "Psoriasis". <i>N. Engl. J. Med.</i> <b>361</b> (5): 496–509. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMra0804595">10.1056/NEJMra0804595</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19641206">19641206</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis&amp;rft.aulast=Nestle+FO%2C+Kaplan+DH%2C+Barker+J&amp;rft.au=Nestle+FO%2C+Kaplan+DH%2C+Barker+J&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra0804595&amp;rft_id=info%3Apmid%2F19641206&amp;rft.issue=5&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=496%E2%80%93509&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=361" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Prieto2013-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-Prieto2013_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Prieto2013_30-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F. (August 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3771250">"Genetics of Psoriasis and Pharmacogenetics of Biological Drugs"</a>. <i>Autoimmune Dis.</i> <b>2013</b> (613086): 613086. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2013%2F613086">10.1155/2013/613086</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3771250">3771250</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24069534">24069534</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Genetics+of+Psoriasis+and+Pharmacogenetics+of+Biological+Drugs&amp;rft.aulast=Prieto-P%C3%A9rez+R%2C+Cabaleiro+T%2C+Daud%C3%A9n+E%2C+Ochoa+D%2C+Roman+M%2C+Abad-Santos+F.&amp;rft.au=Prieto-P%C3%A9rez+R%2C+Cabaleiro+T%2C+Daud%C3%A9n+E%2C+Ochoa+D%2C+Roman+M%2C+Abad-Santos+F.&amp;rft.date=August+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3771250&amp;rft_id=info%3Adoi%2F10.1155%2F2013%2F613086&amp;rft_id=info%3Apmc%2F3771250&amp;rft_id=info%3Apmid%2F24069534&amp;rft.issue=613086&amp;rft.jtitle=Autoimmune+Dis.&amp;rft.pages=613086&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2013" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jordan1-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jordan1_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jordan CT, Cao L, Roberson EDO et al. (April 2012). <a rel="nofollow" class="external text" href="http://www.cell.com/AJHG/abstract/S0002-9297%2812%2900157-7">"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis"</a>. <i>The American Journal of Human Genetics</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.ajhg.2012.03.013">10.1016/j.ajhg.2012.03.013</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Rare+and+common+variants+in+CARD14%2C+encoding+an+epidermal+regulator+of+NF-kappaB%2C+in+psoriasis&amp;rft.au=Jordan+CT%2C+Cao+L%2C+Roberson+EDO+et+al.&amp;rft.aulast=Jordan+CT%2C+Cao+L%2C+Roberson+EDO+et+al.&amp;rft.date=April+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cell.com%2FAJHG%2Fabstract%2FS0002-9297%252812%252900157-7&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ajhg.2012.03.013&amp;rft.jtitle=The+American+Journal+of+Human+Genetics&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jordan2-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jordan2_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jordan CT, Cao L, Roberson EDO et al. (April 2012). <a rel="nofollow" class="external text" href="http://www.cell.com/AJHG/abstract/S0002-9297%2812%2900156-5">"PSORS2 is due to mutations in CARD14"</a>. <i>The American Journal of Human Genetics</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.ajhg.2012.03.012">10.1016/j.ajhg.2012.03.012</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=PSORS2+is+due+to+mutations+in+CARD14&amp;rft.au=Jordan+CT%2C+Cao+L%2C+Roberson+EDO+et+al.&amp;rft.aulast=Jordan+CT%2C+Cao+L%2C+Roberson+EDO+et+al.&amp;rft.date=April+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cell.com%2FAJHG%2Fabstract%2FS0002-9297%252812%252900156-5&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ajhg.2012.03.012&amp;rft.jtitle=The+American+Journal+of+Human+Genetics&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Clarke2011-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-Clarke2011_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Clarke2011_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Clarke P (July 2011). <a rel="nofollow" class="external text" href="http://www.racgp.org.au/download/documents/AFP/2011/July/201107clark.pdf">"Psoriasis"</a>. <i>Aust Fam Physician</i> <b>40</b> (7): 468–73. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21743850">21743850</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis&amp;rft.au=Clarke+P&amp;rft.aulast=Clarke+P&amp;rft.date=July+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.racgp.org.au%2Fdownload%2Fdocuments%2FAFP%2F2011%2FJuly%2F201107clark.pdf&amp;rft_id=info%3Apmid%2F21743850&amp;rft.issue=7&amp;rft.jtitle=Aust+Fam+Physician&amp;rft.pages=468%E2%80%9373&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Richard2013-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-Richard2013_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Richard2013_34-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Richard2013_34-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Richard2013_34-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Richard2013_34-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Richard2013_34-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Richard2013_34-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Richard2013_34-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Richard MA, Barnetche T, Horreau C, Brenaut E, Pouplard C, Aractingi S, Aubin F, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Ortonne JP, Paul C. (August 2013). "Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion". <i>J Eur Acad Dermatol Venereol</i> <b>27</b> (Supplement 3): 2–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fjdv.12162">10.1111/jdv.12162</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23845148">23845148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis%2C+cardiovascular+events%2C+cancer+risk+and+alcohol+use%3A+evidence-based+recommendations+based+on+systematic+review+and+expert+opinion&amp;rft.aulast=Richard+MA%2C+Barnetche+T%2C+Horreau+C%2C+Brenaut+E%2C+Pouplard+C%2C+Aractingi+S%2C+Aubin+F%2C+Cribier+B%2C+Joly+P%2C+Jullien+D%2C+Le+Ma%C3%AEtre+M%2C+Misery+L%2C+Ortonne+JP%2C+Paul+C.&amp;rft.au=Richard+MA%2C+Barnetche+T%2C+Horreau+C%2C+Brenaut+E%2C+Pouplard+C%2C+Aractingi+S%2C+Aubin+F%2C+Cribier+B%2C+Joly+P%2C+Jullien+D%2C+Le+Ma%C3%AEtre+M%2C+Misery+L%2C+Ortonne+JP%2C+Paul+C.&amp;rft.date=August+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fjdv.12162&amp;rft_id=info%3Apmid%2F23845148&amp;rft.issue=Supplement+3&amp;rft.jtitle=J+Eur+Acad+Dermatol+Venereol&amp;rft.pages=2%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Fife2007-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fife2007_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fife2007_35-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Fife DJ, Waller JM, Jeffes EW, Koo JYM (May 2007). <a rel="nofollow" class="external text" href="http://dermatology.cdlib.org/132/reviews/HIV/fife.html">"Unraveling the Paradoxes of HIV-associated Psoriasis: A Review of T-cell Subsets and Cytokine Profiles"</a>. <i>Dermatology Online Journal</i> <b>13</b> (2).</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Unraveling+the+Paradoxes+of+HIV-associated+Psoriasis%3A+A+Review+of+T-cell+Subsets+and+Cytokine+Profiles&amp;rft.au=Fife+DJ%2C+Waller+JM%2C+Jeffes+EW%2C+Koo+JYM&amp;rft.aulast=Fife+DJ%2C+Waller+JM%2C+Jeffes+EW%2C+Koo+JYM&amp;rft.date=May+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fdermatology.cdlib.org%2F132%2Freviews%2FHIV%2Ffife.html&amp;rft.issue=2&amp;rft.jtitle=Dermatology+Online+Journal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cedeno2011-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cedeno2011_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cedeno2011_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cedeno2011_36-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, Trujillo JR (January 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037296">"New insights into HIV-1-primary skin disorders"</a>. <i>J Int AIDS Soc</i> <b>14</b> (5). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1186%2F1758-2652-14-5">10.1186/1758-2652-14-5</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3037296">3037296</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21261982">21261982</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=New+insights+into+HIV-1-primary+skin+disorders&amp;rft.au=Cedeno-Laurent+F%2C+G%C3%B3mez-Flores+M%2C+Mendez+N%2C+Ancer-Rodr%C3%ADguez+J%2C+Bryant+JL%2C+Gaspari+AA%2C+Trujillo+JR&amp;rft.aulast=Cedeno-Laurent+F%2C+G%C3%B3mez-Flores+M%2C+Mendez+N%2C+Ancer-Rodr%C3%ADguez+J%2C+Bryant+JL%2C+Gaspari+AA%2C+Trujillo+JR&amp;rft.date=January+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3037296&amp;rft_id=info%3Adoi%2F10.1186%2F1758-2652-14-5&amp;rft_id=info%3Apmc%2F3037296&amp;rft_id=info%3Apmid%2F21261982&amp;rft.issue=5&amp;rft.jtitle=J+Int+AIDS+Soc&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wong2013-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wong2013_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wong2013_37-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wong T, Hsu L, Liao W (January–February 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3736829">"Phototherapy in psoriasis: a review of mechanisms of action"</a>. <i>J Cutan Med Surg</i> <b>17</b> (1): 6–12. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3736829">3736829</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23364144">23364144</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Phototherapy+in+psoriasis%3A+a+review+of+mechanisms+of+action&amp;rft.aulast=Wong+T%2C+Hsu+L%2C+Liao+W&amp;rft.au=Wong+T%2C+Hsu+L%2C+Liao+W&amp;rft.date=January-February+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3736829&amp;rft_id=info%3Apmc%2F3736829&amp;rft_id=info%3Apmid%2F23364144&amp;rft.issue=1&amp;rft.jtitle=J+Cutan+Med+Surg&amp;rft.pages=6%E2%80%9312&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Martin2013-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-Martin2013_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB (January 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3568997">"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings"</a>. <i>J Invest Dermatol</i> <b>133</b> (1): 17–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1038%2Fjid.2012.194">10.1038/jid.2012.194</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3568997">3568997</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22673731">22673731</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=The+emerging+role+of+IL-17+in+the+pathogenesis+of+psoriasis%3A+preclinical+and+clinical+findings&amp;rft.aulast=Martin+DA%2C+Towne+JE%2C+Kricorian+G%2C+Klekotka+P%2C+Gudjonsson+JE%2C+Krueger+JG%2C+Russell+CB&amp;rft.au=Martin+DA%2C+Towne+JE%2C+Kricorian+G%2C+Klekotka+P%2C+Gudjonsson+JE%2C+Krueger+JG%2C+Russell+CB&amp;rft.date=January+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3568997&amp;rft_id=info%3Adoi%2F10.1038%2Fjid.2012.194&amp;rft_id=info%3Apmc%2F3568997&amp;rft_id=info%3Apmid%2F22673731&amp;rft.issue=1&amp;rft.jtitle=J+Invest+Dermatol&amp;rft.pages=17%E2%80%9326&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rice-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rice_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rice_39-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://cnx.org/content/m14956/latest/">"Images of Memorable Cases: Case 34"</a>. <i>Connexions</i>. Rice University. "This AIDS patient presented with a pruritic eruption over most of his body"</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Images+of+Memorable+Cases%3A+Case+34&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcnx.org%2Fcontent%2Fm14956%2Flatest%2F&amp;rft.jtitle=Connexions&amp;rft.pub=Rice+University&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Guerra2013-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-Guerra2013_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Guerra2013_40-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Guerra2013_40-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Guerra I, Gisbert JP (January 2013). "Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents". <i>Expert Rev Gastroenterol Hepatol</i> <b>7</b> (1): 41–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1586%2Fegh.12.64">10.1586/egh.12.64</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23265148">23265148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Onset+of+psoriasis+in+patients+with+inflammatory+bowel+disease+treated+with+anti-TNF+agents&amp;rft.au=Guerra+I%2C+Gisbert+JP&amp;rft.aulast=Guerra+I%2C+Gisbert+JP&amp;rft.date=January+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2Fegh.12.64&amp;rft_id=info%3Apmid%2F23265148&amp;rft.issue=1&amp;rft.jtitle=Expert+Rev+Gastroenterol+Hepatol&amp;rft.pages=41%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ouyang2010-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ouyang2010_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ouyang2010_41-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ouyang2010_41-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ouyang W (December 2010). "Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease". <i>Cytokine Growth Factor Rev</i> <b>21</b> (6). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.cytogfr.2010.10.007">10.1016/j.cytogfr.2010.10.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21106435">21106435</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Distinct+roles+of+IL-22+in+human+psoriasis+and+inflammatory+bowel+disease&amp;rft.aulast=Ouyang+W&amp;rft.au=Ouyang+W&amp;rft.date=December+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cytogfr.2010.10.007&amp;rft_id=info%3Apmid%2F21106435&amp;rft.issue=6&amp;rft.jtitle=Cytokine+Growth+Factor+Rev&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Parrish2012-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-Parrish2012_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Parrish2012_42-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Parrish2012_42-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Parrish2012_42-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Parrish L. (2012). "Psoriasis: symptoms, treatments and its impact on quality of life". <i>Br J Community Nurs</i> <b>17</b> (11): 524, 526, 528. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23124421">23124421</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis%3A+symptoms%2C+treatments+and+its+impact+on+quality+of+life&amp;rft.aulast=Parrish+L.&amp;rft.au=Parrish+L.&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F23124421&amp;rft.issue=11&amp;rft.jtitle=Br+J+Community+Nurs&amp;rft.pages=524%2C+526%2C+528&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Roberson2010-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Roberson2010_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Roberson ED, Bowcock AM (September 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2957827">"Psoriasis genetics: breaking the barrier"</a>. <i>Trends Genet</i> <b>26</b> (9): 415–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.tig.2010.06.006">10.1016/j.tig.2010.06.006</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2957827">2957827</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20692714">20692714</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+genetics%3A+breaking+the+barrier&amp;rft.aulast=Roberson+ED%2C+Bowcock+AM&amp;rft.au=Roberson+ED%2C+Bowcock+AM&amp;rft.date=September+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2957827&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tig.2010.06.006&amp;rft_id=info%3Apmc%2F2957827&amp;rft_id=info%3Apmid%2F20692714&amp;rft.issue=9&amp;rft.jtitle=Trends+Genet&amp;rft.pages=415%E2%80%9323&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ramos2012-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ramos2012_44-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ramos-e-Silva M, Jacques Cd (May–June 2012). "Epidermal barrier function and systemic diseases". <i>Clin Dermatol</i> <b>30</b> (3): 277–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.clindermatol.2011.08.025">10.1016/j.clindermatol.2011.08.025</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22507041">22507041</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Epidermal+barrier+function+and+systemic+diseases&amp;rft.aulast=Ramos-e-Silva+M%2C+Jacques+Cd&amp;rft.au=Ramos-e-Silva+M%2C+Jacques+Cd&amp;rft.date=May-June+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2011.08.025&amp;rft_id=info%3Apmid%2F22507041&amp;rft.issue=3&amp;rft.jtitle=Clin+Dermatol&amp;rft.pages=277%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dombrowski2012-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dombrowski2012_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dombrowski2012_45-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dombrowski Y, Schauber J (May 2012). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0625.2012.01459.x/full">"Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis"</a>. <i>Exp Dermatol</i> <b>21</b> (5). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1600-0625.2012.01459.x">10.1111/j.1600-0625.2012.01459.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22509827">22509827</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Cathelicidin+LL-37%3A+a+defense+molecule+with+a+potential+role+in+psoriasis+pathogenesis&amp;rft.au=Dombrowski+Y%2C+Schauber+J&amp;rft.aulast=Dombrowski+Y%2C+Schauber+J&amp;rft.date=May+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fj.1600-0625.2012.01459.x%2Ffull&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1600-0625.2012.01459.x&amp;rft_id=info%3Apmid%2F22509827&amp;rft.issue=5&amp;rft.jtitle=Exp+Dermatol&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mudigonda2012-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mudigonda2012_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mudigonda2012_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mudigonda2012_46-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Mudigonda P, Mudigonda T, Feneran AN, Alamdari HS, Sandoval L, Feldman SR. (October 2012). <a rel="nofollow" class="external text" href="http://escholarship.org/uc/item/3n39n8xm">"Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis"</a>. <i>Dermatol Online J</i> <b>18</b> (10): 1. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23122008">23122008</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Interleukin-23+and+interleukin-17%3A+importance+in+pathogenesis+and+therapy+of+psoriasis&amp;rft.aulast=Mudigonda+P%2C+Mudigonda+T%2C+Feneran+AN%2C+Alamdari+HS%2C+Sandoval+L%2C+Feldman+SR.&amp;rft.au=Mudigonda+P%2C+Mudigonda+T%2C+Feneran+AN%2C+Alamdari+HS%2C+Sandoval+L%2C+Feldman+SR.&amp;rft.date=October+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fescholarship.org%2Fuc%2Fitem%2F3n39n8xm&amp;rft_id=info%3Apmid%2F23122008&amp;rft.issue=10&amp;rft.jtitle=Dermatol+Online+J&amp;rft.pages=1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kunz2009-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kunz2009_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kunz M, Ibrahim SM (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768824">"Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity"</a>. <i>Mediators Inflamm</i> <b>2009</b>: 979258. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2009%2F979258">10.1155/2009/979258</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768824">2768824</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19884985">19884985</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Cytokines+and+cytokine+profiles+in+human+autoimmune+diseases+and+animal+models+of+autoimmunity&amp;rft.au=Kunz+M%2C+Ibrahim+SM&amp;rft.aulast=Kunz+M%2C+Ibrahim+SM&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2768824&amp;rft_id=info%3Adoi%2F10.1155%2F2009%2F979258&amp;rft_id=info%3Apmc%2F2768824&amp;rft_id=info%3Apmid%2F19884985&amp;rft.jtitle=Mediators+Inflamm&amp;rft.pages=979258&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2009" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20060709183301/http://web.ilds.org/icd10_list.php?VIEW=1&amp;START_CODE=L40.0&amp;START_EXT=00">Application to Dermatology of International Classification of Disease (ICD-10)</a>. The International League of Dermatological Societies</span></li>
<li id="cite_note-Fitz2-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Fitz2_49-0">^</a></b></span> <span class="reference-text"><span class="citation book">Freedberg, Irwin M.; Fitzpatrick, Thomas B. (2003). <i>Fitzpatrick's dermatology in general medicine</i> (6th ed.). New York: McGraw-Hill. p.&#160;414. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-07-138076-0" title="Special:BookSources/0-07-138076-0">0-07-138076-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.au=Freedberg%2C+Irwin+M.%3B+Fitzpatrick%2C+Thomas+B.&amp;rft.aulast=Freedberg%2C+Irwin+M.%3B+Fitzpatrick%2C+Thomas+B.&amp;rft.btitle=Fitzpatrick%27s+dermatology+in+general+medicine&amp;rft.date=2003&amp;rft.edition=6th&amp;rft.genre=book&amp;rft.isbn=0-07-138076-0&amp;rft.pages=414&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kupetsky2013-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kupetsky2013_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kupetsky2013_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kupetsky EA, Keller M (November–December 2013). <a rel="nofollow" class="external text" href="http://www.jabfm.org/content/26/6/787.long">"Psoriasis vulgaris: an evidence-based guide for primary care"</a>. <i>J Am Board Fam Med</i> <b>26</b> (6): 787–801. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3122%2Fjabfm.2013.06.130055">10.3122/jabfm.2013.06.130055</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24204077">24204077</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+vulgaris%3A+an+evidence-based+guide+for+primary+care&amp;rft.au=Kupetsky+EA%2C+Keller+M&amp;rft.aulast=Kupetsky+EA%2C+Keller+M&amp;rft.date=November-December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.jabfm.org%2Fcontent%2F26%2F6%2F787.long&amp;rft_id=info%3Adoi%2F10.3122%2Fjabfm.2013.06.130055&amp;rft_id=info%3Apmid%2F24204077&amp;rft.issue=6&amp;rft.jtitle=J+Am+Board+Fam+Med&amp;rft.pages=787%E2%80%93801&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Griffiths CE., Christophers E, Barker JN, Chalmers RJ, Chimenti, S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry, L (February 2007). "A classification of psoriasis vulgaris according to phenotype". <i>Br J Dermatol</i> <b>156</b> (2): 258–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2133.2006.07675.x">10.1111/j.1365-2133.2006.07675.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17223864">17223864</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=A+classification+of+psoriasis+vulgaris+according+to+phenotype&amp;rft.au=Griffiths+CE.%2C+Christophers+E%2C+Barker+JN%2C+Chalmers+RJ%2C+Chimenti%2C+S%2C+Krueger+GG%2C+Leonardi+C%2C+Menter+A%2C+Ortonne+JP%2C+Fry%2C+L&amp;rft.aulast=Griffiths+CE.%2C+Christophers+E%2C+Barker+JN%2C+Chalmers+RJ%2C+Chimenti%2C+S%2C+Krueger+GG%2C+Leonardi+C%2C+Menter+A%2C+Ortonne+JP%2C+Fry%2C+L&amp;rft.date=February+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2006.07675.x&amp;rft_id=info%3Apmid%2F17223864&amp;rft.issue=2&amp;rft.jtitle=Br+J+Dermatol&amp;rft.pages=258%E2%80%9362&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=156" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Weidemann2013-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-Weidemann2013_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Weidemann2013_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Weidemann AK, Crawshaw AA, Byrne E, Young HS (September 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3790838">"Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis"</a>. <i>Clin Cosmet Investig Dermatol</i> <b>6</b>: 233–44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2147%2FCCID.S35312">10.2147/CCID.S35312</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3790838">3790838</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24101875">24101875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Vascular+endothelial+growth+factor+inhibitors%3A+investigational+therapies+for+the+treatment+of+psoriasis&amp;rft.aulast=Weidemann+AK%2C+Crawshaw+AA%2C+Byrne+E%2C+Young+HS&amp;rft.au=Weidemann+AK%2C+Crawshaw+AA%2C+Byrne+E%2C+Young+HS&amp;rft.date=September+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3790838&amp;rft_id=info%3Adoi%2F10.2147%2FCCID.S35312&amp;rft_id=info%3Apmc%2F3790838&amp;rft_id=info%3Apmid%2F24101875&amp;rft.jtitle=Clin+Cosmet+Investig+Dermatol&amp;rft.pages=233%E2%80%9344&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Han2012-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Han2012_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Han R, Rostami-Yazdi M, Gerdes S, Mrowietz U (September 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3477344">"Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases"</a>. <i>Br J Clin Dermatol</i> <b>74</b> (3): 424–36. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2125.2012.04221.x">10.1111/j.1365-2125.2012.04221.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3477344">3477344</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22348323">22348323</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Triptolide+in+the+treatment+of+psoriasis+and+other+immune-mediated+inflammatory+diseases&amp;rft.au=Han+R%2C+Rostami-Yazdi+M%2C+Gerdes+S%2C+Mrowietz+U&amp;rft.aulast=Han+R%2C+Rostami-Yazdi+M%2C+Gerdes+S%2C+Mrowietz+U&amp;rft.date=September+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3477344&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2125.2012.04221.x&amp;rft_id=info%3Apmc%2F3477344&amp;rft_id=info%3Apmid%2F22348323&amp;rft.issue=3&amp;rft.jtitle=Br+J+Clin+Dermatol&amp;rft.pages=424%E2%80%9336&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=74" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Quatresooz-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-Quatresooz_54-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Quatresooz P, Hermanns-Lê T, Piérard GE, Humbert P, Delvenne P, Piérard-Franchimont C (June 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3384985">"Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer"</a>. <i>J Biomed Biotechnol</i> <b>2012</b> (147413). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2012%2F147413">10.1155/2012/147413</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3384985">3384985</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22754278">22754278</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Ustekinumab+in+psoriasis+immunopathology+with+emphasis+on+the+Th17-IL23+axis%3A+a+primer&amp;rft.aulast=Quatresooz+P%2C+Hermanns-L%C3%AA+T%2C+Pi%C3%A9rard+GE%2C+Humbert+P%2C+Delvenne+P%2C+Pi%C3%A9rard-Franchimont+C&amp;rft.au=Quatresooz+P%2C+Hermanns-L%C3%AA+T%2C+Pi%C3%A9rard+GE%2C+Humbert+P%2C+Delvenne+P%2C+Pi%C3%A9rard-Franchimont+C&amp;rft.date=June+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3384985&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F147413&amp;rft_id=info%3Apmc%2F3384985&amp;rft_id=info%3Apmid%2F22754278&amp;rft.issue=147413&amp;rft.jtitle=J+Biomed+Biotechnol&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2012" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mrowietz2011-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mrowietz2011_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mrowietz2011_55-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N (January 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3016217">"Definition of treatment goals for moderate to severe psoriasis: a European consensus"</a>. <i>Arch Dermatol Res</i> <b>303</b> (1): 1–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00403-010-1080-1">10.1007/s00403-010-1080-1</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3016217">3016217</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20857129">20857129</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Definition+of+treatment+goals+for+moderate+to+severe+psoriasis%3A+a+European+consensus&amp;rft.aulast=Mrowietz+U%2C+Kragballe+K%2C+Reich+K%2C+Spuls+P%2C+Griffiths+CE%2C+Nast+A%2C+Franke+J%2C+Antoniou+C%2C+Arenberger+P%2C+Balieva+F%2C+Bylaite+M%2C+Correia+O%2C+Daud%C3%A9n+E%2C+Gisondi+P%2C+Iversen+L%2C+Kem%C3%A9ny+L%2C+Lahfa+M%2C+Nijsten+T%2C+Rantanen+T%2C+Reich+A%2C+Rosenbach+T%2C+Segaert+S%2C+Smith+C%2C+Talme+T%2C+Volc-Platzer+B%2C+Yawalkar+N&amp;rft.au=Mrowietz+U%2C+Kragballe+K%2C+Reich+K%2C+Spuls+P%2C+Griffiths+CE%2C+Nast+A%2C+Franke+J%2C+Antoniou+C%2C+Arenberger+P%2C+Balieva+F%2C+Bylaite+M%2C+Correia+O%2C+Daud%C3%A9n+E%2C+Gisondi+P%2C+Iversen+L%2C+Kem%C3%A9ny+L%2C+Lahfa+M%2C+Nijsten+T%2C+Rantanen+T%2C+Reich+A%2C+Rosenbach+T%2C+Segaert+S%2C+Smith+C%2C+Talme+T%2C+Volc-Platzer+B%2C+Yawalkar+N&amp;rft.date=January+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3016217&amp;rft_id=info%3Adoi%2F10.1007%2Fs00403-010-1080-1&amp;rft_id=info%3Apmc%2F3016217&amp;rft_id=info%3Apmid%2F20857129&amp;rft.issue=1&amp;rft.jtitle=Arch+Dermatol+Res&amp;rft.pages=1%E2%80%9310&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=303" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mease2011-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mease2011_56-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mease PJ (November 2011). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1002/acr.20577/full">"Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI)"</a>. <i>Arthritis Care Res (Hoboken)</i> <b>63</b> (Supplement 11): S64–85. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Facr.20577">10.1002/acr.20577</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22588772">22588772</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Measures+of+psoriatic+arthritis%3A+Tender+and+Swollen+Joint+Assessment%2C+Psoriasis+Area+and+Severity+Index+%28PASI%29%2C+Nail+Psoriasis+Severity+Index+%28NAPSI%29%2C+Modified+Nail+Psoriasis+Severity+Index+%28mNAPSI%29%2C+Mander%2FNewcastle+Enthesitis+Index+%28MEI%29%2C+Leeds+Enthesitis+Index+%28LEI%29%2C+Spondyloarthritis+Research+Consortium+of+Canada+%28SPARCC%29%2C+Maastricht+Ankylosing+Spondylitis+Enthesis+Score+%28MASES%29%2C+Leeds+Dactylitis+Index+%28LDI%29%2C+Patient+Global+for+Psoriatic+Arthritis%2C+Dermatology+Life+Quality+Index+%28DLQI%29%2C+Psoriatic+Arthritis+Quality+of+Life+%28PsAQOL%29%2C+Functional+Assessment+of+Chronic+Illness+Therapy-Fatigue+%28FACIT-F%29%2C+Psoriatic+Arthritis+Response+Criteria+%28PsARC%29%2C+Psoriatic+Arthritis+Joint+Activity+Index+%28PsAJAI%29%2C+Disease+Activity+in+Psoriatic+Arthritis+%28DAPSA%29%2C+and+Composite+Psoriatic+Disease+Activity+Index+%28CPDAI%29&amp;rft.aulast=Mease+PJ&amp;rft.au=Mease+PJ&amp;rft.date=November+2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1002%2Facr.20577%2Ffull&amp;rft_id=info%3Adoi%2F10.1002%2Facr.20577&amp;rft_id=info%3Apmid%2F22588772&amp;rft.issue=Supplement+11&amp;rft.jtitle=Arthritis+Care+Res+%28Hoboken%29&amp;rft.pages=S64%E2%80%9385&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><span class="citation journal"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20080601135534/http://www.skinandaging.com/article/5394">"Psoriasis Update"</a>. <i>Skin &amp; Aging</i> <b>14</b> (3): 46–50. 2006. Archived from <a rel="nofollow" class="external text" href="http://www.skinandaging.com/article/5394">the original</a> on 2008-06-01.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+Update&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.skinandaging.com%2Farticle%2F5394&amp;rft.issue=3&amp;rft.jtitle=Skin+%26+Aging&amp;rft.pages=46%E2%80%9350&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15530297-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15530297_58-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Louden BA, Pearce DJ, Lang W, Feldman SR (2004). "A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients". <i>Dermatol. Online J.</i> <b>10</b> (2): 7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15530297">15530297</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=A+Simplified+Psoriasis+Area+Severity+Index+%28SPASI%29+for+rating+psoriasis+severity+in+clinic+patients&amp;rft.aulast=Louden+BA%2C+Pearce+DJ%2C+Lang+W%2C+Feldman+SR&amp;rft.au=Louden+BA%2C+Pearce+DJ%2C+Lang+W%2C+Feldman+SR&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15530297&amp;rft.issue=2&amp;rft.jtitle=Dermatol.+Online+J.&amp;rft.pages=7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lancet07-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet07_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet07_59-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet07_59-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet07_59-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet07_59-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Menter A, Griffiths CE (July 2007). "Current and future management of psoriasis". <i>Lancet</i> <b>370</b> (9583): 272–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961129-5">10.1016/S0140-6736(07)61129-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17658398">17658398</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Current+and+future+management+of+psoriasis&amp;rft.aulast=Menter+A%2C+Griffiths+CE&amp;rft.au=Menter+A%2C+Griffiths+CE&amp;rft.date=July+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2961129-5&amp;rft_id=info%3Apmid%2F17658398&amp;rft.issue=9583&amp;rft.jtitle=Lancet&amp;rft.pages=272%E2%80%9384&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=370" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Samarasekera2013-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-Samarasekera2013_60-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH (2013). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1111/bjd.12276/full">"Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses"</a>. <i>Br J Dermatol</i> <b>168</b> (5): 954–67. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fbjd.12276">10.1111/bjd.12276</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23413913">23413913</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Topical+therapies+for+the+treatment+of+plaque+psoriasis%3A+systematic+review+and+network+meta-analyses&amp;rft.aulast=Samarasekera+EJ%2C+Sawyer+L%2C+Wonderling+D%2C+Tucker+R%2C+Smith+CH&amp;rft.au=Samarasekera+EJ%2C+Sawyer+L%2C+Wonderling+D%2C+Tucker+R%2C+Smith+CH&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fbjd.12276%2Ffull&amp;rft_id=info%3Adoi%2F10.1111%2Fbjd.12276&amp;rft_id=info%3Apmid%2F23413913&amp;rft.issue=5&amp;rft.jtitle=Br+J+Dermatol&amp;rft.pages=954%E2%80%9367&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=168" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mason2013-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mason2013_61-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mason AR, Mason J, Cork M, Dooley G, Hancock H (2013). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005028.pub3/abstract;jsessionid=F6A9290A8409BBDF96F367E57CC285E2.f03t03">"Topical treatments for chronic plaque psoriasis"</a>. <i>Cochrane Database Syst Rev</i> <b>3</b> (CD005028). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD005028.pub3">10.1002/14651858.CD005028.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23543539">23543539</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Topical+treatments+for+chronic+plaque+psoriasis&amp;rft.aulast=Mason+AR%2C+Mason+J%2C+Cork+M%2C+Dooley+G%2C+Hancock+H&amp;rft.au=Mason+AR%2C+Mason+J%2C+Cork+M%2C+Dooley+G%2C+Hancock+H&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1002%2F14651858.CD005028.pub3%2Fabstract%3Bjsessionid%3DF6A9290A8409BBDF96F367E57CC285E2.f03t03&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD005028.pub3&amp;rft_id=info%3Apmid%2F23543539&amp;rft.issue=CD005028&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Asztalos2013-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-Asztalos2013_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Asztalos2013_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Asztalos ML, Heller MM, Lee ES, Koo J (May 2013). "The impact of emollients on phototherapy: a review". <i>J Am Acad Dermatol</i> <b>68</b> (5): 817–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2012.05.034">10.1016/j.jaad.2012.05.034</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23399460">23399460</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=The+impact+of+emollients+on+phototherapy%3A+a+review&amp;rft.au=Asztalos+ML%2C+Heller+MM%2C+Lee+ES%2C+Koo+J&amp;rft.aulast=Asztalos+ML%2C+Heller+MM%2C+Lee+ES%2C+Koo+J&amp;rft.date=May+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2012.05.034&amp;rft_id=info%3Apmid%2F23399460&amp;rft.issue=5&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=817%E2%80%9324&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation journal">Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R; American Academy of Dermatology (2009). "Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies". <i>J Am Acad Dermatol</i> <b>60</b> (4): 643–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2008.12.032">10.1016/j.jaad.2008.12.032</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19217694">19217694</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Guidelines+of+care+for+the+management+of+psoriasis+and+psoriatic+arthritis%3A+Section+3.+Guidelines+of+care+for+the+management+and+treatment+of+psoriasis+with+topical+therapies&amp;rft.aulast=Menter+A%2C+Korman+NJ%2C+Elmets+CA%2C+Feldman+SR%2C+Gelfand+JM%2C+Gordon+KB%2C+Gottlieb+A%2C+Koo+JY%2C+Lebwohl+M%2C+Lim+HW%2C+Van+Voorhees+AS%2C+Beutner+KR%2C+Bhushan+R%3B+American+Academy+of+Dermatology&amp;rft.au=Menter+A%2C+Korman+NJ%2C+Elmets+CA%2C+Feldman+SR%2C+Gelfand+JM%2C+Gordon+KB%2C+Gottlieb+A%2C+Koo+JY%2C+Lebwohl+M%2C+Lim+HW%2C+Van+Voorhees+AS%2C+Beutner+KR%2C+Bhushan+R%3B+American+Academy+of+Dermatology&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2008.12.032&amp;rft_id=info%3Apmid%2F19217694&amp;rft.issue=4&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=643%E2%80%9359&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Halverstam2008-64"><span class="mw-cite-backlink">^ <a href="#cite_ref-Halverstam2008_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Halverstam2008_64-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Halverstam2008_64-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Halverstam CP, Lebwohl M (September-October 2008). "Nonstandard and off-label therapies for psoriasis". <i>Clin Dermatol</i> <b>26</b> (5): 546–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.clindermatol.2007.10.023">10.1016/j.clindermatol.2007.10.023</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18755374">18755374</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Nonstandard+and+off-label+therapies+for+psoriasis&amp;rft.au=Halverstam+CP%2C+Lebwohl+M&amp;rft.aulast=Halverstam+CP%2C+Lebwohl+M&amp;rft.date=September-October+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2007.10.023&amp;rft_id=info%3Apmid%2F18755374&amp;rft.issue=5&amp;rft.jtitle=Clin+Dermatol&amp;rft.pages=546%E2%80%9353&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Check date values in: <code>|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Katz2012-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-Katz2012_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Katz2012_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Katz2012_65-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Katz U, Shoenfeld Y, Zakin V, Sherer Y, Sukenik S (October 2012). "Scientific evidence of the therapeutic effects of dead sea treatments: a systematic review". <i>Semin Arthritis Rheum</i> <b>42</b> (2): 186–200. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.semarthrit.2012.02.006">10.1016/j.semarthrit.2012.02.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22503590">22503590</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Scientific+evidence+of+the+therapeutic+effects+of+dead+sea+treatments%3A+a+systematic+review&amp;rft.au=Katz+U%2C+Shoenfeld+Y%2C+Zakin+V%2C+Sherer+Y%2C+Sukenik+S&amp;rft.aulast=Katz+U%2C+Shoenfeld+Y%2C+Zakin+V%2C+Sherer+Y%2C+Sukenik+S&amp;rft.date=October+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semarthrit.2012.02.006&amp;rft_id=info%3Apmid%2F22503590&amp;rft.issue=2&amp;rft.jtitle=Semin+Arthritis+Rheum&amp;rft.pages=186%E2%80%93200&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dogra2010-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dogra2010_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dogra2010_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Dogra2010_66-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dogra S, De D (November–December 2010). <a rel="nofollow" class="external text" href="http://www.ijdvl.com/article.asp?issn=0378-6323;year=2010;volume=76;issue=6;spage=652;epage=661;aulast=Dogra">"Narrowband ultraviolet B in the treatment of psoriasis: the journey so far!"</a>. <i>Indian J Dermatol Venereol Leprol</i> <b>76</b> (6): 652–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.4103%2F0378-6323.72461">10.4103/0378-6323.72461</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21079308">21079308</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Narrowband+ultraviolet+B+in+the+treatment+of+psoriasis%3A+the+journey+so+far%21&amp;rft.au=Dogra+S%2C+De+D&amp;rft.aulast=Dogra+S%2C+De+D&amp;rft.date=November-December+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ijdvl.com%2Farticle.asp%3Fissn%3D0378-6323%3Byear%3D2010%3Bvolume%3D76%3Bissue%3D6%3Bspage%3D652%3Bepage%3D661%3Baulast%3DDogra&amp;rft_id=info%3Adoi%2F10.4103%2F0378-6323.72461&amp;rft_id=info%3Apmid%2F21079308&amp;rft.issue=6&amp;rft.jtitle=Indian+J+Dermatol+Venereol+Leprol&amp;rft.pages=652%E2%80%9361&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lapolla2011-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lapolla2011_67-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR (May 2011). "A review of phototherapy protocols for psoriasis treatment". <i>J Am Acad Dermatol</i> <b>64</b> (5): 936–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2009.12.054">10.1016/j.jaad.2009.12.054</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21429620">21429620</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=A+review+of+phototherapy+protocols+for+psoriasis+treatment&amp;rft.au=Lapolla+W%2C+Yentzer+BA%2C+Bagel+J%2C+Halvorson+CR%2C+Feldman+SR&amp;rft.aulast=Lapolla+W%2C+Yentzer+BA%2C+Bagel+J%2C+Halvorson+CR%2C+Feldman+SR&amp;rft.date=May+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2009.12.054&amp;rft_id=info%3Apmid%2F21429620&amp;rft.issue=5&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=936%E2%80%9349&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dunn2011-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dunn2011_68-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dunn LK, Gaar LR, Yentzer BA, O'Neill JL, Feldman SR (July 2011). "Acitretin in dermatology: a review". <i>J Drugs Dermatol</i> <b>10</b> (7): 772–82. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21720660">21720660</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Acitretin+in+dermatology%3A+a+review&amp;rft.au=Dunn+LK%2C+Gaar+LR%2C+Yentzer+BA%2C+O%27Neill+JL%2C+Feldman+SR&amp;rft.aulast=Dunn+LK%2C+Gaar+LR%2C+Yentzer+BA%2C+O%27Neill+JL%2C+Feldman+SR&amp;rft.date=July+2011&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F21720660&amp;rft.issue=7&amp;rft.jtitle=J+Drugs+Dermatol&amp;rft.pages=772%E2%80%9382&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dogra2013-69"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dogra2013_69-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dogra2013_69-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dogra S, Mahajan R (August 2013). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1111/ced.12062/full">"Systemic methotrexate therapy for psoriasis: past, present and future"</a>. <i>Clin Exp Dermatol</i> <b>38</b> (6): 573–88. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fced.12062">10.1111/ced.12062</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23837932">23837932</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Systemic+methotrexate+therapy+for+psoriasis%3A+past%2C+present+and+future&amp;rft.au=Dogra+S%2C+Mahajan+R&amp;rft.aulast=Dogra+S%2C+Mahajan+R&amp;rft.date=August+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fced.12062%2Ffull&amp;rft_id=info%3Adoi%2F10.1111%2Fced.12062&amp;rft_id=info%3Apmid%2F23837932&amp;rft.issue=6&amp;rft.jtitle=Clin+Exp+Dermatol&amp;rft.pages=573%E2%80%9388&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rustin2012-70"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rustin2012_70-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Rustin2012_70-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rustin, MH (November 2012). "Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data". <i>Br J Dermatol</i> <b>167</b> (Suppl 3): 3–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2133.2012.11208.x">10.1111/j.1365-2133.2012.11208.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23082810">23082810</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Long-term+safety+of+biologics+in+the+treatment+of+moderate-to-severe+plaque+psoriasis%3A+review+of+current+data&amp;rft.aulast=Rustin%2C+MH&amp;rft.au=Rustin%2C+MH&amp;rft.date=November+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2012.11208.x&amp;rft_id=info%3Apmid%2F23082810&amp;rft.issue=Suppl+3&amp;rft.jtitle=Br+J+Dermatol&amp;rft.pages=3%E2%80%9311&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=167" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Griffiths2012-71"><span class="mw-cite-backlink">^ <a href="#cite_ref-Griffiths2012_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Griffiths2012_71-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Griffiths, CE (November 2012). "Biologics for psoriasis: current evidence and future use". <i>Br J Dermatol</i> <b>167</b> (Suppl 3): 1–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2133.2012.11207.x">10.1111/j.1365-2133.2012.11207.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23082809">23082809</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Biologics+for+psoriasis%3A+current+evidence+and+future+use&amp;rft.au=Griffiths%2C+CE&amp;rft.aulast=Griffiths%2C+CE&amp;rft.date=November+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2133.2012.11207.x&amp;rft_id=info%3Apmid%2F23082809&amp;rft.issue=Suppl+3&amp;rft.jtitle=Br+J+Dermatol&amp;rft.pages=1%E2%80%932&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=167" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation journal">Hueber W, Patel DD, Dryja T, <i>et al.</i> (2010). "Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis". <i>Sci Transl Med</i> <b>2</b> (52): 52ra72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1126%2Fscitranslmed.3001107">10.1126/scitranslmed.3001107</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20926833">20926833</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Effects+of+AIN457%2C+a+fully+human+antibody+to+interleukin-17A%2C+on+psoriasis%2C+rheumatoid+arthritis%2C+and+uveitis&amp;rft.au=Hueber+W%2C+Patel+DD%2C+Dryja+T%2C+%27%27et+al.%27%27&amp;rft.aulast=Hueber+W%2C+Patel+DD%2C+Dryja+T%2C+%27%27et+al.%27%27&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1126%2Fscitranslmed.3001107&amp;rft_id=info%3Apmid%2F20926833&amp;rft.issue=52&amp;rft.jtitle=Sci+Transl+Med&amp;rft.pages=52ra72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kaimal2010-73"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kaimal2010_73-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kaimal2010_73-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kaimal S, Thappa DM (2010). <a rel="nofollow" class="external text" href="http://www.ijdvl.com/article.asp?issn=0378-6323;year=2010;volume=76;issue=2;spage=103;epage=115;aulast=Kaimal#Psoriasis">"Diet in dermatology: revisited."</a>. <i>Indian J Dermatol Venereol Leprol</i> <b>76</b> (2): 103–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.4103%2F0378-6323.60540">10.4103/0378-6323.60540</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20228538">20228538</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Diet+in+dermatology%3A+revisited.&amp;rft.au=Kaimal+S%2C+Thappa+DM&amp;rft.aulast=Kaimal+S%2C+Thappa+DM&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.ijdvl.com%2Farticle.asp%3Fissn%3D0378-6323%3Byear%3D2010%3Bvolume%3D76%3Bissue%3D2%3Bspage%3D103%3Bepage%3D115%3Baulast%3DKaimal%23Psoriasis&amp;rft_id=info%3Adoi%2F10.4103%2F0378-6323.60540&amp;rft_id=info%3Apmid%2F20228538&amp;rft.issue=2&amp;rft.jtitle=Indian+J+Dermatol+Venereol+Leprol&amp;rft.pages=103%E2%80%9315&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dessinioti2013-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dessinioti2013_74-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dessinioti C, Katsambas A (2013). "Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies". <i>Clin Dermatol</i> <b>31</b> (4): 343–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.clindermatol.2013.01.001">10.1016/j.clindermatol.2013.01.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23806151">23806151</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Seborrheic+dermatitis%3A+etiology%2C+risk+factors%2C+and+treatments%3A+facts+and+controversies&amp;rft.au=Dessinioti+C%2C+Katsambas+A&amp;rft.aulast=Dessinioti+C%2C+Katsambas+A&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2013.01.001&amp;rft_id=info%3Apmid%2F23806151&amp;rft.issue=4&amp;rft.jtitle=Clin+Dermatol&amp;rft.pages=343%E2%80%9351&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bhosle-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bhosle_75-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R (2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1501000">"Quality of life in patients with psoriasis"</a>. <i>Health Qual Life Outcomes</i> <b>4</b>: 35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1186%2F1477-7525-4-35">10.1186/1477-7525-4-35</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1501000">1501000</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16756666">16756666</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Quality+of+life+in+patients+with+psoriasis&amp;rft.au=Bhosle+MJ%2C+Kulkarni+A%2C+Feldman+SR%2C+Balkrishnan+R&amp;rft.aulast=Bhosle+MJ%2C+Kulkarni+A%2C+Feldman+SR%2C+Balkrishnan+R&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1501000&amp;rft_id=info%3Adoi%2F10.1186%2F1477-7525-4-35&amp;rft_id=info%3Apmc%2F1501000&amp;rft_id=info%3Apmid%2F16756666&amp;rft.jtitle=Health+Qual+Life+Outcomes&amp;rft.pages=35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><span class="citation journal">Magin, P (2013 Jan-Feb). "Appearance-related bullying and skin disorders.". <i>Clinics in dermatology</i> <b>31</b> (1): 66–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.clindermatol.2011.11.009">10.1016/j.clindermatol.2011.11.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23245976">23245976</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Appearance-related+bullying+and+skin+disorders.&amp;rft.aufirst=P&amp;rft.aulast=Magin&amp;rft.au=Magin%2C+P&amp;rft.date=2013+Jan-Feb&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2011.11.009&amp;rft_id=info%3Apmid%2F23245976&amp;rft.issue=1&amp;rft.jtitle=Clinics+in+dermatology&amp;rft.pages=66%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Check date values in: <code>|date=</code> (<a href="/wiki/Help:CS1_errors#bad_date" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Habif2010-77"><span class="mw-cite-backlink">^ <a href="#cite_ref-Habif2010_77-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Habif2010_77-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Habif2010_77-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Habif, Thomas P. (2010). <a rel="nofollow" class="external text" href="http://books.google.com/?id=kDWlWR5UbqQC&amp;printsec=frontcover&amp;dq=clinical+dermatology#v=onepage&amp;q=psoriasis&amp;f=false">"8"</a>. <i>Clinical dermatology a color guide to diagnosis and therapy</i> (5th ed.). Edinburgh: Mosby Elsevier. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-323-08037-8" title="Special:BookSources/978-0-323-08037-8">978-0-323-08037-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Clinical+dermatology+a+color+guide+to+diagnosis+and+therapy&amp;rft.aufirst=Thomas+P.&amp;rft.au=Habif%2C+Thomas+P.&amp;rft.aulast=Habif&amp;rft.btitle=8&amp;rft.date=2010&amp;rft.edition=5th&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fbooks.google.com%2F%3Fid%3DkDWlWR5UbqQC%26printsec%3Dfrontcover%26dq%3Dclinical%2Bdermatology%23v%3Donepage%26q%3Dpsoriasis%26f%3Dfalse&amp;rft.isbn=978-0-323-08037-8&amp;rft.place=Edinburgh&amp;rft.pub=Mosby+Elsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Armstrong2013-78"><span class="mw-cite-backlink">^ <a href="#cite_ref-Armstrong2013_78-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Armstrong2013_78-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Armstrong AW, Harskamp CT, Armstrong EJ (January 2013). "Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis". <i>JAMA Dermatol</i> <b>149</b> (1): 84–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2F2013.jamadermatol.406">10.1001/2013.jamadermatol.406</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23407990">23407990</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+and+the+risk+of+diabetes+mellitus%3A+a+systematic+review+and+meta-analysis&amp;rft.au=Armstrong+AW%2C+Harskamp+CT%2C+Armstrong+EJ&amp;rft.aulast=Armstrong+AW%2C+Harskamp+CT%2C+Armstrong+EJ&amp;rft.date=January+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2F2013.jamadermatol.406&amp;rft_id=info%3Apmid%2F23407990&amp;rft.issue=1&amp;rft.jtitle=JAMA+Dermatol&amp;rft.pages=84%E2%80%9391&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=149" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hypertension2013-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hypertension2013_79-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Armstrong AW, Harskamp CT, Armstrong EJ (2013). "The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies". <i>J Hypertens</i> <b>31</b> (3): 433–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FHJH.0b013e32835bcce1">10.1097/HJH.0b013e32835bcce1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23249828">23249828</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=The+association+between+psoriasis+and+hypertension%3A+a+systematic+review+and+meta-analysis+of+observational+studies&amp;rft.au=Armstrong+AW%2C+Harskamp+CT%2C+Armstrong+EJ&amp;rft.aulast=Armstrong+AW%2C+Harskamp+CT%2C+Armstrong+EJ&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FHJH.0b013e32835bcce1&amp;rft_id=info%3Apmid%2F23249828&amp;rft.issue=3&amp;rft.jtitle=J+Hypertens&amp;rft.pages=433%E2%80%9342&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tablazon2013-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tablazon2013_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tablazon2013_80-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR (February 2013). "Risk of cardiovascular disorders in psoriasis patients: current and future". <i>Am J Clin Dermatol</i> <b>14</b> (1): 1–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs40257-012-0005-5">10.1007/s40257-012-0005-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23329076">23329076</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Risk+of+cardiovascular+disorders+in+psoriasis+patients%3A+current+and+future&amp;rft.aulast=Tablazon+IL%2C+Al-Dabagh+A%2C+Davis+SA%2C+Feldman+SR&amp;rft.au=Tablazon+IL%2C+Al-Dabagh+A%2C+Davis+SA%2C+Feldman+SR&amp;rft.date=February+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs40257-012-0005-5&amp;rft_id=info%3Apmid%2F23329076&amp;rft.issue=1&amp;rft.jtitle=Am+J+Clin+Dermatol&amp;rft.pages=1%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.bbc.co.uk/news/health-14559523">"Psoriasis Linked to Stroke Risk"</a>. BBC. August 2011.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.btitle=Psoriasis+Linked+to+Stroke+Risk&amp;rft.date=August+2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fhealth-14559523&amp;rft.pub=BBC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-Ghazizadeh2011-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ghazizadeh2011_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ghazizadeh2011_82-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ghazizadeh R, Tosa M, Ghazizadeh M (2011). "Clinical Improvement in Psoriasis with Treatment of Associated Hyperlipidemia". <i>Am J Med Sci</i> <b>341</b> (5): 394–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FMAJ.0b013e3181ff8eeb">10.1097/MAJ.0b013e3181ff8eeb</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21233693">21233693</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Clinical+Improvement+in+Psoriasis+with+Treatment+of+Associated+Hyperlipidemia&amp;rft.au=Ghazizadeh+R%2C+Tosa+M%2C+Ghazizadeh+M&amp;rft.aulast=Ghazizadeh+R%2C+Tosa+M%2C+Ghazizadeh+M&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMAJ.0b013e3181ff8eeb&amp;rft_id=info%3Apmid%2F21233693&amp;rft.issue=5&amp;rft.jtitle=Am+J+Med+Sci&amp;rft.pages=394%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=341" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hsu2012-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hsu2012_83-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hsu LN, Armstrong AW. (November 2012). "Psoriasis and autoimmune disorders: a review of the literature". <i>J Am Acad Dermatol</i> <b>67</b> (5): 1076–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.jaad.2012.01.029">10.1016/j.jaad.2012.01.029</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23062896">23062896</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+and+autoimmune+disorders%3A+a+review+of+the+literature&amp;rft.au=Hsu+LN%2C+Armstrong+AW.&amp;rft.aulast=Hsu+LN%2C+Armstrong+AW.&amp;rft.date=November+2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jaad.2012.01.029&amp;rft_id=info%3Apmid%2F23062896&amp;rft.issue=5&amp;rft.jtitle=J+Am+Acad+Dermatol&amp;rft.pages=1076%E2%80%939&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation journal">Benoit S, Hamm H (2007). "Childhood Psoriasis". <i>Clinics in Dermatology</i> <b>25</b> (6): 555–562. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.clindermatol.2007.08.009">10.1016/j.clindermatol.2007.08.009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18021892">18021892</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Childhood+Psoriasis&amp;rft.au=Benoit+S%2C+Hamm+H&amp;rft.aulast=Benoit+S%2C+Hamm+H&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clindermatol.2007.08.009&amp;rft_id=info%3Apmid%2F18021892&amp;rft.issue=6&amp;rft.jtitle=Clinics+in+Dermatology&amp;rft.pages=555%E2%80%93562&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gruber2004-85"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gruber2004_85-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gruber2004_85-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Gruber2004_85-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Gruber2004_85-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Gruber2004_85-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Gruber2004_85-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gruber F, Kastelan M, Brajac I (2004). "Psoriasis treatment--yesterday, today, and tomorrow". <i>Acta Dermatovenereol Croat</i> <b>12</b> (1): 30–4. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15072746">15072746</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+treatment--yesterday%2C+today%2C+and+tomorrow&amp;rft.au=Gruber+F%2C+Kastelan+M%2C+Brajac+I&amp;rft.aulast=Gruber+F%2C+Kastelan+M%2C+Brajac+I&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15072746&amp;rft.issue=1&amp;rft.jtitle=Acta+Dermatovenereol+Croat&amp;rft.pages=30%E2%80%934&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation journal">Meenan FO (March 1955). "A note on the history of psoriasis". <i>Ir J Med Sci</i> (351): 141–2. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14353580">14353580</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=A+note+on+the+history+of+psoriasis&amp;rft.aulast=Meenan+FO&amp;rft.au=Meenan+FO&amp;rft.date=March+1955&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14353580&amp;rft.issue=351&amp;rft.jtitle=Ir+J+Med+Sci&amp;rft.pages=141%E2%80%932&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Benedek2013-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-Benedek2013_87-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Benedek TG (June 2013). "Psoriasis and psoriatic arthropathy, historical aspects: part I". <i>J Clin Rheumatol</i> <b>19</b> (4): 193–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FRHU.0b013e318293eaeb">10.1097/RHU.0b013e318293eaeb</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23669809">23669809</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+and+psoriatic+arthropathy%2C+historical+aspects%3A+part+I&amp;rft.au=Benedek+TG&amp;rft.aulast=Benedek+TG&amp;rft.date=June+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FRHU.0b013e318293eaeb&amp;rft_id=info%3Apmid%2F23669809&amp;rft.issue=4&amp;rft.jtitle=J+Clin+Rheumatol&amp;rft.pages=193%E2%80%938&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Benedek2013_Part_2-88"><span class="mw-cite-backlink">^ <a href="#cite_ref-Benedek2013_Part_2_88-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Benedek2013_Part_2_88-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Benedek TG (June 2013). "Psoriasis and psoriatic arthropathy: historical aspects: part II". <i>J Clin Rheumatol</i> <b>19</b> (5): 267–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FRHU.0b013e31829d4ad4">10.1097/RHU.0b013e31829d4ad4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23872545">23872545</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Psoriasis+and+psoriatic+arthropathy%3A+historical+aspects%3A+part+II&amp;rft.au=Benedek+TG&amp;rft.aulast=Benedek+TG&amp;rft.date=June+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FRHU.0b013e31829d4ad4&amp;rft_id=info%3Apmid%2F23872545&amp;rft.issue=5&amp;rft.jtitle=J+Clin+Rheumatol&amp;rft.pages=267%E2%80%9371&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.ifpa-pso.org/">International Federation of Psoriasis Associations</a>. Ifpa-pso.org. Retrieved on 2013-06-08.</span></li>
<li id="cite_note-Dubois2013-90"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dubois2013_90-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dubois2013_90-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Dubois2013_90-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dubois Declercq S, Pouliot R. (July 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3713318">"Promising new treatments for psoriasis"</a>. <i>ScientificWorldJournal</i> <b>2013</b> (980419). <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2013%2F980419">10.1155/2013/980419</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3713318">3713318</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23935446">23935446</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Promising+new+treatments+for+psoriasis&amp;rft.au=Dubois+Declercq+S%2C+Pouliot+R.&amp;rft.aulast=Dubois+Declercq+S%2C+Pouliot+R.&amp;rft.date=July+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3713318&amp;rft_id=info%3Adoi%2F10.1155%2F2013%2F980419&amp;rft_id=info%3Apmc%2F3713318&amp;rft_id=info%3Apmid%2F23935446&amp;rft.issue=980419&amp;rft.jtitle=ScientificWorldJournal&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2013" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Patel2012-91"><span class="mw-cite-backlink">^ <a href="#cite_ref-Patel2012_91-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Patel2012_91-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Patel2012_91-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Patel2012_91-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Patel M, Day A, Warren RB, Menter A (December 2012). <a rel="nofollow" class="external text" href="http://link.springer.com/article/10.1007%2Fs13555-012-0016-4/fulltext.html">"Emerging Therapies for the Treatment of Psoriasis"</a>. <i>Dermatol There (Heidelb)</i> <b>2</b> (1): 16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs13555-012-0016-4">10.1007/s13555-012-0016-4</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3510410">3510410</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23205338">23205338</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.atitle=Emerging+Therapies+for+the+Treatment+of+Psoriasis&amp;rft.aulast=Patel+M%2C+Day+A%2C+Warren+RB%2C+Menter+A&amp;rft.au=Patel+M%2C+Day+A%2C+Warren+RB%2C+Menter+A&amp;rft.date=December+2012&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%252Fs13555-012-0016-4%2Ffulltext.html&amp;rft_id=info%3Adoi%2F10.1007%2Fs13555-012-0016-4&amp;rft_id=info%3Apmc%2F3510410&amp;rft_id=info%3Apmid%2F23205338&amp;rft.issue=1&amp;rft.jtitle=Dermatol+There+%28Heidelb%29&amp;rft.pages=16&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="Further_reading">Further reading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=32" title="Edit section: Further reading">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><span class="citation book">Baker, Barbara S. (2008). <a rel="nofollow" class="external text" href="http://books.google.com/books?id=W8HZtSkDhXgC&amp;pg=PP1#v=onepage"><i>From Arsenic to Biologicals: A 200 Year History of Psoriasis</i></a>. Beckenham UK: Garner Press. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-9551603-2-4" title="Special:BookSources/0-9551603-2-4">0-9551603-2-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.au=Baker%2C+Barbara+S.&amp;rft.aufirst=Barbara+S.&amp;rft.aulast=Baker&amp;rft.btitle=From+Arsenic+to+Biologicals%3A+A+200+Year+History+of+Psoriasis&amp;rft.date=2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DW8HZtSkDhXgC%26pg%3DPP1%23v%3Donepage&amp;rft.isbn=0-9551603-2-4&amp;rft.place=Beckenham+UK&amp;rft.pub=Garner+Press&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Psoriasis&amp;action=edit&amp;section=33" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata mbox-small plainlinks" style="border:1px solid #aaa; background-color:#f9f9f9;">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" /></td>
<td class="mbox-text plainlist" style="">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Psoriasis" class="extiw" title="commons:Category:Psoriasis">Psoriasis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.dmoz.org/Health/Conditions_and_Diseases/Skin_Disorders/Psoriasis/">Psoriasis</a> on the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><span class="citation web"><a rel="nofollow" class="external text" href="http://www.aad.org/education/clinical-guidelines/current-and-upcoming-guidelines">"Guidelines for the care and treatment of psoriasis and psoriatic arthritis"</a>. U.S. <a href="/wiki/National_Guideline_Clearinghouse" title="National Guideline Clearinghouse">National Guideline Clearinghouse</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.btitle=Guidelines+for+the+care+and+treatment+of+psoriasis+and+psoriatic+arthritis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.aad.org%2Feducation%2Fclinical-guidelines%2Fcurrent-and-upcoming-guidelines&amp;rft.pub=U.S.+National+Guideline+Clearinghouse&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
<li><span class="citation web"><a rel="nofollow" class="external text" href="http://www.guideline.gov/content.aspx?id=38575">"Guidelines for the assessment and management of psoriasis"</a>. U.S. <a href="/wiki/National_Guideline_Clearinghouse" title="National Guideline Clearinghouse">National Guideline Clearinghouse</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APsoriasis&amp;rft.btitle=Guidelines+for+the+assessment+and+management+of+psoriasis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.guideline.gov%2Fcontent.aspx%3Fid%3D38575&amp;rft.pub=U.S.+National+Guideline+Clearinghouse&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
<table cellspacing="0" class="navbox" style="border-spacing:0;line-height: 1.3;;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Diseases_of_the_skin_and_appendages_by_morphology" title="Template:Diseases of the skin and appendages by morphology"><span title="View this template" style=";background:Silver;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Diseases_of_the_skin_and_appendages_by_morphology" title="Template talk:Diseases of the skin and appendages by morphology"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Diseases_of_the_skin_and_appendages_by_morphology&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;">Diseases of the skin and appendages by morphology</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: linen; text-align:left;;">Growths</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Epidermis_(skin)" title="Epidermis (skin)">Epidermal</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Wart" title="Wart">wart</a></li>
<li><a href="/wiki/Callus" title="Callus">callus</a></li>
<li><a href="/wiki/Seborrheic_keratosis" title="Seborrheic keratosis">seborrheic keratosis</a></li>
<li><a href="/wiki/Acrochordon" title="Acrochordon">acrochordon</a></li>
<li><a href="/wiki/Molluscum_contagiosum" title="Molluscum contagiosum">molluscum contagiosum</a></li>
<li><a href="/wiki/Actinic_keratosis" title="Actinic keratosis">actinic keratosis</a></li>
<li><a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma" class="mw-redirect">squamous cell carcinoma</a></li>
<li><a href="/wiki/Basal_cell_carcinoma" title="Basal cell carcinoma" class="mw-redirect">basal cell carcinoma</a></li>
<li><a href="/wiki/Merkel_cell_cancer" title="Merkel cell cancer" class="mw-redirect">merkel cell carcinoma</a></li>
<li><a href="/wiki/Nevus_sebaceous" title="Nevus sebaceous">nevus sebaceous</a></li>
<li><a href="/wiki/Trichoepithelioma" title="Trichoepithelioma">trichoepithelioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Pigmented</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Freckle" title="Freckle">Freckles</a></li>
<li><a href="/wiki/Lentigo" title="Lentigo">lentigo</a></li>
<li><a href="/wiki/Melasma" title="Melasma">melasma</a></li>
<li><a href="/wiki/Nevus" title="Nevus">nevus</a></li>
<li><a href="/wiki/Melanoma" title="Melanoma">melanoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dermis" title="Dermis">Dermal</a> and<br />
subcutaneous</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Epidermoid_cyst" title="Epidermoid cyst">epidermal inclusion cyst</a></li>
<li><a href="/wiki/Hemangioma" title="Hemangioma">hemangioma</a></li>
<li><a href="/wiki/Dermatofibroma" title="Dermatofibroma" class="mw-redirect">dermatofibroma</a></li>
<li><a href="/wiki/Keloid" title="Keloid">keloid</a></li>
<li><a href="/wiki/Lipoma" title="Lipoma">lipoma</a></li>
<li><a href="/wiki/Neurofibroma" title="Neurofibroma">neurofibroma</a></li>
<li><a href="/wiki/Xanthoma" title="Xanthoma">xanthoma</a></li>
<li><a href="/wiki/Kaposi%27s_sarcoma" title="Kaposi's sarcoma">Kaposi's sarcoma</a></li>
<li><a href="/wiki/Infantile_digital_fibromatosis" title="Infantile digital fibromatosis">infantile digital fibromatosis</a></li>
<li><a href="/wiki/Granular_cell_tumor" title="Granular cell tumor">granular cell tumor</a></li>
<li><a href="/wiki/Leiomyoma" title="Leiomyoma">leiomyoma</a></li>
<li><a href="/wiki/Lymphangioma_circumscriptum" title="Lymphangioma circumscriptum">lymphangioma circumscriptum</a></li>
<li><a href="/wiki/Myxoid_cyst" title="Myxoid cyst">myxoid cyst</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: linen; text-align:left;;"><a href="/wiki/Rash" title="Rash">Rashes</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">With<br />
epidermal<br />
involvement</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Eczematous</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Contact_dermatitis" title="Contact dermatitis">contact dermatitis</a></li>
<li><a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">atopic dermatitis</a></li>
<li><a href="/wiki/Seborrhoeic_dermatitis" title="Seborrhoeic dermatitis">seborrheic dermatitis</a></li>
<li><a href="/wiki/Stasis_dermatitis" title="Stasis dermatitis">stasis dermatitis</a></li>
<li><a href="/wiki/Lichen_simplex_chronicus" title="Lichen simplex chronicus">lichen simplex chronicus</a></li>
<li><a href="/wiki/Darier%27s_disease" title="Darier's disease">Darier's disease</a></li>
<li><a href="/wiki/Glucagonoma_syndrome" title="Glucagonoma syndrome" class="mw-redirect">glucagonoma syndrome</a></li>
<li><a href="/wiki/Langerhans_cell_histiocytosis" title="Langerhans cell histiocytosis">langerhans cell histiocytosis</a></li>
<li><a href="/wiki/Lichen_sclerosus" title="Lichen sclerosus">lichen sclerosus</a></li>
<li><a href="/wiki/Pemphigus" title="Pemphigus">pemphigus foliaceus</a></li>
<li><a href="/wiki/Wiskott-Aldrich_syndrome" title="Wiskott-Aldrich syndrome" class="mw-redirect">Wiskott-Aldrich syndrome</a></li>
<li><a href="/wiki/Zinc_deficiency" title="Zinc deficiency">Zinc deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Scale_(dermatology)" title="Scale (dermatology)" class="mw-redirect">Scaling</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><strong class="selflink">psoriasis</strong></li>
<li>tinea (<a href="/wiki/Tinea_corporis" title="Tinea corporis">corporis</a></li>
<li><a href="/wiki/Tinea_cruris" title="Tinea cruris">cruris</a></li>
<li><a href="/wiki/Athlete%27s_foot" title="Athlete's foot">pedis</a></li>
<li><a href="/wiki/Tinea_manuum" title="Tinea manuum">manuum</a></li>
<li><a href="/wiki/Tinea_faciei" title="Tinea faciei">faciei</a>)</li>
<li><a href="/wiki/Pityriasis_rosea" title="Pityriasis rosea">pityriasis rosea</a></li>
<li><a href="/wiki/Syphilis" title="Syphilis">secondary syphilis</a></li>
<li><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">mycosis fungoides</a></li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a></li>
<li><a href="/wiki/Pityriasis_rubra_pilaris" title="Pityriasis rubra pilaris">pityriasis rubra pilaris</a></li>
<li><a href="/wiki/Parapsoriasis" title="Parapsoriasis">parapsoriasis</a></li>
<li><a href="/wiki/Ichthyosis" title="Ichthyosis">ichthyosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Blister" title="Blister">Blistering</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Herpes_simplex" title="Herpes simplex">herpes simplex</a></li>
<li><a href="/wiki/Herpes_zoster" title="Herpes zoster">herpes zoster</a></li>
<li><a href="/wiki/Chickenpox" title="Chickenpox">varicella</a></li>
<li><a href="/wiki/Impetigo" title="Impetigo">bullous impetigo</a></li>
<li><a href="/wiki/Contact_dermatitis" title="Contact dermatitis">acute contact dermatitis</a></li>
<li><a href="/wiki/Pemphigus_vulgaris" title="Pemphigus vulgaris">pemphigus vulgaris</a></li>
<li><a href="/wiki/Bullous_pemphigoid" title="Bullous pemphigoid">bullous pemphigoid</a></li>
<li><a href="/wiki/Dermatitis_herpetiformis" title="Dermatitis herpetiformis">dermatitis herpetiformis</a></li>
<li><a href="/wiki/Porphyria_cutanea_tarda" title="Porphyria cutanea tarda">porphyria cutanea tarda</a></li>
<li><a href="/wiki/Epidermolysis_bullosa_simplex" title="Epidermolysis bullosa simplex">epidermolysis bullosa simplex</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Papule" title="Papule">Papular</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Scabies" title="Scabies">scabies</a></li>
<li><a href="/wiki/Insect_bites_and_stings" title="Insect bites and stings">insect bite reactions</a></li>
<li><a href="/wiki/Lichen_planus" title="Lichen planus">lichen planus</a></li>
<li><a href="/wiki/Miliaria" title="Miliaria">miliaria</a></li>
<li><a href="/wiki/Keratosis_pilaris" title="Keratosis pilaris">keratosis pilaris</a></li>
<li><a href="/wiki/Lichen_spinulosus" title="Lichen spinulosus">lichen spinulosus</a></li>
<li><a href="/wiki/Transient_acantholytic_dermatosis" title="Transient acantholytic dermatosis">transient acantholytic dermatosis</a></li>
<li><a href="/wiki/Lichen_nitidus" title="Lichen nitidus">lichen nitidus</a></li>
<li><a href="/wiki/Pityriasis_lichenoides_et_varioliformis_acuta" title="Pityriasis lichenoides et varioliformis acuta">pityriasis lichenoides et varioliformis acuta</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pustule" title="Pustule" class="mw-redirect">Pustular</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Acne_vulgaris" title="Acne vulgaris">acne vulgaris</a></li>
<li><a href="/wiki/Acne_rosacea" title="Acne rosacea" class="mw-redirect">acne rosacea</a></li>
<li><a href="/wiki/Folliculitis" title="Folliculitis">folliculitis</a></li>
<li><a href="/wiki/Impetigo" title="Impetigo">impetigo</a></li>
<li><a href="/wiki/Candidiasis" title="Candidiasis">candidiasis</a></li>
<li><a href="/wiki/Neisseria_gonorrhoeae" title="Neisseria gonorrhoeae">gonococcemia</a></li>
<li><a href="/wiki/Dermatophyte" title="Dermatophyte">dermatophyte</a></li>
<li><a href="/wiki/Coccidioidomycosis" title="Coccidioidomycosis">coccidioidomycosis</a></li>
<li><a href="/wiki/Subcorneal_pustular_dermatosis" title="Subcorneal pustular dermatosis" class="mw-redirect">subcorneal pustular dermatosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Hypopigmented</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Tinea_versicolor" title="Tinea versicolor">tinea versicolor</a></li>
<li><a href="/wiki/Vitiligo" title="Vitiligo">vitiligo</a></li>
<li><a href="/wiki/Pityriasis_alba" title="Pityriasis alba">pityriasis alba</a></li>
<li><a href="/wiki/Postinflammatory_hyperpigmentation" title="Postinflammatory hyperpigmentation">postinflammatory hyperpigmentation</a></li>
<li><a href="/wiki/Tuberous_sclerosis" title="Tuberous sclerosis">tuberous sclerosis</a></li>
<li><a href="/wiki/Idiopathic_guttate_hypomelanosis" title="Idiopathic guttate hypomelanosis">idiopathic guttate hypomelanosis</a></li>
<li><a href="/wiki/Leprosy" title="Leprosy">leprosy</a></li>
<li><a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">hypopigmented mycosis fungoides</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Without<br />
epidermal<br />
involvement</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Red</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Blanchable<br />
<a href="/wiki/Erythema" title="Erythema">Erythema</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Generalized</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Drug_eruption" title="Drug eruption">drug eruptions</a></li>
<li><a href="/wiki/Exanthem" title="Exanthem">viral exanthems</a></li>
<li><a href="/wiki/Toxic_erythema" title="Toxic erythema" class="mw-redirect">toxic erythema</a></li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Localized</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Cellulitis" title="Cellulitis">cellulitis</a></li>
<li><a href="/wiki/Abscess" title="Abscess">abscess</a></li>
<li><a href="/wiki/Boil" title="Boil">boil</a></li>
<li><a href="/wiki/Erythema_nodosum" title="Erythema nodosum">erythema nodosum</a></li>
<li><a href="/wiki/Carcinoid_syndrome" title="Carcinoid syndrome">carcinoid syndrome</a></li>
<li><a href="/wiki/Fixed_drug_eruption" title="Fixed drug eruption" class="mw-redirect">fixed drug eruption</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Specialized</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Urticaria" title="Urticaria">urticaria</a></li>
<li>erythema (<a href="/wiki/Erythema_multiforme" title="Erythema multiforme">multiforme</a></li>
<li><a href="/wiki/Erythema_chronicum_migrans" title="Erythema chronicum migrans">migrans</a></li>
<li><a href="/wiki/Erythema_gyratum_repens" title="Erythema gyratum repens">gyratum repens</a></li>
<li><a href="/wiki/Erythema_annulare_centrifugum" title="Erythema annulare centrifugum">annulare centrifugum</a></li>
<li><a href="/wiki/Erythema_ab_igne" title="Erythema ab igne">ab igne</a>)</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Nonblanchable<br />
Purpura</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Macular</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Thrombocytopenic_purpura" title="Thrombocytopenic purpura">thrombocytopenic purpura</a></li>
<li><a href="/wiki/Actinic_purpura" title="Actinic purpura" class="mw-redirect">actinic purpura</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Papular</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Disseminated_intravascular_coagulation" title="Disseminated intravascular coagulation">disseminated intravascular coagulation</a></li>
<li><a href="/wiki/Vasculitis" title="Vasculitis">vasculitis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;">Indurated</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Scleroderma" title="Scleroderma">scleroderma</a>/<a href="/wiki/Morphea" title="Morphea">morphea</a></li>
<li><a href="/wiki/Granuloma_annulare" title="Granuloma annulare">granuloma annulare</a></li>
<li><a href="/wiki/Lichen_sclerosus" title="Lichen sclerosus">lichen sclerosis et atrophicus</a></li>
<li><a href="/wiki/Necrobiosis_lipoidica" title="Necrobiosis lipoidica">necrobiosis lipoidica</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: linen; text-align:left;;">Miscellaneous<br />
disorders</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ulcer_(dermatology)" title="Ulcer (dermatology)">Ulcers</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hair" title="Hair">Hair</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Telogen_effluvium" title="Telogen effluvium">telogen effluvium</a></li>
<li><a href="/wiki/Androgenic_alopecia" title="Androgenic alopecia">androgenic alopecia</a></li>
<li><a href="/wiki/Trichotillomania" title="Trichotillomania">trichotillomania</a></li>
<li><a href="/wiki/Alopecia_areata" title="Alopecia areata">alopecia areata</a></li>
<li><a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a></li>
<li><a href="/wiki/Tinea_capitis" title="Tinea capitis">tinea capitis</a></li>
<li><a href="/wiki/Loose_anagen_syndrome" title="Loose anagen syndrome">loose anagen syndrome</a></li>
<li><a href="/wiki/Lichen_planopilaris" title="Lichen planopilaris" class="mw-redirect">lichen planopilaris</a></li>
<li><a href="/wiki/Folliculitis_decalvans" title="Folliculitis decalvans">folliculitis decalvans</a></li>
<li><a href="/wiki/Pseudofolliculitis_barbae" title="Pseudofolliculitis barbae">acne keloidalis nuchae</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Nail_(anatomy)" title="Nail (anatomy)">Nail</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Onychomycosis" title="Onychomycosis">onychomycosis</a></li>
<li><strong class="selflink">psoriasis</strong></li>
<li><a href="/wiki/Paronychia" title="Paronychia">paronychia</a></li>
<li><a href="/wiki/Ingrown_nail" title="Ingrown nail">ingrown nail</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: linen; text-align:left;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Mucous_membrane" title="Mucous membrane">Mucous<br />
membrane</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Aphthous_ulcer" title="Aphthous ulcer" class="mw-redirect">aphthous stomatitis</a></li>
<li><a href="/wiki/Oral_candidiasis" title="Oral candidiasis">oral candidiasis</a></li>
<li><a href="/wiki/Lichen_planus" title="Lichen planus">lichen planus</a></li>
<li><a href="/wiki/Leukoplakia" title="Leukoplakia">leukoplakia</a></li>
<li><a href="/wiki/Pemphigus" title="Pemphigus">pemphigus vulgaris</a></li>
<li><a href="/wiki/Mucous_membrane_pemphigoid" title="Mucous membrane pemphigoid" class="mw-redirect">mucous membrane pemphigoid</a></li>
<li><a href="/wiki/Mucous_membrane_pemphigoid" title="Mucous membrane pemphigoid" class="mw-redirect">cicatricial pemphigoid</a></li>
<li><a href="/wiki/Herpesviridae" title="Herpesviridae">herpesvirus</a></li>
<li><a href="/wiki/Coxsackievirus" title="Coxsackievirus">coxsackievirus</a></li>
<li><a href="/wiki/Syphilis" title="Syphilis">syphilis</a></li>
<li><a href="/wiki/Histoplasmosis" title="Histoplasmosis">systemic histoplasmosis</a></li>
<li><a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma" class="mw-redirect">squamous cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver;">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Papulosquamous_disorders" title="Template:Papulosquamous disorders"><span title="View this template" style=";background:Silver;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Papulosquamous_disorders" title="Template talk:Papulosquamous disorders"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Papulosquamous_disorders&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;"><a href="/wiki/Papulosquamous_disorder" title="Papulosquamous disorder">Papulosquamous disorders</a> (<a href="/wiki/ICD-10_Chapter_XII:_Diseases_of_the_skin_and_subcutaneous_tissue#.28L40.E2.80.93L45.29_Papulosquamous_disorders" title="ICD-10 Chapter XII: Diseases of the skin and subcutaneous tissue">L40–L45</a>, <a href="/wiki/List_of_ICD-9_codes_680%E2%80%93709:_diseases_of_the_skin_and_subcutaneous_tissue#Other_inflammatory_conditions_of_skin_and_subcutaneous_tissue_.28690.E2.80.93698.29" title="List of ICD-9 codes 680–709: diseases of the skin and subcutaneous tissue">696–697</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: Linen;"><strong class="selflink">Psoriasis</strong></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;"><a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">Pustular</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"><a href="/wiki/Generalized_pustular_psoriasis" title="Generalized pustular psoriasis">Generalized pustular psoriasis</a> (<a href="/wiki/Impetigo_herpetiformis" title="Impetigo herpetiformis">Impetigo herpetiformis</a>)&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Acropustulosis" title="Acropustulosis">Acropustulosis</a>/<a href="/wiki/Pustulosis_palmaris_et_plantaris" title="Pustulosis palmaris et plantaris">Pustulosis palmaris et plantaris</a> (<a href="/wiki/Pustular_bacterid" title="Pustular bacterid">Pustular bacterid</a>)&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Annular_pustular_psoriasis" title="Annular pustular psoriasis">Annular pustular psoriasis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Localized_pustular_psoriasis" title="Localized pustular psoriasis">Localized pustular psoriasis</a></div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<div><a href="/wiki/Guttate_psoriasis" title="Guttate psoriasis">Guttate psoriasis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Psoriatic_arthritis" title="Psoriatic arthritis">Psoriatic arthritis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Psoriatic_erythroderma" title="Psoriatic erythroderma">Psoriatic erythroderma</a></div>
<div><a href="/wiki/Drug-induced_psoriasis" title="Drug-induced psoriasis" class="mw-redirect">Drug-induced psoriasis</a>&#160;<span style="font-weight:bold;">·</span> <a href="/wiki/Inverse_psoriasis" title="Inverse psoriasis">Inverse psoriasis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Napkin_psoriasis" title="Napkin psoriasis">Napkin psoriasis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Seborrheic-like_psoriasis" title="Seborrheic-like psoriasis">Seborrheic-like psoriasis</a></div>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: Linen;"><a href="/wiki/Parapsoriasis" title="Parapsoriasis">Parapsoriasis</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"><a href="/wiki/Pityriasis_lichenoides" title="Pityriasis lichenoides">Pityriasis lichenoides</a> (<a href="/wiki/Pityriasis_lichenoides_et_varioliformis_acuta" title="Pityriasis lichenoides et varioliformis acuta">Pityriasis lichenoides et varioliformis acuta</a>, <a href="/wiki/Pityriasis_lichenoides_chronica" title="Pityriasis lichenoides chronica">Pityriasis lichenoides chronica</a>)&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Small_plaque_parapsoriasis" title="Small plaque parapsoriasis">Small plaque parapsoriasis</a> (<a href="/wiki/Digitate_dermatosis" title="Digitate dermatosis">Digitate dermatosis</a>, <a href="/wiki/Xanthoerythrodermia_perstans" title="Xanthoerythrodermia perstans" class="mw-redirect">Xanthoerythrodermia perstans</a>)&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Large_plaque_parapsoriasis" title="Large plaque parapsoriasis">Large plaque parapsoriasis</a> (<a href="/wiki/Retiform_parapsoriasis" title="Retiform parapsoriasis">Retiform parapsoriasis</a>)</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: Linen;">Other <a href="/wiki/Pityriasis" title="Pityriasis">pityriasis</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"><a href="/wiki/Pityriasis_rosea" title="Pityriasis rosea">Pityriasis rosea</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Pityriasis_rubra_pilaris" title="Pityriasis rubra pilaris">Pityriasis rubra pilaris</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Pityriasis_rotunda" title="Pityriasis rotunda">Pityriasis rotunda</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Pityriasis_amiantacea" title="Pityriasis amiantacea">Pityriasis amiantacea</a></div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: Linen;">Other <a href="/wiki/Lichenoid_eruption" title="Lichenoid eruption">lichenoid</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lichen_planus" title="Lichen planus">Lichen planus</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>configuration</i>
<ul>
<li><a href="/wiki/Annular_lichen_planus" title="Annular lichen planus" class="mw-redirect">Annular</a></li>
<li><a href="/wiki/Linear_lichen_planus" title="Linear lichen planus" class="mw-redirect">Linear</a></li>
</ul>
</li>
<li><i>morphology</i>
<ul>
<li><a href="/wiki/Hypertrophic_lichen_planus" title="Hypertrophic lichen planus" class="mw-redirect">Hypertrophic</a></li>
<li><a href="/wiki/Atrophic_lichen_planus" title="Atrophic lichen planus" class="mw-redirect">Atrophic</a></li>
<li><a href="/wiki/Bullous_lichen_planus" title="Bullous lichen planus" class="mw-redirect">Bullous</a></li>
<li><a href="/wiki/Ulcerative_lichen_planus" title="Ulcerative lichen planus" class="mw-redirect">Ulcerative</a></li>
<li><a href="/wiki/Lichen_planus_actinicus" title="Lichen planus actinicus" class="mw-redirect">Actinic</a></li>
<li><a href="/wiki/Lichen_planus_pigmentosus" title="Lichen planus pigmentosus" class="mw-redirect">Pigmented</a></li>
</ul>
</li>
<li><i>site</i>
<ul>
<li><a href="/wiki/Mucosal_lichen_planus" title="Mucosal lichen planus" class="mw-redirect">Mucosal</a></li>
<li><a href="/wiki/Lichen_planus_of_the_nails" title="Lichen planus of the nails" class="mw-redirect">Nails</a></li>
<li><a href="/wiki/Peno-gingival_syndrome" title="Peno-gingival syndrome" class="mw-redirect">Peno-ginival</a></li>
<li><a href="/wiki/Vulvovaginal_gingival_syndrome" title="Vulvovaginal gingival syndrome" class="mw-redirect">Vulvovaginal</a></li>
</ul>
</li>
<li><i>overlap synromes</i>
<ul>
<li><a href="/wiki/Lichen_planus%E2%80%93lichen_sclerosus_overlap_syndrome" title="Lichen planus–lichen sclerosus overlap syndrome" class="mw-redirect">with lichen sclerosus</a></li>
<li><a href="/wiki/Lupus_erythematosus%E2%80%93lichen_planus_overlap_syndrome" title="Lupus erythematosus–lichen planus overlap syndrome" class="mw-redirect">with lupus erythematosis</a></li>
</ul>
</li>
<li><i>other:</i>
<ul>
<li><a href="/wiki/Hepatitis-associated_lichen_planus" title="Hepatitis-associated lichen planus" class="mw-redirect">Hepatitis-associated lichen planus</a></li>
<li><a href="/wiki/Lichen_planus_pemphigoides" title="Lichen planus pemphigoides" class="mw-redirect">Lichen planus pemphigoides</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background-color: Linen;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<div><a href="/wiki/Lichen_nitidus" title="Lichen nitidus">Lichen nitidus</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lichen_striatus" title="Lichen striatus">Lichen striatus</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lichen_ruber_moniliformis" title="Lichen ruber moniliformis">Lichen ruber moniliformis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Gianotti%E2%80%93Crosti_syndrome" title="Gianotti–Crosti syndrome">Gianotti–Crosti syndrome</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Erythema_dyschromicum_perstans" title="Erythema dyschromicum perstans">Erythema dyschromicum perstans</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Idiopathic_eruptive_macular_pigmentation" title="Idiopathic eruptive macular pigmentation">Idiopathic eruptive macular pigmentation</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Keratosis_lichenoides_chronica" title="Keratosis lichenoides chronica" class="mw-redirect">Keratosis lichenoides chronica</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Kraurosis_vulvae" title="Kraurosis vulvae">Kraurosis vulvae</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lichen_sclerosus" title="Lichen sclerosus">Lichen sclerosus</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lichenoid_dermatitis" title="Lichenoid dermatitis" class="mw-redirect">Lichenoid dermatitis</a>&#160;<span style="font-weight:bold;">·</span>  <a href="/wiki/Lichenoid_reaction_of_graft-versus-host_disease" title="Lichenoid reaction of graft-versus-host disease" class="mw-redirect">Lichenoid reaction of graft-versus-host disease</a></div>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:Linen;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Integumentary_system" title="Integumentary system">INT</a>, <a href="/wiki/Superficial_fascia" title="Superficial fascia">SF</a>, <a href="/wiki/Loose_connective_tissue" title="Loose connective tissue">LCT</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Integumentary_system" title="Template:Integumentary system">anat</a>/<a href="/wiki/Template:Integumentary_physiology" title="Template:Integumentary physiology">phys</a>/<a href="/wiki/Template:Development_of_integument" title="Template:Development of integument">devp</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p>noco (<a href="/wiki/Template:Bacterial_cutaneous_infections" title="Template:Bacterial cutaneous infections">i</a>/<a href="/wiki/Template:Vesiculobullous_disease" title="Template:Vesiculobullous disease">b</a>/<a href="/wiki/Template:Dermatitis_and_eczema" title="Template:Dermatitis and eczema">d</a>/<a href="/wiki/Template:Papulosquamous_disorders" title="Template:Papulosquamous disorders">q</a>/<a href="/wiki/Template:Urticaria_and_erythema" title="Template:Urticaria and erythema">u</a>/<a href="/wiki/Template:Radiation-related_disorders" title="Template:Radiation-related disorders">r</a>/<a href="/wiki/Template:Pigmentation_disorders" title="Template:Pigmentation disorders">p</a>/<a href="/wiki/Template:Mucinoses" title="Template:Mucinoses">m</a>/<a href="/wiki/Template:Cutaneous_keratosis,_ulcer,_atrophy,_and_necrobiosis" title="Template:Cutaneous keratosis, ulcer, atrophy, and necrobiosis">k</a>/<a href="/wiki/Template:Cutaneous_vasculitis" title="Template:Cutaneous vasculitis">v</a>/<a href="/wiki/Template:Disorders_of_subcutaneous_fat" title="Template:Disorders of subcutaneous fat">f</a>)/<a href="/wiki/Template:Congenital_malformations_and_deformations_of_integument" title="Template:Congenital malformations and deformations of integument">cong</a>/tumr (<a href="/wiki/Template:Skin_tumors,_nevi_and_melanomas" title="Template:Skin tumors, nevi and melanomas">n</a>/<a href="/wiki/Template:Skin_tumors,_epidermis" title="Template:Skin tumors, epidermis">e</a>/<a href="/wiki/Template:Skin_tumors,_dermis" title="Template:Skin tumors, dermis">d</a>), <a href="/wiki/Template:Skin_and_subcutaneous_tissue_symptoms_and_signs" title="Template:Skin and subcutaneous tissue symptoms and signs">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_integumentary_system" title="Template:Eponymous medical signs for integumentary system">epon</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Skin_and_subcutaneous_tissue_procedures" title="Template:Skin and subcutaneous tissue procedures">proc</a>, <a href="/wiki/ATC_code_D" title="ATC code D">drug</a> (<a href="/wiki/Template:Emollients_and_protectives" title="Template:Emollients and protectives">D2</a>/<a href="/wiki/Template:Preparations_for_treatment_of_wounds_and_ulcers" title="Template:Preparations for treatment of wounds and ulcers">3</a>/<a href="/wiki/Template:Antipruritics" title="Template:Antipruritics">4</a>/<a href="/wiki/Template:Antipsoriatics" title="Template:Antipsoriatics">5</a>/<a href="/wiki/Template:Antiseptics_and_disinfectants" title="Template:Antiseptics and disinfectants">8</a>/<a href="/wiki/Template:Other_dermatological_preparations" title="Template:Other dermatological preparations">11</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<p><span id="interwiki-es-ga"></span></p>


<!-- 
NewPP limit report
Parsed by mw1063
CPU time usage: 6.320 seconds
Real time usage: 6.418 seconds
Preprocessor visited node count: 14036/1000000
Preprocessor generated node count: 45267/1500000
Post‐expand include size: 409498/2048000 bytes
Template argument size: 30193/2048000 bytes
Highest expansion depth: 20/40
Expensive parser function count: 4/500
Lua time usage: 0.360/10.000 seconds
Lua memory usage: 3.11 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:101965-0!*!0!!en!4!* and timestamp 20140328044032
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Psoriasis&amp;oldid=601607406">http://en.wikipedia.org/w/index.php?title=Psoriasis&amp;oldid=601607406</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Psoriasis" title="Category:Psoriasis">Psoriasis</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:CS1_errors:_dates" title="Category:CS1 errors: dates">CS1 errors: dates</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Articles_using_fixed_number_of_columns_in_reflist" title="Category:Articles using fixed number of columns in reflist">Articles using fixed number of columns in reflist</a></li><li><a href="/wiki/Category:Commons_category_template_with_no_category_set" title="Category:Commons category template with no category set">Commons category template with no category set</a></li><li><a href="/wiki/Category:Commons_category_with_page_title_same_as_on_Wikidata" title="Category:Commons category with page title same as on Wikidata">Commons category with page title same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Open_Directory_Project_links" title="Category:Articles with Open Directory Project links">Articles with Open Directory Project links</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Psoriasis&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Psoriasis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Psoriasis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Psoriasis"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Psoriasis" >Read</a></span></li>
					<li id="ca-edit"><span><a href="/w/index.php?title=Psoriasis&amp;action=edit"  title="You can edit this page. &#10;Please review your changes before saving. [e]" accesskey="e">Edit</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Psoriasis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Psoriasis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Psoriasis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Psoriasis&amp;oldid=601607406" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Psoriasis&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q179945" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Psoriasis&amp;id=601607406" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Psoriasis">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Psoriasis&amp;oldid=601607406&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Psoriasis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%B5%D8%AF%D8%A7%D9%81" title="صداف – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-bn"><a href="//bn.wikipedia.org/wiki/%E0%A6%B8%E0%A7%8B%E0%A6%B0%E0%A6%BF%E0%A6%AF%E0%A6%BC%E0%A6%BE%E0%A6%B8%E0%A6%BF%E0%A6%B8" title="সোরিয়াসিস – Bengali" lang="bn" hreflang="bn">বাংলা</a></li>
			<li class="interlanguage-link interwiki-be"><a href="//be.wikipedia.org/wiki/%D0%9F%D1%81%D0%B0%D1%80%D1%8B%D1%8F%D0%B7" title="Псарыяз – Belarusian" lang="be" hreflang="be">Беларуская</a></li>
			<li class="interlanguage-link interwiki-be-x-old"><a href="//be-x-old.wikipedia.org/wiki/%D0%9B%D1%83%D1%81%D0%BA%D0%B0%D0%B2%D0%B0%D1%82%D1%8B_%D0%BB%D1%96%D1%88%D0%B0%D0%B9" title="Лускаваты лішай – беларуская (тарашкевіца)‎" lang="be-x-old" hreflang="be-x-old">Беларуская (тарашкевіца)‎</a></li>
			<li class="interlanguage-link interwiki-bg"><a href="//bg.wikipedia.org/wiki/%D0%9F%D1%81%D0%BE%D1%80%D0%B8%D0%B0%D0%B7%D0%B8%D1%81" title="Псориазис – Bulgarian" lang="bg" hreflang="bg">Български</a></li>
			<li class="interlanguage-link interwiki-bs"><a href="//bs.wikipedia.org/wiki/Psorijaza" title="Psorijaza – Bosnian" lang="bs" hreflang="bs">Bosanski</a></li>
			<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Psoriasi" title="Psoriasi – Catalan" lang="ca" hreflang="ca">Català</a></li>
			<li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Psori%C3%A1za" title="Psoriáza – Czech" lang="cs" hreflang="cs">Čeština</a></li>
			<li class="interlanguage-link interwiki-cy"><a href="//cy.wikipedia.org/wiki/Soriasis" title="Soriasis – Welsh" lang="cy" hreflang="cy">Cymraeg</a></li>
			<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Danish" lang="da" hreflang="da">Dansk</a></li>
			<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Schuppenflechte" title="Schuppenflechte – German" lang="de" hreflang="de">Deutsch</a></li>
			<li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%A8%CF%89%CF%81%CE%AF%CE%B1%CF%83%CE%B7" title="Ψωρίαση – Greek" lang="el" hreflang="el">Ελληνικά</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-eo"><a href="//eo.wikipedia.org/wiki/Psoriazo" title="Psoriazo – Esperanto" lang="eo" hreflang="eo">Esperanto</a></li>
			<li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Psoriasi" title="Psoriasi – Basque" lang="eu" hreflang="eu">Euskara</a></li>
			<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%BE%D8%B3%D9%88%D8%B1%DB%8C%D8%A7%D8%B2%DB%8C%D8%B3" title="پسوریازیس – Persian" lang="fa" hreflang="fa">فارسی</a></li>
			<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Psoriasis" title="Psoriasis – French" lang="fr" hreflang="fr">Français</a></li>
			<li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Soiri%C3%A1is" title="Soiriáis – Irish" lang="ga" hreflang="ga">Gaeilge</a></li>
			<li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EA%B1%B4%EC%84%A0" title="건선 – Korean" lang="ko" hreflang="ko">한국어</a></li>
			<li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%9B%E0%A4%BE%E0%A4%B2_%E0%A4%B0%E0%A5%8B%E0%A4%97" title="छाल रोग – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li>
			<li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Psorijaza" title="Psorijaza – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li>
			<li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Psoriasi" title="Psoriasi – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%A4%D7%A1%D7%95%D7%A8%D7%99%D7%90%D7%96%D7%99%D7%A1" title="פסוריאזיס – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-ka"><a href="//ka.wikipedia.org/wiki/%E1%83%A4%E1%83%A1%E1%83%9D%E1%83%A0%E1%83%98%E1%83%90%E1%83%96%E1%83%98" title="ფსორიაზი – Georgian" lang="ka" hreflang="ka">ქართული</a></li>
			<li class="interlanguage-link interwiki-ky"><a href="//ky.wikipedia.org/wiki/%D0%9A%D0%B0%D0%B1%D1%8B%D1%80%D1%87%D1%8B%D0%BA%D1%82%D1%83%D1%83_%D1%87%D0%B0%D0%BA%D0%B0%D0%BB%D0%B0%D0%B9" title="Кабырчыктуу чакалай – Kyrgyz" lang="ky" hreflang="ky">Кыргызча</a></li>
			<li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/%C5%BDvynelin%C4%97" title="Žvynelinė – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li>
			<li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Pikkelys%C3%B6m%C3%B6r" title="Pikkelysömör – Hungarian" lang="hu" hreflang="hu">Magyar</a></li>
			<li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%9F%D1%81%D0%BE%D1%80%D0%B8%D1%98%D0%B0%D0%B7%D0%B0" title="Псоријаза – Macedonian" lang="mk" hreflang="mk">Македонски</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-ne"><a href="//ne.wikipedia.org/wiki/%E0%A4%B8%E0%A5%8B%E0%A4%B0%E0%A4%BF%E0%A4%AF%E0%A4%BE%E0%A4%B8%E0%A4%BF%E0%A4%B8" title="सोरियासिस – Nepali" lang="ne" hreflang="ne">नेपाली</a></li>
			<li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E4%B9%BE%E7%99%AC" title="乾癬 – Japanese" lang="ja" hreflang="ja">日本語</a></li>
			<li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Norwegian (bokmål)" lang="no" hreflang="no">Norsk bokmål</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/%C5%81uszczyca" title="Łuszczyca – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Psor%C3%ADase" title="Psoríase – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Psoriazis" title="Psoriazis – Romanian" lang="ro" hreflang="ro">Română</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9F%D1%81%D0%BE%D1%80%D0%B8%D0%B0%D0%B7" title="Псориаз – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Simple English" lang="simple" hreflang="simple">Simple English</a></li>
			<li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Luskavica" title="Luskavica – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Psoriasis" title="Psoriasis – Swedish" lang="sv" hreflang="sv">Svenska</a></li>
			<li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%A4%E0%AE%9F%E0%AE%BF%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%A4%E0%AF%8D_%E0%AE%A4%E0%AF%8B%E0%AE%B2%E0%AF%8D_%E0%AE%85%E0%AE%B4%E0%AE%B1%E0%AF%8D%E0%AE%9A%E0%AE%BF" title="தடிப்புத் தோல் அழற்சி – Tamil" lang="ta" hreflang="ta">தமிழ்</a></li>
			<li class="interlanguage-link interwiki-te"><a href="//te.wikipedia.org/wiki/%E0%B0%B8%E0%B1%8B%E0%B0%B0%E0%B0%BF%E0%B0%AF%E0%B0%BE%E0%B0%B8%E0%B0%BF%E0%B0%B8%E0%B1%8D" title="సోరియాసిస్ – Telugu" lang="te" hreflang="te">తెలుగు</a></li>
			<li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%AA%E0%B8%B0%E0%B9%80%E0%B8%81%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%87%E0%B8%B4%E0%B8%99" title="โรคสะเก็ดเงิน – Thai" lang="th" hreflang="th">ไทย</a></li>
			<li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Sedef_hastal%C4%B1%C4%9F%C4%B1" title="Sedef hastalığı – Turkish" lang="tr" hreflang="tr">Türkçe</a></li>
			<li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%9F%D1%81%D0%BE%D1%80%D1%96%D0%B0%D0%B7" title="Псоріаз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li>
			<li class="interlanguage-link interwiki-vi"><a href="//vi.wikipedia.org/wiki/B%E1%BB%87nh_v%E1%BA%A9y_n%E1%BA%BFn" title="Bệnh vẩy nến – Vietnamese" lang="vi" hreflang="vi">Tiếng Việt</a></li>
			<li class="interlanguage-link interwiki-zh-yue"><a href="//zh-yue.wikipedia.org/wiki/%E7%89%9B%E7%9A%AE%E7%99%AC" title="牛皮癬 – Cantonese" lang="zh-yue" hreflang="zh-yue">粵語</a></li>
			<li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%8A%80%E5%B1%91%E7%97%85" title="銀屑病 – Chinese" lang="zh" hreflang="zh">中文</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q179945#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 28 March 2014 at 04:40.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Psoriasis" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mobile.desktop","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1073 in 0.619 secs. -->
	</body>
</html>
